id	sid	tid	token	lemma	pos
dpc-4338	1	1	dermatology	dermatology	NOUN
dpc-4338	1	2	:	:	PUNCT
dpc-4338	1	3	practical	practical	ADJ
dpc-4338	1	4	and	and	CCONJ
dpc-4338	1	5	conceptual	conceptual	ADJ
dpc-4338	1	6	original	original	ADJ
dpc-4338	1	7	article	article	NOUN
dpc-4338	1	8	|	|	ADV
dpc-4338	1	9	dermatol	dermatol	ADJ
dpc-4338	1	10	pract	pract	NOUN
dpc-4338	1	11	concept	concept	NOUN
dpc-4338	1	12	.	.	PUNCT
dpc-4338	2	1	2024;14(4):e2024231	2024;14(4):e2024231	NUM
dpc-4338	2	2	1	1	NUM
dpc-4338	2	3	differential	differential	ADJ
dpc-4338	2	4	diagnosis	diagnosis	NOUN
dpc-4338	2	5	of	of	ADP
dpc-4338	2	6	irritant	irritant	ADJ
dpc-4338	2	7	versus	versus	ADP
dpc-4338	2	8	allergic	allergic	ADJ
dpc-4338	2	9	contact	contact	NOUN
dpc-4338	2	10	dermatitis	dermatitis	NOUN
dpc-4338	2	11	based	base	VERB
dpc-4338	2	12	on	on	ADP
dpc-4338	2	13	noninvasive	noninvasive	ADJ
dpc-4338	2	14	methods	method	NOUN
dpc-4338	2	15	panagiota	panagiota	NOUN
dpc-4338	2	16	gkagkari1	gkagkari1	PROPN
dpc-4338	2	17	,	,	PUNCT
dpc-4338	2	18	anna	anna	PROPN
dpc-4338	2	19	tagka2	tagka2	PROPN
dpc-4338	2	20	,	,	PUNCT
dpc-4338	2	21	alexandros	alexandros	PROPN
dpc-4338	2	22	stratigos2	stratigos2	PROPN
dpc-4338	2	23	,	,	PUNCT
dpc-4338	2	24	vangelis	vangelis	PROPN
dpc-4338	2	25	karalis1	karalis1	PROPN
dpc-4338	2	26	,	,	PUNCT
dpc-4338	2	27	aikaterini	aikaterini	PROPN
dpc-4338	2	28	kyritsi1	kyritsi1	PROPN
dpc-4338	2	29	,	,	PUNCT
dpc-4338	2	30	andreas	andreas	PROPN
dpc-4338	2	31	vitsos1	vitsos1	PROPN
dpc-4338	2	32	,	,	PUNCT
dpc-4338	2	33	michail	michail	ADJ
dpc-4338	2	34	christou	christou	ADJ
dpc-4338	2	35	rallis1	rallis1	NOUN
dpc-4338	2	36	1	1	NUM
dpc-4338	2	37	section	section	NOUN
dpc-4338	2	38	of	of	ADP
dpc-4338	2	39	pharmaceutical	pharmaceutical	NOUN
dpc-4338	2	40	technology	technology	NOUN
dpc-4338	2	41	,	,	PUNCT
dpc-4338	2	42	department	department	NOUN
dpc-4338	2	43	of	of	ADP
dpc-4338	2	44	pharmacy	pharmacy	NOUN
dpc-4338	2	45	,	,	PUNCT
dpc-4338	2	46	school	school	NOUN
dpc-4338	2	47	of	of	ADP
dpc-4338	2	48	health	health	NOUN
dpc-4338	2	49	sciences	sciences	PROPN
dpc-4338	2	50	,	,	PUNCT
dpc-4338	2	51	national	national	ADJ
dpc-4338	2	52	and	and	CCONJ
dpc-4338	2	53	kapodistrian	kapodistrian	ADJ
dpc-4338	2	54	university	university	PROPN
dpc-4338	2	55	of	of	ADP
dpc-4338	2	56	 	 	SPACE
dpc-4338	2	57	athens	athens	PROPN
dpc-4338	2	58	,	,	PUNCT
dpc-4338	2	59	athens	athens	PROPN
dpc-4338	2	60	,	,	PUNCT
dpc-4338	2	61	greece	greece	PROPN
dpc-4338	2	62	2	2	NUM
dpc-4338	2	63	first	first	ADJ
dpc-4338	2	64	department	department	NOUN
dpc-4338	2	65	of	of	ADP
dpc-4338	2	66	dermatology	dermatology	NOUN
dpc-4338	2	67	-	-	PUNCT
dpc-4338	2	68	venereology	venereology	NOUN
dpc-4338	2	69	,	,	PUNCT
dpc-4338	2	70	national	national	ADJ
dpc-4338	2	71	and	and	CCONJ
dpc-4338	2	72	kapodistrian	kapodistrian	ADJ
dpc-4338	2	73	university	university	PROPN
dpc-4338	2	74	of	of	ADP
dpc-4338	2	75	athens	athens	PROPN
dpc-4338	2	76	,	,	PUNCT
dpc-4338	2	77	andreas	andreas	PROPN
dpc-4338	2	78	syggros	syggros	PROPN
dpc-4338	2	79	hospital	hospital	PROPN
dpc-4338	2	80	,	,	PUNCT
dpc-4338	2	81	athens	athens	PROPN
dpc-4338	2	82	,	,	PUNCT
dpc-4338	2	83	greece	greece	PROPN
dpc-4338	2	84	key	key	ADJ
dpc-4338	2	85	words	word	NOUN
dpc-4338	2	86	:	:	PUNCT
dpc-4338	2	87	irritant	irritant	VERB
dpc-4338	2	88	contact	contact	NOUN
dpc-4338	2	89	dermatitis	dermatitis	NOUN
dpc-4338	2	90	,	,	PUNCT
dpc-4338	2	91	allergic	allergic	ADJ
dpc-4338	2	92	contact	contact	NOUN
dpc-4338	2	93	dermatitis	dermatitis	NOUN
dpc-4338	2	94	,	,	PUNCT
dpc-4338	2	95	antera	antera	NOUN
dpc-4338	2	96	®	®	NOUN
dpc-4338	2	97	3d	3d	PROPN
dpc-4338	2	98	camera	camera	NOUN
dpc-4338	2	99	,	,	PUNCT
dpc-4338	2	100	transepidermal	transepidermal	ADJ
dpc-4338	2	101	water	water	NOUN
dpc-4338	2	102	loss	loss	NOUN
dpc-4338	2	103	,	,	PUNCT
dpc-4338	2	104	oxidative	oxidative	ADJ
dpc-4338	2	105	stress	stress	NOUN
dpc-4338	2	106	citation	citation	NOUN
dpc-4338	2	107	:	:	PUNCT
dpc-4338	2	108	gkagkari	gkagkari	PROPN
dpc-4338	2	109	p	p	X
dpc-4338	2	110	,	,	PUNCT
dpc-4338	2	111	tagka	tagka	PROPN
dpc-4338	2	112	a	a	X
dpc-4338	2	113	,	,	PUNCT
dpc-4338	2	114	stratigos	stratigos	PROPN
dpc-4338	2	115	a	a	X
dpc-4338	2	116	,	,	PUNCT
dpc-4338	2	117	et	et	PROPN
dpc-4338	2	118	al	al	PROPN
dpc-4338	2	119	.	.	PROPN
dpc-4338	2	120	differential	differential	ADJ
dpc-4338	2	121	diagnosis	diagnosis	NOUN
dpc-4338	2	122	of	of	ADP
dpc-4338	2	123	irritant	irritant	ADJ
dpc-4338	2	124	versus	versus	ADP
dpc-4338	2	125	allergic	allergic	ADJ
dpc-4338	2	126	contact	contact	NOUN
dpc-4338	2	127	dermatitis	dermatitis	NOUN
dpc-4338	2	128	based	base	VERB
dpc-4338	2	129	on	on	ADP
dpc-4338	2	130	noninvasive	noninvasive	ADJ
dpc-4338	2	131	methods	method	NOUN
dpc-4338	2	132	.	.	PUNCT
dpc-4338	3	1	dermatol	dermatol	NOUN
dpc-4338	3	2	pract	pract	PROPN
dpc-4338	3	3	concept	concept	NOUN
dpc-4338	3	4	.	.	PUNCT
dpc-4338	4	1	2024;14(4):e2024231	2024;14(4):e2024231	X
dpc-4338	4	2	.	.	PUNCT
dpc-4338	4	3	doi	doi	NOUN
dpc-4338	4	4	:	:	PUNCT
dpc-4338	4	5	https://doi.org/10.5826/dpc.1404a231	https://doi.org/10.5826/dpc.1404a231	ADJ
dpc-4338	4	6	accepted	accept	VERB
dpc-4338	4	7	:	:	PUNCT
dpc-4338	4	8	june	june	PROPN
dpc-4338	4	9	19	19	NUM
dpc-4338	4	10	,	,	PUNCT
dpc-4338	4	11	2024	2024	NUM
dpc-4338	4	12	;	;	PUNCT
dpc-4338	4	13	published	publish	VERB
dpc-4338	4	14	:	:	PUNCT
dpc-4338	5	1	october	october	PROPN
dpc-4338	5	2	2024	2024	NUM
dpc-4338	5	3	copyright	copyright	NOUN
dpc-4338	5	4	:	:	PUNCT
dpc-4338	5	5	©	©	PROPN
dpc-4338	5	6	2024	2024	NUM
dpc-4338	5	7	gkagkari	gkagkari	PROPN
dpc-4338	5	8	et	et	PROPN
dpc-4338	5	9	al	al	PROPN
dpc-4338	5	10	.	.	PUNCT
dpc-4338	6	1	this	this	PRON
dpc-4338	6	2	is	be	AUX
dpc-4338	6	3	an	an	DET
dpc-4338	6	4	open	open	ADJ
dpc-4338	6	5	-	-	PUNCT
dpc-4338	6	6	access	access	NOUN
dpc-4338	6	7	article	article	NOUN
dpc-4338	6	8	distributed	distribute	VERB
dpc-4338	6	9	under	under	ADP
dpc-4338	6	10	the	the	DET
dpc-4338	6	11	terms	term	NOUN
dpc-4338	6	12	of	of	ADP
dpc-4338	6	13	the	the	DET
dpc-4338	6	14	creative	creative	ADJ
dpc-4338	6	15	commons	common	NOUN
dpc-4338	6	16	attributionnoncommercial	attributionnoncommercial	ADJ
dpc-4338	6	17	license	license	NOUN
dpc-4338	6	18	(	(	PUNCT
dpc-4338	6	19	by	by	ADP
dpc-4338	6	20	-	-	PUNCT
dpc-4338	6	21	nc-4.0	nc-4.0	NOUN
dpc-4338	6	22	)	)	PUNCT
dpc-4338	6	23	,	,	PUNCT
dpc-4338	6	24	https://creativecommons.org/licenses/by-nc/4.0/	https://creativecommons.org/licenses/by-nc/4.0/	PROPN
dpc-4338	6	25	,	,	PUNCT
dpc-4338	6	26	which	which	PRON
dpc-4338	6	27	permits	permit	VERB
dpc-4338	6	28	unrestricted	unrestricted	ADJ
dpc-4338	6	29	noncommercial	noncommercial	ADJ
dpc-4338	6	30	use	use	NOUN
dpc-4338	6	31	,	,	PUNCT
dpc-4338	6	32	distribution	distribution	NOUN
dpc-4338	6	33	,	,	PUNCT
dpc-4338	6	34	and	and	CCONJ
dpc-4338	6	35	reproduction	reproduction	NOUN
dpc-4338	6	36	in	in	ADP
dpc-4338	6	37	any	any	DET
dpc-4338	6	38	medium	medium	NOUN
dpc-4338	6	39	,	,	PUNCT
dpc-4338	6	40	provided	provide	VERB
dpc-4338	6	41	the	the	DET
dpc-4338	6	42	original	original	ADJ
dpc-4338	6	43	authors	author	NOUN
dpc-4338	6	44	and	and	CCONJ
dpc-4338	6	45	source	source	NOUN
dpc-4338	6	46	are	be	AUX
dpc-4338	6	47	credited	credit	VERB
dpc-4338	6	48	.	.	PUNCT
dpc-4338	7	1	funding	funding	NOUN
dpc-4338	7	2	:	:	PUNCT
dpc-4338	7	3	none	none	NOUN
dpc-4338	7	4	.	.	PUNCT
dpc-4338	8	1	competing	compete	VERB
dpc-4338	8	2	interests	interest	NOUN
dpc-4338	8	3	:	:	PUNCT
dpc-4338	8	4	none	none	NOUN
dpc-4338	8	5	.	.	PUNCT
dpc-4338	9	1	authorship	authorship	NOUN
dpc-4338	9	2	:	:	PUNCT
dpc-4338	9	3	all	all	DET
dpc-4338	9	4	authors	author	NOUN
dpc-4338	9	5	have	have	AUX
dpc-4338	9	6	contributed	contribute	VERB
dpc-4338	9	7	significantly	significantly	ADV
dpc-4338	9	8	to	to	ADP
dpc-4338	9	9	this	this	DET
dpc-4338	9	10	publication	publication	NOUN
dpc-4338	9	11	.	.	PUNCT
dpc-4338	10	1	corresponding	correspond	VERB
dpc-4338	10	2	author	author	NOUN
dpc-4338	10	3	:	:	PUNCT
dpc-4338	10	4	anna	anna	PROPN
dpc-4338	10	5	tagka	tagka	PROPN
dpc-4338	10	6	,	,	PUNCT
dpc-4338	10	7	md	md	PROPN
dpc-4338	10	8	,	,	PUNCT
dpc-4338	10	9	first	first	ADJ
dpc-4338	10	10	department	department	NOUN
dpc-4338	10	11	of	of	ADP
dpc-4338	10	12	dermatology	dermatology	NOUN
dpc-4338	10	13	-	-	PUNCT
dpc-4338	10	14	venereology	venereology	NOUN
dpc-4338	10	15	,	,	PUNCT
dpc-4338	10	16	national	national	ADJ
dpc-4338	10	17	and	and	CCONJ
dpc-4338	10	18	kapodistrian	kapodistrian	ADJ
dpc-4338	10	19	university	university	PROPN
dpc-4338	10	20	of	of	ADP
dpc-4338	10	21	athens	athens	PROPN
dpc-4338	10	22	,	,	PUNCT
dpc-4338	10	23	andreas	andreas	PROPN
dpc-4338	10	24	syggros	syggros	PROPN
dpc-4338	10	25	hospital	hospital	PROPN
dpc-4338	10	26	,	,	PUNCT
dpc-4338	10	27	5	5	NUM
dpc-4338	10	28	ionos	ionos	NOUN
dpc-4338	10	29	dragoumi	dragoumi	PROPN
dpc-4338	10	30	str	str	PROPN
dpc-4338	10	31	.	.	PUNCT
dpc-4338	10	32	,	,	PUNCT
dpc-4338	10	33	11621	11621	NUM
dpc-4338	10	34	athens	athens	PROPN
dpc-4338	10	35	,	,	PUNCT
dpc-4338	10	36	greece	greece	PROPN
dpc-4338	10	37	;	;	PUNCT
dpc-4338	10	38	tel	tel	PROPN
dpc-4338	10	39	.	.	PROPN
dpc-4338	10	40	+30	+30	PROPN
dpc-4338	10	41	-	-	PUNCT
dpc-4338	10	42	210	210	NUM
dpc-4338	10	43	-	-	PUNCT
dpc-4338	10	44	726	726	NUM
dpc-4338	10	45	-	-	NUM
dpc-4338	10	46	5100	5100	NUM
dpc-4338	10	47	.	.	PUNCT
dpc-4338	11	1	e	e	X
dpc-4338	11	2	-	-	NOUN
dpc-4338	11	3	mail	mail	NOUN
dpc-4338	11	4	:	:	PUNCT
dpc-4338	11	5	annatagka3@gmail.com	annatagka3@gmail.com	X
dpc-4338	11	6	introduction	introduction	NOUN
dpc-4338	11	7	:	:	PUNCT
dpc-4338	11	8	irritant	irritant	VERB
dpc-4338	11	9	contact	contact	NOUN
dpc-4338	11	10	dermatitis	dermatitis	PROPN
dpc-4338	11	11	(	(	PUNCT
dpc-4338	11	12	icd	icd	PROPN
dpc-4338	11	13	)	)	PUNCT
dpc-4338	11	14	is	be	AUX
dpc-4338	11	15	characterized	characterize	VERB
dpc-4338	11	16	by	by	ADP
dpc-4338	11	17	direct	direct	ADJ
dpc-4338	11	18	injury	injury	NOUN
dpc-4338	11	19	to	to	ADP
dpc-4338	11	20	the	the	DET
dpc-4338	11	21	epidermal	epidermal	ADJ
dpc-4338	11	22	cells	cell	NOUN
dpc-4338	11	23	,	,	PUNCT
dpc-4338	11	24	activating	activate	VERB
dpc-4338	11	25	the	the	DET
dpc-4338	11	26	innate	innate	ADJ
dpc-4338	11	27	immune	immune	ADJ
dpc-4338	11	28	response	response	NOUN
dpc-4338	11	29	.	.	PUNCT
dpc-4338	12	1	allergic	allergic	ADJ
dpc-4338	12	2	contact	contact	NOUN
dpc-4338	12	3	dermatitis	dermatitis	PROPN
dpc-4338	12	4	(	(	PUNCT
dpc-4338	12	5	acd	acd	NOUN
dpc-4338	12	6	)	)	PUNCT
dpc-4338	12	7	,	,	PUNCT
dpc-4338	12	8	in	in	ADP
dpc-4338	12	9	contrast	contrast	NOUN
dpc-4338	12	10	,	,	PUNCT
dpc-4338	12	11	is	be	AUX
dpc-4338	12	12	delineated	delineate	VERB
dpc-4338	12	13	by	by	ADP
dpc-4338	12	14	a	a	DET
dpc-4338	12	15	delayed	delay	VERB
dpc-4338	12	16	hypersensitivity	hypersensitivity	NOUN
dpc-4338	12	17	reaction	reaction	NOUN
dpc-4338	12	18	of	of	ADP
dpc-4338	12	19	type	type	NOUN
dpc-4338	12	20	iv	iv	NOUN
dpc-4338	12	21	.	.	PUNCT
dpc-4338	13	1	despite	despite	SCONJ
dpc-4338	13	2	the	the	DET
dpc-4338	13	3	distinct	distinct	ADJ
dpc-4338	13	4	etiopathogenic	etiopathogenic	ADJ
dpc-4338	13	5	mechanisms	mechanism	NOUN
dpc-4338	13	6	underpinning	underpin	VERB
dpc-4338	13	7	each	each	DET
dpc-4338	13	8	condition	condition	NOUN
dpc-4338	13	9	,	,	PUNCT
dpc-4338	13	10	the	the	DET
dpc-4338	13	11	differentiation	differentiation	NOUN
dpc-4338	13	12	between	between	ADP
dpc-4338	13	13	them	they	PRON
dpc-4338	13	14	presents	present	VERB
dpc-4338	13	15	a	a	DET
dpc-4338	13	16	significant	significant	ADJ
dpc-4338	13	17	diagnostic	diagnostic	ADJ
dpc-4338	13	18	challenge	challenge	NOUN
dpc-4338	13	19	.	.	PUNCT
dpc-4338	14	1	objective	objective	NOUN
dpc-4338	14	2	:	:	PUNCT
dpc-4338	14	3	this	this	DET
dpc-4338	14	4	study	study	NOUN
dpc-4338	14	5	aimed	aim	VERB
dpc-4338	14	6	to	to	PART
dpc-4338	14	7	determine	determine	VERB
dpc-4338	14	8	whether	whether	SCONJ
dpc-4338	14	9	a	a	DET
dpc-4338	14	10	combination	combination	NOUN
dpc-4338	14	11	of	of	ADP
dpc-4338	14	12	clinical	clinical	ADJ
dpc-4338	14	13	evaluation	evaluation	NOUN
dpc-4338	14	14	and	and	CCONJ
dpc-4338	14	15	noninvasive	noninvasive	ADJ
dpc-4338	14	16	measurements	measurement	NOUN
dpc-4338	14	17	—	—	PUNCT
dpc-4338	14	18	encompassing	encompass	VERB
dpc-4338	14	19	oxidative	oxidative	ADJ
dpc-4338	14	20	stress	stress	NOUN
dpc-4338	14	21	,	,	PUNCT
dpc-4338	14	22	erythema	erythema	ADV
dpc-4338	14	23	,	,	PUNCT
dpc-4338	14	24	hydration	hydration	NOUN
dpc-4338	14	25	,	,	PUNCT
dpc-4338	14	26	melanin	melanin	NOUN
dpc-4338	14	27	content	content	NOUN
dpc-4338	14	28	,	,	PUNCT
dpc-4338	14	29	transepidermal	transepidermal	ADJ
dpc-4338	14	30	water	water	NOUN
dpc-4338	14	31	loss	loss	NOUN
dpc-4338	14	32	(	(	PUNCT
dpc-4338	14	33	tewl	tewl	NOUN
dpc-4338	14	34	)	)	PUNCT
dpc-4338	14	35	,	,	PUNCT
dpc-4338	14	36	hemoglobin	hemoglobin	NOUN
dpc-4338	14	37	concentration	concentration	NOUN
dpc-4338	14	38	,	,	PUNCT
dpc-4338	14	39	and	and	CCONJ
dpc-4338	14	40	skin	skin	NOUN
dpc-4338	14	41	texture	texture	NOUN
dpc-4338	14	42	and	and	CCONJ
dpc-4338	14	43	volume	volume	NOUN
dpc-4338	14	44	—	—	PUNCT
dpc-4338	14	45	could	could	AUX
dpc-4338	14	46	distinguish	distinguish	VERB
dpc-4338	14	47	icd	icd	PROPN
dpc-4338	14	48	from	from	ADP
dpc-4338	14	49	acd	acd	PROPN
dpc-4338	14	50	.	.	PUNCT
dpc-4338	15	1	methods	method	NOUN
dpc-4338	15	2	:	:	PUNCT
dpc-4338	15	3	two	two	NUM
dpc-4338	15	4	cohorts	cohort	NOUN
dpc-4338	15	5	,	,	PUNCT
dpc-4338	15	6	each	each	PRON
dpc-4338	15	7	comprising	comprise	VERB
dpc-4338	15	8	21	21	NUM
dpc-4338	15	9	patients	patient	NOUN
dpc-4338	15	10	,	,	PUNCT
dpc-4338	15	11	were	be	AUX
dpc-4338	15	12	evaluated	evaluate	VERB
dpc-4338	15	13	:	:	PUNCT
dpc-4338	15	14	one	one	NUM
dpc-4338	15	15	diagnosed	diagnose	VERB
dpc-4338	15	16	with	with	ADP
dpc-4338	15	17	icd	icd	PROPN
dpc-4338	15	18	and	and	CCONJ
dpc-4338	15	19	the	the	DET
dpc-4338	15	20	other	other	ADJ
dpc-4338	15	21	with	with	ADP
dpc-4338	15	22	acd	acd	NOUN
dpc-4338	15	23	.	.	PUNCT
dpc-4338	16	1	all	all	DET
dpc-4338	16	2	participants	participant	NOUN
dpc-4338	16	3	underwent	undergo	VERB
dpc-4338	16	4	biophysical	biophysical	ADJ
dpc-4338	16	5	and	and	CCONJ
dpc-4338	16	6	clinical	clinical	ADJ
dpc-4338	16	7	assessments	assessment	NOUN
dpc-4338	16	8	,	,	PUNCT
dpc-4338	16	9	along	along	ADP
dpc-4338	16	10	with	with	ADP
dpc-4338	16	11	antera	antera	NOUN
dpc-4338	16	12	®	®	NOUN
dpc-4338	16	13	3d	3d	NOUN
dpc-4338	16	14	evaluations	evaluation	NOUN
dpc-4338	16	15	.	.	PUNCT
dpc-4338	17	1	tape	tape	NOUN
dpc-4338	17	2	strips	strip	NOUN
dpc-4338	17	3	were	be	AUX
dpc-4338	17	4	utilized	utilize	VERB
dpc-4338	17	5	for	for	ADP
dpc-4338	17	6	skin	skin	NOUN
dpc-4338	17	7	sampling	sampling	NOUN
dpc-4338	17	8	,	,	PUNCT
dpc-4338	17	9	and	and	CCONJ
dpc-4338	17	10	oxidative	oxidative	ADJ
dpc-4338	17	11	stress	stress	NOUN
dpc-4338	17	12	levels	level	NOUN
dpc-4338	17	13	were	be	AUX
dpc-4338	17	14	measured	measure	VERB
dpc-4338	17	15	via	via	ADP
dpc-4338	17	16	fluorescence	fluorescence	NOUN
dpc-4338	17	17	assessments	assessment	NOUN
dpc-4338	17	18	.	.	PUNCT
dpc-4338	18	1	results	result	NOUN
dpc-4338	18	2	:	:	PUNCT
dpc-4338	18	3	icd	icd	PROPN
dpc-4338	18	4	prompted	prompt	VERB
dpc-4338	18	5	an	an	DET
dpc-4338	18	6	almost	almost	ADV
dpc-4338	18	7	immediate	immediate	ADJ
dpc-4338	18	8	inflammatory	inflammatory	ADJ
dpc-4338	18	9	reaction	reaction	NOUN
dpc-4338	18	10	(	(	PUNCT
dpc-4338	18	11	peaking	peak	VERB
dpc-4338	18	12	at	at	ADP
dpc-4338	18	13	24	24	NUM
dpc-4338	18	14	hours	hour	NOUN
dpc-4338	18	15	)	)	PUNCT
dpc-4338	18	16	,	,	PUNCT
dpc-4338	18	17	whereas	whereas	SCONJ
dpc-4338	18	18	acd	acd	NOUN
dpc-4338	18	19	incited	incite	VERB
dpc-4338	18	20	a	a	DET
dpc-4338	18	21	delayed	delay	VERB
dpc-4338	18	22	response	response	NOUN
dpc-4338	18	23	(	(	PUNCT
dpc-4338	18	24	72	72	NUM
dpc-4338	18	25	hours	hour	NOUN
dpc-4338	18	26	)	)	PUNCT
dpc-4338	18	27	.	.	PUNCT
dpc-4338	19	1	noninvasive	noninvasive	ADJ
dpc-4338	19	2	evaluated	evaluate	VERB
dpc-4338	19	3	parameters	parameter	NOUN
dpc-4338	19	4	such	such	ADJ
dpc-4338	19	5	as	as	ADP
dpc-4338	19	6	hemoglobin	hemoglobin	NOUN
dpc-4338	19	7	concentration	concentration	NOUN
dpc-4338	19	8	,	,	PUNCT
dpc-4338	19	9	skin	skin	NOUN
dpc-4338	19	10	texture	texture	NOUN
dpc-4338	19	11	and	and	CCONJ
dpc-4338	19	12	volume	volume	NOUN
dpc-4338	19	13	,	,	PUNCT
dpc-4338	19	14	melanin	melanin	NOUN
dpc-4338	19	15	content	content	NOUN
dpc-4338	19	16	,	,	PUNCT
dpc-4338	19	17	erythema	erythema	ADV
dpc-4338	19	18	,	,	PUNCT
dpc-4338	19	19	and	and	CCONJ
dpc-4338	19	20	tewl	tewl	NOUN
dpc-4338	19	21	showed	show	VERB
dpc-4338	19	22	significant	significant	ADJ
dpc-4338	19	23	differences	difference	NOUN
dpc-4338	19	24	between	between	ADP
dpc-4338	19	25	the	the	DET
dpc-4338	19	26	icd	icd	PROPN
dpc-4338	19	27	and	and	CCONJ
dpc-4338	19	28	acd	acd	NOUN
dpc-4338	19	29	cohorts	cohort	NOUN
dpc-4338	19	30	(	(	PUNCT
dpc-4338	19	31	p	p	X
dpc-4338	19	32	<	<	X
dpc-4338	19	33	0.05	0.05	NUM
dpc-4338	19	34	)	)	PUNCT
dpc-4338	19	35	.	.	PUNCT
dpc-4338	20	1	the	the	DET
dpc-4338	20	2	allergens	allergen	NOUN
dpc-4338	20	3	amcinonide	amcinonide	ADV
dpc-4338	20	4	,	,	PUNCT
dpc-4338	20	5	nickel	nickel	NOUN
dpc-4338	20	6	sulphate	sulphate	NOUN
dpc-4338	20	7	,	,	PUNCT
dpc-4338	20	8	cobalt	cobalt	NOUN
dpc-4338	20	9	chloride	chloride	NOUN
dpc-4338	20	10	,	,	PUNCT
dpc-4338	20	11	budesonide	budesonide	NOUN
dpc-4338	20	12	,	,	PUNCT
dpc-4338	20	13	ppd	ppd	NOUN
dpc-4338	20	14	,	,	PUNCT
dpc-4338	20	15	and	and	CCONJ
dpc-4338	20	16	thiuram	thiuram	NOUN
dpc-4338	20	17	mix	mix	NOUN
dpc-4338	20	18	were	be	AUX
dpc-4338	20	19	found	find	VERB
dpc-4338	20	20	to	to	PART
dpc-4338	20	21	induce	induce	VERB
dpc-4338	20	22	elevated	elevated	ADJ
dpc-4338	20	23	levels	level	NOUN
dpc-4338	20	24	of	of	ADP
dpc-4338	20	25	oxidative	oxidative	ADJ
dpc-4338	20	26	stress	stress	NOUN
dpc-4338	20	27	.	.	PUNCT
dpc-4338	21	1	conclusions	conclusion	NOUN
dpc-4338	21	2	:	:	PUNCT
dpc-4338	21	3	the	the	DET
dpc-4338	21	4	evaluation	evaluation	NOUN
dpc-4338	21	5	of	of	ADP
dpc-4338	21	6	patients	patient	NOUN
dpc-4338	21	7	with	with	ADP
dpc-4338	21	8	noninvasive	noninvasive	ADJ
dpc-4338	21	9	parameters	parameter	NOUN
dpc-4338	21	10	,	,	PUNCT
dpc-4338	21	11	including	include	VERB
dpc-4338	21	12	transepidermal	transepidermal	ADJ
dpc-4338	21	13	water	water	NOUN
dpc-4338	21	14	loss	loss	NOUN
dpc-4338	21	15	(	(	PUNCT
dpc-4338	21	16	tewl	tewl	NOUN
dpc-4338	21	17	)	)	PUNCT
dpc-4338	21	18	,	,	PUNCT
dpc-4338	21	19	hemoglobin	hemoglobin	NOUN
dpc-4338	21	20	concentration	concentration	NOUN
dpc-4338	21	21	,	,	PUNCT
dpc-4338	21	22	and	and	CCONJ
dpc-4338	21	23	skin	skin	NOUN
dpc-4338	21	24	texture	texture	NOUN
dpc-4338	21	25	and	and	CCONJ
dpc-4338	21	26	volume	volume	NOUN
dpc-4338	21	27	,	,	PUNCT
dpc-4338	21	28	could	could	AUX
dpc-4338	21	29	markedly	markedly	ADV
dpc-4338	21	30	aid	aid	VERB
dpc-4338	21	31	in	in	ADP
dpc-4338	21	32	distinguishing	distinguish	VERB
dpc-4338	21	33	irritant	irritant	ADJ
dpc-4338	21	34	contact	contact	NOUN
dpc-4338	21	35	dermatitis	dermatitis	NOUN
dpc-4338	21	36	from	from	ADP
dpc-4338	21	37	allergic	allergic	ADJ
dpc-4338	21	38	contact	contact	NOUN
dpc-4338	21	39	dermatitis	dermatitis	NOUN
dpc-4338	21	40	(	(	PUNCT
dpc-4338	21	41	acd	acd	NOUN
dpc-4338	21	42	)	)	PUNCT
dpc-4338	21	43	.	.	PUNCT
dpc-4338	22	1	nevertheless	nevertheless	ADV
dpc-4338	22	2	,	,	PUNCT
dpc-4338	22	3	the	the	DET
dpc-4338	22	4	study	study	NOUN
dpc-4338	22	5	was	be	AUX
dpc-4338	22	6	constrained	constrain	VERB
dpc-4338	22	7	by	by	ADP
dpc-4338	22	8	a	a	DET
dpc-4338	22	9	limited	limited	ADJ
dpc-4338	22	10	sample	sample	NOUN
dpc-4338	22	11	size	size	NOUN
dpc-4338	22	12	.	.	PUNCT
dpc-4338	23	1	abstract	abstract	ADJ
dpc-4338	23	2	2	2	NUM
dpc-4338	23	3	original	original	ADJ
dpc-4338	23	4	article	article	NOUN
dpc-4338	23	5	|	|	ADV
dpc-4338	23	6	dermatol	dermatol	ADJ
dpc-4338	23	7	pract	pract	NOUN
dpc-4338	23	8	concept	concept	NOUN
dpc-4338	23	9	.	.	PUNCT
dpc-4338	24	1	2024;14(4):e2024231	2024;14(4):e2024231	NUM
dpc-4338	24	2	introduction	introduction	NOUN
dpc-4338	24	3	contact	contact	NOUN
dpc-4338	24	4	dermatitis	dermatitis	NOUN
dpc-4338	24	5	manifests	manifest	VERB
dpc-4338	24	6	in	in	ADP
dpc-4338	24	7	two	two	NUM
dpc-4338	24	8	primary	primary	ADJ
dpc-4338	24	9	forms	form	NOUN
dpc-4338	24	10	:	:	PUNCT
dpc-4338	24	11	irritant	irritant	VERB
dpc-4338	24	12	contact	contact	NOUN
dpc-4338	24	13	dermatitis	dermatitis	PROPN
dpc-4338	24	14	(	(	PUNCT
dpc-4338	24	15	icd	icd	PROPN
dpc-4338	24	16	)	)	PUNCT
dpc-4338	24	17	,	,	PUNCT
dpc-4338	24	18	accounting	account	VERB
dpc-4338	24	19	for	for	ADP
dpc-4338	24	20	80	80	NUM
dpc-4338	24	21	%	%	NOUN
dpc-4338	24	22	of	of	ADP
dpc-4338	24	23	cases	case	NOUN
dpc-4338	24	24	,	,	PUNCT
dpc-4338	24	25	and	and	CCONJ
dpc-4338	24	26	allergic	allergic	ADJ
dpc-4338	24	27	contact	contact	NOUN
dpc-4338	24	28	dermatitis	dermatitis	NOUN
dpc-4338	24	29	(	(	PUNCT
dpc-4338	24	30	acd	acd	NOUN
dpc-4338	24	31	)	)	PUNCT
dpc-4338	24	32	,	,	PUNCT
dpc-4338	24	33	comprising	comprise	VERB
dpc-4338	24	34	the	the	DET
dpc-4338	24	35	remaining	remain	VERB
dpc-4338	24	36	20	20	NUM
dpc-4338	24	37	%	%	NOUN
dpc-4338	25	1	[	[	X
dpc-4338	25	2	1,2	1,2	NUM
dpc-4338	25	3	]	]	PUNCT
dpc-4338	25	4	.	.	PUNCT
dpc-4338	26	1	icd	icd	PROPN
dpc-4338	26	2	is	be	AUX
dpc-4338	26	3	distinguished	distinguish	VERB
dpc-4338	26	4	by	by	ADP
dpc-4338	26	5	direct	direct	ADJ
dpc-4338	26	6	damage	damage	NOUN
dpc-4338	26	7	to	to	ADP
dpc-4338	26	8	keratinocytes	keratinocyte	NOUN
dpc-4338	26	9	,	,	PUNCT
dpc-4338	26	10	initiating	initiate	VERB
dpc-4338	26	11	the	the	DET
dpc-4338	26	12	activation	activation	NOUN
dpc-4338	26	13	of	of	ADP
dpc-4338	26	14	the	the	DET
dpc-4338	26	15	innate	innate	ADJ
dpc-4338	26	16	immune	immune	ADJ
dpc-4338	26	17	system	system	NOUN
dpc-4338	26	18	and	and	CCONJ
dpc-4338	26	19	leading	lead	VERB
dpc-4338	26	20	to	to	ADP
dpc-4338	26	21	the	the	DET
dpc-4338	26	22	release	release	NOUN
dpc-4338	26	23	of	of	ADP
dpc-4338	26	24	a	a	DET
dpc-4338	26	25	cascade	cascade	NOUN
dpc-4338	26	26	of	of	ADP
dpc-4338	26	27	proinflammatory	proinflammatory	ADJ
dpc-4338	26	28	cytokines	cytokine	NOUN
dpc-4338	26	29	to	to	PART
dpc-4338	26	30	mediate	mediate	VERB
dpc-4338	26	31	the	the	DET
dpc-4338	26	32	damage	damage	NOUN
dpc-4338	26	33	[	[	X
dpc-4338	26	34	3	3	NUM
dpc-4338	26	35	-	-	SYM
dpc-4338	26	36	7	7	NUM
dpc-4338	26	37	]	]	PUNCT
dpc-4338	26	38	.	.	PUNCT
dpc-4338	27	1	these	these	DET
dpc-4338	27	2	cytokines	cytokine	NOUN
dpc-4338	27	3	stimulate	stimulate	VERB
dpc-4338	27	4	the	the	DET
dpc-4338	27	5	activation	activation	NOUN
dpc-4338	27	6	of	of	ADP
dpc-4338	27	7	epidermal	epidermal	ADJ
dpc-4338	27	8	langerhans	langerhan	NOUN
dpc-4338	27	9	cells	cell	NOUN
dpc-4338	27	10	,	,	PUNCT
dpc-4338	27	11	dermal	dermal	ADJ
dpc-4338	27	12	dendritic	dendritic	ADJ
dpc-4338	27	13	cells	cell	NOUN
dpc-4338	27	14	,	,	PUNCT
dpc-4338	27	15	and	and	CCONJ
dpc-4338	27	16	endothelial	endothelial	ADJ
dpc-4338	27	17	cells	cell	NOUN
dpc-4338	27	18	.	.	PUNCT
dpc-4338	28	1	experimentally	experimentally	ADV
dpc-4338	28	2	,	,	PUNCT
dpc-4338	28	3	sodium	sodium	NOUN
dpc-4338	28	4	lauryl	lauryl	NOUN
dpc-4338	28	5	sulfate	sulfate	NOUN
dpc-4338	28	6	(	(	PUNCT
dpc-4338	28	7	sls	sls	PROPN
dpc-4338	28	8	)	)	PUNCT
dpc-4338	28	9	induces	induce	VERB
dpc-4338	28	10	damage	damage	NOUN
dpc-4338	28	11	analogous	analogous	ADJ
dpc-4338	28	12	to	to	ADP
dpc-4338	28	13	that	that	PRON
dpc-4338	28	14	observed	observe	VERB
dpc-4338	28	15	in	in	ADP
dpc-4338	28	16	icd	icd	PROPN
dpc-4338	28	17	[	[	X
dpc-4338	28	18	3,8	3,8	NUM
dpc-4338	28	19	]	]	PUNCT
dpc-4338	28	20	.	.	PUNCT
dpc-4338	29	1	conversely	conversely	ADV
dpc-4338	29	2	,	,	PUNCT
dpc-4338	29	3	acd	acd	NOUN
dpc-4338	29	4	is	be	AUX
dpc-4338	29	5	typified	typify	VERB
dpc-4338	29	6	by	by	ADP
dpc-4338	29	7	a	a	DET
dpc-4338	29	8	delayed	delay	VERB
dpc-4338	29	9	hypersensitivity	hypersensitivity	NOUN
dpc-4338	29	10	reaction	reaction	NOUN
dpc-4338	29	11	of	of	ADP
dpc-4338	29	12	type	type	NOUN
dpc-4338	29	13	iv	iv	ADP
dpc-4338	29	14	(	(	PUNCT
dpc-4338	29	15	gell	gell	NOUN
dpc-4338	29	16	-	-	PUNCT
dpc-4338	29	17	coombs	coomb	NOUN
dpc-4338	29	18	)	)	PUNCT
dpc-4338	29	19	,	,	PUNCT
dpc-4338	29	20	induced	induce	VERB
dpc-4338	29	21	by	by	ADP
dpc-4338	29	22	dermal	dermal	ADJ
dpc-4338	29	23	contact	contact	NOUN
dpc-4338	29	24	with	with	ADP
dpc-4338	29	25	haptens	haptens	PROPN
dpc-4338	29	26	or	or	CCONJ
dpc-4338	29	27	non	non	ADJ
dpc-4338	29	28	-	-	ADJ
dpc-4338	29	29	protein	protein	ADJ
dpc-4338	29	30	allergens	allergen	NOUN
dpc-4338	29	31	.	.	PUNCT
dpc-4338	30	1	acute	acute	ADJ
dpc-4338	30	2	manifestations	manifestation	NOUN
dpc-4338	30	3	include	include	VERB
dpc-4338	30	4	erythema	erythema	ADJ
dpc-4338	30	5	,	,	PUNCT
dpc-4338	30	6	vesicles	vesicle	NOUN
dpc-4338	30	7	,	,	PUNCT
dpc-4338	30	8	and	and	CCONJ
dpc-4338	30	9	blisters	blister	NOUN
dpc-4338	30	10	,	,	PUNCT
dpc-4338	30	11	while	while	SCONJ
dpc-4338	30	12	chronic	chronic	ADJ
dpc-4338	30	13	exposure	exposure	NOUN
dpc-4338	30	14	may	may	AUX
dpc-4338	30	15	result	result	VERB
dpc-4338	30	16	in	in	ADP
dpc-4338	30	17	lichenification	lichenification	NOUN
dpc-4338	30	18	accompanied	accompany	VERB
dpc-4338	30	19	by	by	ADP
dpc-4338	30	20	cracks	crack	NOUN
dpc-4338	30	21	and	and	CCONJ
dpc-4338	30	22	fissures	fissure	NOUN
dpc-4338	30	23	[	[	X
dpc-4338	30	24	9	9	NUM
dpc-4338	30	25	]	]	PUNCT
dpc-4338	30	26	.	.	PUNCT
dpc-4338	31	1	the	the	DET
dpc-4338	31	2	mediation	mediation	NOUN
dpc-4338	31	3	of	of	ADP
dpc-4338	31	4	acd	acd	NOUN
dpc-4338	31	5	involves	involve	VERB
dpc-4338	31	6	t	t	NOUN
dpc-4338	31	7	cells	cell	NOUN
dpc-4338	31	8	that	that	PRON
dpc-4338	31	9	recognize	recognize	VERB
dpc-4338	31	10	small	small	ADJ
dpc-4338	31	11	chemical	chemical	NOUN
dpc-4338	31	12	molecules	molecule	NOUN
dpc-4338	31	13	or	or	CCONJ
dpc-4338	31	14	metal	metal	NOUN
dpc-4338	31	15	ions	ion	NOUN
dpc-4338	31	16	within	within	ADP
dpc-4338	31	17	the	the	DET
dpc-4338	31	18	major	major	ADJ
dpc-4338	31	19	histocompatibility	histocompatibility	NOUN
dpc-4338	31	20	complex	complex	NOUN
dpc-4338	31	21	(	(	PUNCT
dpc-4338	31	22	mhc	mhc	PROPN
dpc-4338	31	23	)	)	PUNCT
dpc-4338	32	1	[	[	X
dpc-4338	32	2	10	10	NUM
dpc-4338	32	3	]	]	PUNCT
dpc-4338	32	4	.	.	PUNCT
dpc-4338	33	1	these	these	DET
dpc-4338	33	2	electrophilic	electrophilic	ADJ
dpc-4338	33	3	chemicals	chemical	NOUN
dpc-4338	33	4	penetrate	penetrate	VERB
dpc-4338	33	5	the	the	DET
dpc-4338	33	6	skin	skin	NOUN
dpc-4338	33	7	and	and	CCONJ
dpc-4338	33	8	interact	interact	VERB
dpc-4338	33	9	with	with	ADP
dpc-4338	33	10	extracellular	extracellular	ADJ
dpc-4338	33	11	and	and	CCONJ
dpc-4338	33	12	intracellular	intracellular	ADJ
dpc-4338	33	13	proteins	protein	NOUN
dpc-4338	33	14	,	,	PUNCT
dpc-4338	33	15	a	a	DET
dpc-4338	33	16	property	property	NOUN
dpc-4338	33	17	underpinning	underpin	VERB
dpc-4338	33	18	their	their	PRON
dpc-4338	33	19	capability	capability	NOUN
dpc-4338	33	20	to	to	PART
dpc-4338	33	21	activate	activate	VERB
dpc-4338	33	22	both	both	DET
dpc-4338	33	23	innate	innate	ADJ
dpc-4338	33	24	immune	immune	NOUN
dpc-4338	33	25	and	and	CCONJ
dpc-4338	33	26	t	t	NOUN
dpc-4338	33	27	cell	cell	NOUN
dpc-4338	33	28	responses	response	NOUN
dpc-4338	33	29	[	[	X
dpc-4338	33	30	11	11	NUM
dpc-4338	33	31	-	-	SYM
dpc-4338	33	32	13	13	NUM
dpc-4338	33	33	]	]	PUNCT
dpc-4338	33	34	.	.	PUNCT
dpc-4338	34	1	following	follow	VERB
dpc-4338	34	2	contact	contact	NOUN
dpc-4338	34	3	with	with	ADP
dpc-4338	34	4	a	a	DET
dpc-4338	34	5	specific	specific	ADJ
dpc-4338	34	6	allergen	allergen	NOUN
dpc-4338	34	7	,	,	PUNCT
dpc-4338	34	8	allergen	allergen	NOUN
dpc-4338	34	9	specific	specific	ADJ
dpc-4338	34	10	t	t	NOUN
dpc-4338	34	11	cells	cell	NOUN
dpc-4338	34	12	proliferate	proliferate	VERB
dpc-4338	34	13	and	and	CCONJ
dpc-4338	34	14	differentiate	differentiate	VERB
dpc-4338	34	15	into	into	ADP
dpc-4338	34	16	effector	effector	NOUN
dpc-4338	34	17	t	t	NOUN
dpc-4338	34	18	cells	cell	NOUN
dpc-4338	34	19	,	,	PUNCT
dpc-4338	34	20	which	which	PRON
dpc-4338	34	21	enter	enter	VERB
dpc-4338	34	22	the	the	DET
dpc-4338	34	23	circulation	circulation	NOUN
dpc-4338	34	24	[	[	X
dpc-4338	34	25	14	14	NUM
dpc-4338	34	26	]	]	PUNCT
dpc-4338	34	27	.	.	PUNCT
dpc-4338	35	1	the	the	DET
dpc-4338	35	2	repeated	repeat	VERB
dpc-4338	35	3	application	application	NOUN
dpc-4338	35	4	of	of	ADP
dpc-4338	35	5	a	a	DET
dpc-4338	35	6	specific	specific	ADJ
dpc-4338	35	7	allergen	allergen	NOUN
dpc-4338	35	8	on	on	ADP
dpc-4338	35	9	the	the	DET
dpc-4338	35	10	skin	skin	NOUN
dpc-4338	35	11	leads	lead	VERB
dpc-4338	35	12	to	to	ADP
dpc-4338	35	13	the	the	DET
dpc-4338	35	14	recruitment	recruitment	NOUN
dpc-4338	35	15	of	of	ADP
dpc-4338	35	16	these	these	DET
dpc-4338	35	17	t	t	NOUN
dpc-4338	35	18	cells	cell	NOUN
dpc-4338	35	19	back	back	ADV
dpc-4338	35	20	to	to	ADP
dpc-4338	35	21	the	the	DET
dpc-4338	35	22	dermal	dermal	ADJ
dpc-4338	35	23	layer	layer	NOUN
dpc-4338	35	24	,	,	PUNCT
dpc-4338	35	25	inducing	induce	VERB
dpc-4338	35	26	apoptosis	apoptosis	NOUN
dpc-4338	35	27	in	in	ADP
dpc-4338	35	28	keratinocytes	keratinocyte	NOUN
dpc-4338	35	29	and	and	CCONJ
dpc-4338	35	30	culminating	culminate	VERB
dpc-4338	35	31	in	in	ADP
dpc-4338	35	32	acd	acd	NOUN
dpc-4338	35	33	[	[	X
dpc-4338	35	34	15,16	15,16	NUM
dpc-4338	35	35	]	]	PUNCT
dpc-4338	35	36	.	.	PUNCT
dpc-4338	36	1	notably	notably	ADV
dpc-4338	36	2	,	,	PUNCT
dpc-4338	36	3	skin	skin	NOUN
dpc-4338	36	4	lesions	lesion	NOUN
dpc-4338	36	5	in	in	ADP
dpc-4338	36	6	acd	acd	NOUN
dpc-4338	36	7	manifest	manifest	NOUN
dpc-4338	36	8	upon	upon	SCONJ
dpc-4338	36	9	re	re	NOUN
dpc-4338	36	10	-	-	NOUN
dpc-4338	36	11	exposure	exposure	NOUN
dpc-4338	36	12	to	to	ADP
dpc-4338	36	13	the	the	DET
dpc-4338	36	14	allergens	allergen	NOUN
dpc-4338	36	15	,	,	PUNCT
dpc-4338	36	16	with	with	ADP
dpc-4338	36	17	metals	metal	NOUN
dpc-4338	36	18	,	,	PUNCT
dpc-4338	36	19	preservatives	preservative	NOUN
dpc-4338	36	20	,	,	PUNCT
dpc-4338	36	21	antibiotics	antibiotic	NOUN
dpc-4338	36	22	,	,	PUNCT
dpc-4338	36	23	and	and	CCONJ
dpc-4338	36	24	fragrances	fragrance	NOUN
dpc-4338	36	25	being	be	AUX
dpc-4338	36	26	the	the	DET
dpc-4338	36	27	most	most	ADV
dpc-4338	36	28	common	common	ADJ
dpc-4338	36	29	allergens	allergen	NOUN
dpc-4338	36	30	linked	link	VERB
dpc-4338	36	31	to	to	ADP
dpc-4338	36	32	sensitization	sensitization	NOUN
dpc-4338	36	33	within	within	ADP
dpc-4338	36	34	the	the	DET
dpc-4338	36	35	general	general	ADJ
dpc-4338	36	36	population	population	NOUN
dpc-4338	37	1	[	[	X
dpc-4338	37	2	17	17	NUM
dpc-4338	37	3	]	]	PUNCT
dpc-4338	37	4	.	.	PUNCT
dpc-4338	38	1	objectives	objective	NOUN
dpc-4338	38	2	this	this	DET
dpc-4338	38	3	study	study	NOUN
dpc-4338	38	4	endeavored	endeavor	VERB
dpc-4338	38	5	to	to	PART
dpc-4338	38	6	enhance	enhance	VERB
dpc-4338	38	7	the	the	DET
dpc-4338	38	8	clinical	clinical	ADJ
dpc-4338	38	9	differential	differential	NOUN
dpc-4338	38	10	evaluation	evaluation	NOUN
dpc-4338	38	11	of	of	ADP
dpc-4338	38	12	acd	acd	NOUN
dpc-4338	38	13	and	and	CCONJ
dpc-4338	38	14	icd	icd	NOUN
dpc-4338	38	15	by	by	ADP
dpc-4338	38	16	integrating	integrate	VERB
dpc-4338	38	17	the	the	DET
dpc-4338	38	18	analysis	analysis	NOUN
dpc-4338	38	19	of	of	ADP
dpc-4338	38	20	noninvasive	noninvasive	ADJ
dpc-4338	38	21	parameters	parameter	NOUN
dpc-4338	38	22	.	.	PUNCT
dpc-4338	39	1	the	the	DET
dpc-4338	39	2	investigation	investigation	NOUN
dpc-4338	39	3	focused	focus	VERB
dpc-4338	39	4	on	on	ADP
dpc-4338	39	5	several	several	ADJ
dpc-4338	39	6	key	key	ADJ
dpc-4338	39	7	indicators	indicator	NOUN
dpc-4338	39	8	of	of	ADP
dpc-4338	39	9	skin	skin	NOUN
dpc-4338	39	10	health	health	NOUN
dpc-4338	39	11	as	as	ADP
dpc-4338	39	12	response	response	NOUN
dpc-4338	39	13	to	to	ADP
dpc-4338	39	14	irritants	irritant	NOUN
dpc-4338	39	15	or	or	CCONJ
dpc-4338	39	16	allergens	allergen	NOUN
dpc-4338	39	17	,	,	PUNCT
dpc-4338	39	18	including	include	VERB
dpc-4338	39	19	oxidative	oxidative	ADJ
dpc-4338	39	20	stress	stress	NOUN
dpc-4338	39	21	levels	level	NOUN
dpc-4338	39	22	,	,	PUNCT
dpc-4338	39	23	erythema	erythema	ADV
dpc-4338	39	24	,	,	PUNCT
dpc-4338	39	25	skin	skin	NOUN
dpc-4338	39	26	hydration	hydration	NOUN
dpc-4338	39	27	,	,	PUNCT
dpc-4338	39	28	melanin	melanin	NOUN
dpc-4338	39	29	content	content	NOUN
dpc-4338	39	30	,	,	PUNCT
dpc-4338	39	31	transepidermal	transepidermal	ADJ
dpc-4338	39	32	water	water	NOUN
dpc-4338	39	33	loss	loss	NOUN
dpc-4338	39	34	(	(	PUNCT
dpc-4338	39	35	tewl	tewl	NOUN
dpc-4338	39	36	)	)	PUNCT
dpc-4338	39	37	,	,	PUNCT
dpc-4338	39	38	hemoglobin	hemoglobin	NOUN
dpc-4338	39	39	concentration	concentration	NOUN
dpc-4338	39	40	,	,	PUNCT
dpc-4338	39	41	and	and	CCONJ
dpc-4338	39	42	the	the	DET
dpc-4338	39	43	texture	texture	NOUN
dpc-4338	39	44	and	and	CCONJ
dpc-4338	39	45	volume	volume	NOUN
dpc-4338	39	46	of	of	ADP
dpc-4338	39	47	the	the	DET
dpc-4338	39	48	skin	skin	NOUN
dpc-4338	39	49	fraction	fraction	NOUN
dpc-4338	39	50	affected	affect	VERB
dpc-4338	39	51	.	.	PUNCT
dpc-4338	40	1	oxidative	oxidative	ADJ
dpc-4338	40	2	stress	stress	NOUN
dpc-4338	40	3	,	,	PUNCT
dpc-4338	40	4	for	for	ADP
dpc-4338	40	5	instance	instance	NOUN
dpc-4338	40	6	,	,	PUNCT
dpc-4338	40	7	can	can	AUX
dpc-4338	40	8	provide	provide	VERB
dpc-4338	40	9	insights	insight	NOUN
dpc-4338	40	10	into	into	ADP
dpc-4338	40	11	the	the	DET
dpc-4338	40	12	cellular	cellular	ADJ
dpc-4338	40	13	damage	damage	NOUN
dpc-4338	40	14	and	and	CCONJ
dpc-4338	40	15	inflammatory	inflammatory	ADJ
dpc-4338	40	16	response	response	NOUN
dpc-4338	40	17	triggered	trigger	VERB
dpc-4338	40	18	by	by	ADP
dpc-4338	40	19	contact	contact	NOUN
dpc-4338	40	20	with	with	ADP
dpc-4338	40	21	irritants	irritant	NOUN
dpc-4338	40	22	or	or	CCONJ
dpc-4338	40	23	allergens	allergen	NOUN
dpc-4338	40	24	.	.	PUNCT
dpc-4338	41	1	similarly	similarly	ADV
dpc-4338	41	2	,	,	PUNCT
dpc-4338	41	3	changes	change	NOUN
dpc-4338	41	4	in	in	ADP
dpc-4338	41	5	tewl	tewl	NOUN
dpc-4338	41	6	,	,	PUNCT
dpc-4338	41	7	erythema	erythema	ADJ
dpc-4338	41	8	,	,	PUNCT
dpc-4338	41	9	and	and	CCONJ
dpc-4338	41	10	skin	skin	NOUN
dpc-4338	41	11	hydration	hydration	NOUN
dpc-4338	41	12	offer	offer	VERB
dpc-4338	41	13	quantitative	quantitative	ADJ
dpc-4338	41	14	measures	measure	NOUN
dpc-4338	41	15	of	of	ADP
dpc-4338	41	16	the	the	DET
dpc-4338	41	17	skin	skin	NOUN
dpc-4338	41	18	's	's	PART
dpc-4338	41	19	barrier	barrier	NOUN
dpc-4338	41	20	function	function	NOUN
dpc-4338	41	21	and	and	CCONJ
dpc-4338	41	22	inflammatory	inflammatory	ADJ
dpc-4338	41	23	status	status	NOUN
dpc-4338	41	24	.	.	PUNCT
dpc-4338	42	1	by	by	ADP
dpc-4338	42	2	comparing	compare	VERB
dpc-4338	42	3	these	these	DET
dpc-4338	42	4	parameters	parameter	NOUN
dpc-4338	42	5	between	between	ADP
dpc-4338	42	6	individuals	individual	NOUN
dpc-4338	42	7	diagnosed	diagnose	VERB
dpc-4338	42	8	with	with	ADP
dpc-4338	42	9	acd	acd	NOUN
dpc-4338	42	10	and	and	CCONJ
dpc-4338	42	11	those	those	PRON
dpc-4338	42	12	with	with	ADP
dpc-4338	42	13	icd	icd	PROPN
dpc-4338	42	14	,	,	PUNCT
dpc-4338	42	15	the	the	DET
dpc-4338	42	16	study	study	NOUN
dpc-4338	42	17	aimed	aim	VERB
dpc-4338	42	18	to	to	PART
dpc-4338	42	19	identify	identify	VERB
dpc-4338	42	20	distinctive	distinctive	ADJ
dpc-4338	42	21	patterns	pattern	NOUN
dpc-4338	42	22	that	that	PRON
dpc-4338	42	23	could	could	AUX
dpc-4338	42	24	aid	aid	VERB
dpc-4338	42	25	in	in	ADP
dpc-4338	42	26	their	their	PRON
dpc-4338	42	27	differentiation	differentiation	NOUN
dpc-4338	42	28	.	.	PUNCT
dpc-4338	43	1	incorporating	incorporate	VERB
dpc-4338	43	2	such	such	ADJ
dpc-4338	43	3	noninvasive	noninvasive	ADJ
dpc-4338	43	4	assessments	assessment	NOUN
dpc-4338	43	5	into	into	ADP
dpc-4338	43	6	the	the	DET
dpc-4338	43	7	diagnostic	diagnostic	ADJ
dpc-4338	43	8	process	process	NOUN
dpc-4338	43	9	seems	seem	VERB
dpc-4338	43	10	promising	promise	VERB
dpc-4338	43	11	for	for	ADP
dpc-4338	43	12	improving	improve	VERB
dpc-4338	43	13	the	the	DET
dpc-4338	43	14	accuracy	accuracy	NOUN
dpc-4338	43	15	of	of	ADP
dpc-4338	43	16	acd	acd	NOUN
dpc-4338	43	17	and	and	CCONJ
dpc-4338	43	18	icd	icd	NOUN
dpc-4338	43	19	diagnosis	diagnosis	NOUN
dpc-4338	43	20	.	.	PUNCT
dpc-4338	44	1	by	by	ADP
dpc-4338	44	2	providing	provide	VERB
dpc-4338	44	3	a	a	DET
dpc-4338	44	4	more	more	ADV
dpc-4338	44	5	nuanced	nuanced	ADJ
dpc-4338	44	6	understanding	understanding	NOUN
dpc-4338	44	7	of	of	ADP
dpc-4338	44	8	the	the	DET
dpc-4338	44	9	skin	skin	NOUN
dpc-4338	44	10	's	's	PART
dpc-4338	44	11	response	response	NOUN
dpc-4338	44	12	to	to	ADP
dpc-4338	44	13	irritants	irritant	NOUN
dpc-4338	44	14	and	and	CCONJ
dpc-4338	44	15	allergens	allergen	NOUN
dpc-4338	44	16	,	,	PUNCT
dpc-4338	44	17	healthcare	healthcare	NOUN
dpc-4338	44	18	professionals	professional	NOUN
dpc-4338	44	19	could	could	AUX
dpc-4338	44	20	tailor	tailor	VERB
dpc-4338	44	21	treatment	treatment	NOUN
dpc-4338	44	22	strategies	strategy	NOUN
dpc-4338	44	23	more	more	ADV
dpc-4338	44	24	effectively	effectively	ADV
dpc-4338	44	25	.	.	PUNCT
dpc-4338	45	1	moreover	moreover	ADV
dpc-4338	45	2	,	,	PUNCT
dpc-4338	45	3	this	this	DET
dpc-4338	45	4	approach	approach	NOUN
dpc-4338	45	5	aligns	align	VERB
dpc-4338	45	6	with	with	ADP
dpc-4338	45	7	the	the	DET
dpc-4338	45	8	growing	grow	VERB
dpc-4338	45	9	emphasis	emphasis	NOUN
dpc-4338	45	10	on	on	ADP
dpc-4338	45	11	minimally	minimally	ADV
dpc-4338	45	12	invasive	invasive	ADJ
dpc-4338	45	13	techniques	technique	NOUN
dpc-4338	45	14	in	in	ADP
dpc-4338	45	15	dermatological	dermatological	ADJ
dpc-4338	45	16	diagnosis	diagnosis	NOUN
dpc-4338	45	17	.	.	PUNCT
dpc-4338	46	1	as	as	SCONJ
dpc-4338	46	2	the	the	DET
dpc-4338	46	3	study	study	NOUN
dpc-4338	46	4	progresses	progress	VERB
dpc-4338	46	5	,	,	PUNCT
dpc-4338	46	6	the	the	DET
dpc-4338	46	7	findings	finding	NOUN
dpc-4338	46	8	could	could	AUX
dpc-4338	46	9	contribute	contribute	VERB
dpc-4338	46	10	valuable	valuable	ADJ
dpc-4338	46	11	insights	insight	NOUN
dpc-4338	46	12	into	into	ADP
dpc-4338	46	13	the	the	DET
dpc-4338	46	14	pathophysiological	pathophysiological	ADJ
dpc-4338	46	15	distinctions	distinction	NOUN
dpc-4338	46	16	between	between	ADP
dpc-4338	46	17	acd	acd	NOUN
dpc-4338	46	18	and	and	CCONJ
dpc-4338	46	19	icd	icd	PROPN
dpc-4338	46	20	,	,	PUNCT
dpc-4338	46	21	ultimately	ultimately	ADV
dpc-4338	46	22	enhancing	enhance	VERB
dpc-4338	46	23	patient	patient	ADJ
dpc-4338	46	24	care	care	NOUN
dpc-4338	46	25	and	and	CCONJ
dpc-4338	46	26	therapeutic	therapeutic	ADJ
dpc-4338	46	27	outcomes	outcome	NOUN
dpc-4338	46	28	.	.	PUNCT
dpc-4338	47	1	methods	method	NOUN
dpc-4338	47	2	sls	sls	VERB
dpc-4338	47	3	gauze	gauze	PROPN
dpc-4338	47	4	a	a	DET
dpc-4338	47	5	gauze	gauze	NOUN
dpc-4338	47	6	impregnated	impregnate	VERB
dpc-4338	47	7	with	with	ADP
dpc-4338	47	8	a	a	DET
dpc-4338	47	9	6	6	NUM
dpc-4338	47	10	%	%	NOUN
dpc-4338	47	11	w	w	NOUN
dpc-4338	47	12	/	/	SYM
dpc-4338	47	13	v	v	NOUN
dpc-4338	47	14	solution	solution	NOUN
dpc-4338	47	15	of	of	ADP
dpc-4338	47	16	sls	sls	PROPN
dpc-4338	47	17	(	(	PUNCT
dpc-4338	47	18	farmalabor	farmalabor	PROPN
dpc-4338	47	19	,	,	PUNCT
dpc-4338	47	20	italy	italy	PROPN
dpc-4338	47	21	)	)	PUNCT
dpc-4338	47	22	was	be	AUX
dpc-4338	47	23	applied	apply	VERB
dpc-4338	47	24	to	to	ADP
dpc-4338	47	25	the	the	DET
dpc-4338	47	26	forearm	forearm	NOUN
dpc-4338	47	27	skin	skin	NOUN
dpc-4338	47	28	for	for	ADP
dpc-4338	47	29	24	24	NUM
dpc-4338	47	30	 	 	SPACE
dpc-4338	47	31	hours	hour	NOUN
dpc-4338	47	32	.	.	PUNCT
dpc-4338	48	1	the	the	DET
dpc-4338	48	2	clinical	clinical	ADJ
dpc-4338	48	3	manifestations	manifestation	NOUN
dpc-4338	48	4	were	be	AUX
dpc-4338	48	5	evaluated	evaluate	VERB
dpc-4338	48	6	following	follow	VERB
dpc-4338	48	7	the	the	DET
dpc-4338	48	8	removal	removal	NOUN
dpc-4338	48	9	of	of	ADP
dpc-4338	48	10	the	the	DET
dpc-4338	48	11	sls	sls	NOUN
dpc-4338	48	12	-	-	PUNCT
dpc-4338	48	13	impregnated	impregnate	VERB
dpc-4338	48	14	gauze	gauze	NOUN
dpc-4338	48	15	.	.	PUNCT
dpc-4338	49	1	patch	patch	PROPN
dpc-4338	49	2	test	test	NOUN
dpc-4338	49	3	patch	patch	PROPN
dpc-4338	49	4	testing	testing	NOUN
dpc-4338	49	5	remains	remain	VERB
dpc-4338	49	6	the	the	DET
dpc-4338	49	7	definitive	definitive	ADJ
dpc-4338	49	8	standard	standard	NOUN
dpc-4338	49	9	for	for	ADP
dpc-4338	49	10	diagnosing	diagnose	VERB
dpc-4338	49	11	acd	acd	NOUN
dpc-4338	49	12	.	.	PUNCT
dpc-4338	50	1	following	follow	VERB
dpc-4338	50	2	the	the	DET
dpc-4338	50	3	european	european	ADJ
dpc-4338	50	4	society	society	NOUN
dpc-4338	50	5	of	of	ADP
dpc-4338	50	6	contact	contact	NOUN
dpc-4338	50	7	dermatitis	dermatitis	NOUN
dpc-4338	50	8	guidelines	guideline	NOUN
dpc-4338	50	9	for	for	ADP
dpc-4338	50	10	patch	patch	NOUN
dpc-4338	50	11	testing	testing	NOUN
dpc-4338	50	12	,	,	PUNCT
dpc-4338	50	13	substances	substance	NOUN
dpc-4338	50	14	were	be	AUX
dpc-4338	50	15	applied	apply	VERB
dpc-4338	50	16	to	to	ADP
dpc-4338	50	17	the	the	DET
dpc-4338	50	18	upper	upper	ADJ
dpc-4338	50	19	back	back	NOUN
dpc-4338	50	20	and	and	CCONJ
dpc-4338	50	21	removed	remove	VERB
dpc-4338	50	22	after	after	ADP
dpc-4338	50	23	48	48	NUM
dpc-4338	50	24	hours	hour	NOUN
dpc-4338	50	25	.	.	PUNCT
dpc-4338	51	1	the	the	DET
dpc-4338	51	2	evaluations	evaluation	NOUN
dpc-4338	51	3	were	be	AUX
dpc-4338	51	4	conducted	conduct	VERB
dpc-4338	51	5	72	72	NUM
dpc-4338	51	6	hours	hour	NOUN
dpc-4338	51	7	post	post	NOUN
dpc-4338	51	8	-	-	NOUN
dpc-4338	51	9	application	application	NOUN
dpc-4338	51	10	,	,	PUNCT
dpc-4338	51	11	utilizing	utilize	VERB
dpc-4338	51	12	a	a	DET
dpc-4338	51	13	european	european	ADJ
dpc-4338	51	14	baseline	baseline	NOUN
dpc-4338	51	15	and	and	CCONJ
dpc-4338	51	16	supplemental	supplemental	ADJ
dpc-4338	51	17	series	series	NOUN
dpc-4338	51	18	of	of	ADP
dpc-4338	51	19	allergens	allergen	NOUN
dpc-4338	51	20	(	(	PUNCT
dpc-4338	51	21	allergeaze	allergeaze	NOUN
dpc-4338	51	22	®	®	NOUN
dpc-4338	51	23	patch	patch	PROPN
dpc-4338	51	24	test	test	NOUN
dpc-4338	51	25	chambers	chamber	NOUN
dpc-4338	51	26	,	,	PUNCT
dpc-4338	51	27	smartpractice	smartpractice	PROPN
dpc-4338	51	28	canada	canada	PROPN
dpc-4338	51	29	)	)	PUNCT
dpc-4338	51	30	.	.	PUNCT
dpc-4338	52	1	study	study	NOUN
dpc-4338	52	2	design	design	NOUN
dpc-4338	52	3	all	all	DET
dpc-4338	52	4	conducted	conduct	VERB
dpc-4338	52	5	procedures	procedure	NOUN
dpc-4338	52	6	adhered	adhere	VERB
dpc-4338	52	7	to	to	ADP
dpc-4338	52	8	the	the	DET
dpc-4338	52	9	good	good	ADJ
dpc-4338	52	10	clinical	clinical	ADJ
dpc-4338	52	11	practice	practice	NOUN
dpc-4338	52	12	(	(	PUNCT
dpc-4338	52	13	gcp	gcp	NOUN
dpc-4338	52	14	)	)	PUNCT
dpc-4338	52	15	guidelines	guideline	NOUN
dpc-4338	52	16	as	as	SCONJ
dpc-4338	52	17	outlined	outline	VERB
dpc-4338	52	18	in	in	ADP
dpc-4338	52	19	directive	directive	NOUN
dpc-4338	52	20	2001/20/	2001/20/	PROPN
dpc-4338	52	21	ec	ec	PROPN
dpc-4338	52	22	,	,	PUNCT
dpc-4338	52	23	the	the	DET
dpc-4338	52	24	us	us	PROPN
dpc-4338	52	25	federal	federal	PROPN
dpc-4338	52	26	code	code	NOUN
dpc-4338	52	27	of	of	ADP
dpc-4338	52	28	users	user	NOUN
dpc-4338	52	29	(	(	PUNCT
dpc-4338	52	30	21	21	NUM
dpc-4338	52	31	cfr	cfr	NOUN
dpc-4338	52	32	part	part	NOUN
dpc-4338	52	33	312	312	NUM
dpc-4338	52	34	)	)	PUNCT
dpc-4338	52	35	,	,	PUNCT
dpc-4338	52	36	and	and	CCONJ
dpc-4338	52	37	the	the	DET
dpc-4338	52	38	international	international	ADJ
dpc-4338	52	39	conference	conference	NOUN
dpc-4338	52	40	on	on	ADP
dpc-4338	52	41	harmonization	harmonization	NOUN
dpc-4338	52	42	(	(	PUNCT
dpc-4338	52	43	ich	ich	NOUN
dpc-4338	52	44	)	)	PUNCT
dpc-4338	52	45	.	.	PUNCT
dpc-4338	53	1	the	the	DET
dpc-4338	53	2	research	research	NOUN
dpc-4338	53	3	was	be	AUX
dpc-4338	53	4	performed	perform	VERB
dpc-4338	53	5	in	in	ADP
dpc-4338	53	6	alignment	alignment	NOUN
dpc-4338	53	7	with	with	ADP
dpc-4338	53	8	the	the	DET
dpc-4338	53	9	declaration	declaration	NOUN
dpc-4338	53	10	of	of	ADP
dpc-4338	53	11	helsinki	helsinki	PROPN
dpc-4338	53	12	principles	principle	NOUN
dpc-4338	53	13	(	(	PUNCT
dpc-4338	53	14	directive	directive	NOUN
dpc-4338	53	15	2001/83	2001/83	NUM
dpc-4338	53	16	/	/	SYM
dpc-4338	53	17	ec	ec	PROPN
dpc-4338	53	18	;	;	PUNCT
dpc-4338	53	19	ich	ich	NOUN
dpc-4338	53	20	issue	issue	NOUN
dpc-4338	53	21	e9	e9	PROPN
dpc-4338	53	22	1996	1996	NUM
dpc-4338	53	23	;	;	PUNCT
dpc-4338	53	24	directive	directive	NOUN
dpc-4338	53	25	2001/20	2001/20	NUM
dpc-4338	53	26	/	/	SYM
dpc-4338	53	27	ec	ec	PROPN
dpc-4338	53	28	;	;	PUNCT
dpc-4338	53	29	directive	directive	NOUN
dpc-4338	53	30	2002/98	2002/98	NUM
dpc-4338	53	31	/	/	SYM
dpc-4338	53	32	ec	ec	PROPN
dpc-4338	53	33	;	;	PUNCT
dpc-4338	53	34	directive	directive	NOUN
dpc-4338	53	35	2003/63	2003/63	NUM
dpc-4338	53	36	/	/	SYM
dpc-4338	53	37	ec	ec	PROPN
dpc-4338	53	38	;	;	PUNCT
dpc-4338	53	39	ich	ich	PROPN
dpc-4338	53	40	e(6	e(6	PROPN
dpc-4338	53	41	)	)	PUNCT
dpc-4338	53	42	r1	r1	NOUN
dpc-4338	53	43	;	;	PUNCT
dpc-4338	53	44	21	21	NUM
dpc-4338	53	45	cfr	cfr	NOUN
dpc-4338	53	46	part	part	NOUN
dpc-4338	53	47	312	312	NUM
dpc-4338	53	48	;	;	PUNCT
dpc-4338	53	49	who	who	PRON
dpc-4338	53	50	2008	2008	NUM
dpc-4338	53	51	)	)	PUNCT
dpc-4338	53	52	.	.	PUNCT
dpc-4338	54	1	approval	approval	NOUN
dpc-4338	54	2	for	for	ADP
dpc-4338	54	3	the	the	DET
dpc-4338	54	4	protocol	protocol	NOUN
dpc-4338	54	5	was	be	AUX
dpc-4338	54	6	granted	grant	VERB
dpc-4338	54	7	by	by	ADP
dpc-4338	54	8	the	the	DET
dpc-4338	54	9	institutional	institutional	ADJ
dpc-4338	54	10	scientific	scientific	ADJ
dpc-4338	54	11	review	review	NOUN
dpc-4338	54	12	board	board	NOUN
dpc-4338	54	13	of	of	ADP
dpc-4338	54	14	the	the	DET
dpc-4338	54	15	andreas	andreas	PROPN
dpc-4338	54	16	syggros	syggros	PROPN
dpc-4338	54	17	hospital	hospital	PROPN
dpc-4338	54	18	,	,	PUNCT
dpc-4338	54	19	nkua	nkua	NOUN
dpc-4338	54	20	,	,	PUNCT
dpc-4338	54	21	university	university	NOUN
dpc-4338	54	22	medical	medical	ADJ
dpc-4338	54	23	school	school	NOUN
dpc-4338	54	24	(	(	PUNCT
dpc-4338	54	25	protocol	protocol	PROPN
dpc-4338	54	26	nr	nr	PROPN
dpc-4338	54	27	.	.	PROPN
dpc-4338	54	28	3612/2021	3612/2021	NUM
dpc-4338	54	29	)	)	PUNCT
dpc-4338	54	30	.	.	PUNCT
dpc-4338	55	1	participants	participant	NOUN
dpc-4338	55	2	forty	forty	NUM
dpc-4338	55	3	-	-	PUNCT
dpc-4338	55	4	two	two	NUM
dpc-4338	55	5	participants	participant	NOUN
dpc-4338	55	6	(	(	PUNCT
dpc-4338	55	7	21	21	NUM
dpc-4338	55	8	acd	acd	NOUN
dpc-4338	55	9	and	and	CCONJ
dpc-4338	55	10	21	21	NUM
dpc-4338	55	11	icd	icd	NOUN
dpc-4338	55	12	diagnosed	diagnose	VERB
dpc-4338	55	13	patients	patient	NOUN
dpc-4338	55	14	)	)	PUNCT
dpc-4338	55	15	were	be	AUX
dpc-4338	55	16	recruited	recruit	VERB
dpc-4338	55	17	from	from	ADP
dpc-4338	55	18	the	the	DET
dpc-4338	55	19	1st	1st	ADJ
dpc-4338	55	20	department	department	NOUN
dpc-4338	55	21	of	of	ADP
dpc-4338	55	22	dermatology	dermatology	NOUN
dpc-4338	55	23	and	and	CCONJ
dpc-4338	55	24	venereal	venereal	ADJ
dpc-4338	55	25	diseases	disease	NOUN
dpc-4338	55	26	,	,	PUNCT
dpc-4338	55	27	andreas	andreas	PROPN
dpc-4338	55	28	syggros	syggros	PROPN
dpc-4338	55	29	university	university	PROPN
dpc-4338	55	30	hospital	hospital	NOUN
dpc-4338	55	31	,	,	PUNCT
dpc-4338	55	32	between	between	ADP
dpc-4338	55	33	june	june	PROPN
dpc-4338	55	34	2021	2021	NUM
dpc-4338	55	35	and	and	CCONJ
dpc-4338	55	36	december	december	PROPN
dpc-4338	55	37	2021	2021	NUM
dpc-4338	55	38	.	.	PUNCT
dpc-4338	56	1	all	all	DET
dpc-4338	56	2	patients	patient	NOUN
dpc-4338	56	3	provided	provide	VERB
dpc-4338	56	4	informed	informed	ADJ
dpc-4338	56	5	consent	consent	NOUN
dpc-4338	56	6	.	.	PUNCT
dpc-4338	57	1	exclusion	exclusion	NOUN
dpc-4338	57	2	criteria	criterion	NOUN
dpc-4338	57	3	included	include	VERB
dpc-4338	57	4	original	original	ADJ
dpc-4338	57	5	article	article	NOUN
dpc-4338	57	6	|	|	ADV
dpc-4338	57	7	dermatol	dermatol	ADJ
dpc-4338	57	8	pract	pract	NOUN
dpc-4338	57	9	concept	concept	NOUN
dpc-4338	57	10	.	.	PUNCT
dpc-4338	58	1	2024;14(4):e2024231	2024;14(4):e2024231	NUM
dpc-4338	58	2	3	3	NUM
dpc-4338	58	3	pregnancy	pregnancy	NOUN
dpc-4338	58	4	,	,	PUNCT
dpc-4338	58	5	the	the	DET
dpc-4338	58	6	use	use	NOUN
dpc-4338	58	7	of	of	ADP
dpc-4338	58	8	anti	anti	ADJ
dpc-4338	58	9	-	-	ADJ
dpc-4338	58	10	inflammatory	inflammatory	ADJ
dpc-4338	58	11	and	and	CCONJ
dpc-4338	58	12	antihistaminic	antihistaminic	NOUN
dpc-4338	58	13	medications	medication	NOUN
dpc-4338	58	14	,	,	PUNCT
dpc-4338	58	15	sweating	sweating	NOUN
dpc-4338	58	16	,	,	PUNCT
dpc-4338	58	17	and	and	CCONJ
dpc-4338	58	18	physical	physical	ADJ
dpc-4338	58	19	activity	activity	NOUN
dpc-4338	58	20	.	.	PUNCT
dpc-4338	59	1	inclusion	inclusion	NOUN
dpc-4338	59	2	criteria	criterion	NOUN
dpc-4338	59	3	encompassed	encompass	VERB
dpc-4338	59	4	a	a	DET
dpc-4338	59	5	history	history	NOUN
dpc-4338	59	6	of	of	ADP
dpc-4338	59	7	acute	acute	NOUN
dpc-4338	59	8	,	,	PUNCT
dpc-4338	59	9	subacute	subacute	VERB
dpc-4338	59	10	,	,	PUNCT
dpc-4338	59	11	and	and	CCONJ
dpc-4338	59	12	chronic	chronic	ADJ
dpc-4338	59	13	dermatitis	dermatitis	NOUN
dpc-4338	59	14	and	and	CCONJ
dpc-4338	59	15	the	the	DET
dpc-4338	59	16	manifestation	manifestation	NOUN
dpc-4338	59	17	of	of	ADP
dpc-4338	59	18	rashes	rash	NOUN
dpc-4338	59	19	following	follow	VERB
dpc-4338	59	20	exposure	exposure	NOUN
dpc-4338	59	21	to	to	ADP
dpc-4338	59	22	allergens	allergen	NOUN
dpc-4338	59	23	and	and	CCONJ
dpc-4338	59	24	irritants	irritant	NOUN
dpc-4338	59	25	.	.	PUNCT
dpc-4338	60	1	clinical	clinical	ADJ
dpc-4338	60	2	assessment	assessment	NOUN
dpc-4338	60	3	all	all	DET
dpc-4338	60	4	participants	participant	NOUN
dpc-4338	60	5	successfully	successfully	ADV
dpc-4338	60	6	completed	complete	VERB
dpc-4338	60	7	the	the	DET
dpc-4338	60	8	study	study	NOUN
dpc-4338	60	9	.	.	PUNCT
dpc-4338	61	1	medical	medical	ADJ
dpc-4338	61	2	history	history	NOUN
dpc-4338	61	3	and	and	CCONJ
dpc-4338	61	4	demographic	demographic	ADJ
dpc-4338	61	5	data	datum	NOUN
dpc-4338	61	6	such	such	ADJ
dpc-4338	61	7	as	as	ADP
dpc-4338	61	8	sex	sex	NOUN
dpc-4338	61	9	,	,	PUNCT
dpc-4338	61	10	age	age	NOUN
dpc-4338	61	11	,	,	PUNCT
dpc-4338	61	12	body	body	NOUN
dpc-4338	61	13	mass	mass	NOUN
dpc-4338	61	14	index	index	NOUN
dpc-4338	61	15	(	(	PUNCT
dpc-4338	61	16	bmi	bmi	PROPN
dpc-4338	61	17	)	)	PUNCT
dpc-4338	61	18	,	,	PUNCT
dpc-4338	61	19	phototype	phototype	NOUN
dpc-4338	61	20	(	(	PUNCT
dpc-4338	61	21	fitzpatrick	fitzpatrick	PROPN
dpc-4338	61	22	skin	skin	PROPN
dpc-4338	61	23	type	type	NOUN
dpc-4338	61	24	)	)	PUNCT
dpc-4338	61	25	,	,	PUNCT
dpc-4338	61	26	medical	medical	ADJ
dpc-4338	61	27	conditions	condition	NOUN
dpc-4338	61	28	,	,	PUNCT
dpc-4338	61	29	family	family	NOUN
dpc-4338	61	30	history	history	NOUN
dpc-4338	61	31	,	,	PUNCT
dpc-4338	61	32	and	and	CCONJ
dpc-4338	61	33	smoking	smoking	NOUN
dpc-4338	61	34	habits	habit	NOUN
dpc-4338	61	35	were	be	AUX
dpc-4338	61	36	collected	collect	VERB
dpc-4338	61	37	and	and	CCONJ
dpc-4338	61	38	found	find	VERB
dpc-4338	61	39	to	to	PART
dpc-4338	61	40	be	be	AUX
dpc-4338	61	41	homogeneous	homogeneous	ADJ
dpc-4338	61	42	(	(	PUNCT
dpc-4338	61	43	table	table	NOUN
dpc-4338	61	44	1	1	NUM
dpc-4338	61	45	)	)	PUNCT
dpc-4338	61	46	.	.	PUNCT
dpc-4338	62	1	contact	contact	NOUN
dpc-4338	62	2	dermatitis	dermatitis	PROPN
dpc-4338	62	3	evaluation	evaluation	NOUN
dpc-4338	62	4	the	the	DET
dpc-4338	62	5	international	international	ADJ
dpc-4338	62	6	contact	contact	NOUN
dpc-4338	62	7	dermatitis	dermatitis	PROPN
dpc-4338	62	8	research	research	NOUN
dpc-4338	62	9	group	group	NOUN
dpc-4338	62	10	(	(	PUNCT
dpc-4338	62	11	icdrg	icdrg	ADJ
dpc-4338	62	12	)	)	PUNCT
dpc-4338	62	13	criteria	criterion	NOUN
dpc-4338	62	14	were	be	AUX
dpc-4338	62	15	employed	employ	VERB
dpc-4338	62	16	to	to	PART
dpc-4338	62	17	assess	assess	VERB
dpc-4338	62	18	the	the	DET
dpc-4338	62	19	intensity	intensity	NOUN
dpc-4338	62	20	of	of	ADP
dpc-4338	62	21	positive	positive	ADJ
dpc-4338	62	22	reactions	reaction	NOUN
dpc-4338	62	23	in	in	ADP
dpc-4338	62	24	acd	acd	NOUN
dpc-4338	62	25	patients	patient	NOUN
dpc-4338	62	26	,	,	PUNCT
dpc-4338	62	27	ranging	range	VERB
dpc-4338	62	28	from	from	ADP
dpc-4338	62	29	weak	weak	ADJ
dpc-4338	62	30	positive	positive	ADJ
dpc-4338	62	31	reactions	reaction	NOUN
dpc-4338	62	32	,	,	PUNCT
dpc-4338	62	33	characterized	characterize	VERB
dpc-4338	62	34	by	by	ADP
dpc-4338	62	35	erythema	erythema	ADJ
dpc-4338	62	36	,	,	PUNCT
dpc-4338	62	37	infiltration	infiltration	NOUN
dpc-4338	62	38	,	,	PUNCT
dpc-4338	62	39	and	and	CCONJ
dpc-4338	62	40	possibly	possibly	ADV
dpc-4338	62	41	papules	papule	NOUN
dpc-4338	62	42	(	(	PUNCT
dpc-4338	62	43	1	1	NUM
dpc-4338	62	44	+	+	NOUN
dpc-4338	62	45	)	)	PUNCT
dpc-4338	62	46	,	,	PUNCT
dpc-4338	62	47	to	to	ADP
dpc-4338	62	48	extreme	extreme	ADJ
dpc-4338	62	49	positive	positive	ADJ
dpc-4338	62	50	reactions	reaction	NOUN
dpc-4338	62	51	,	,	PUNCT
dpc-4338	62	52	marked	mark	VERB
dpc-4338	62	53	by	by	ADP
dpc-4338	62	54	intense	intense	ADJ
dpc-4338	62	55	erythema	erythema	NOUN
dpc-4338	62	56	,	,	PUNCT
dpc-4338	62	57	infiltration	infiltration	NOUN
dpc-4338	62	58	,	,	PUNCT
dpc-4338	62	59	and	and	CCONJ
dpc-4338	62	60	coalescing	coalesce	VERB
dpc-4338	62	61	vesicles	vesicle	NOUN
dpc-4338	62	62	(	(	PUNCT
dpc-4338	62	63	3	3	NUM
dpc-4338	62	64	+	+	NOUN
dpc-4338	62	65	)	)	PUNCT
dpc-4338	62	66	.	.	PUNCT
dpc-4338	63	1	for	for	ADP
dpc-4338	63	2	icd	icd	PROPN
dpc-4338	63	3	patients	patient	NOUN
dpc-4338	63	4	,	,	PUNCT
dpc-4338	63	5	the	the	DET
dpc-4338	63	6	clinical	clinical	ADJ
dpc-4338	63	7	evaluation	evaluation	NOUN
dpc-4338	63	8	was	be	AUX
dpc-4338	63	9	based	base	VERB
dpc-4338	63	10	on	on	ADP
dpc-4338	63	11	the	the	DET
dpc-4338	63	12	reaction	reaction	NOUN
dpc-4338	63	13	within	within	ADP
dpc-4338	63	14	24	24	NUM
dpc-4338	63	15	hours	hour	NOUN
dpc-4338	63	16	and	and	CCONJ
dpc-4338	63	17	the	the	DET
dpc-4338	63	18	clinical	clinical	ADJ
dpc-4338	63	19	assessment	assessment	NOUN
dpc-4338	63	20	of	of	ADP
dpc-4338	63	21	irritation	irritation	NOUN
dpc-4338	63	22	.	.	PUNCT
dpc-4338	64	1	oxidative	oxidative	ADJ
dpc-4338	64	2	stress	stress	NOUN
dpc-4338	64	3	evaluation	evaluation	NOUN
dpc-4338	64	4	prior	prior	ADV
dpc-4338	64	5	to	to	ADP
dpc-4338	64	6	and	and	CCONJ
dpc-4338	64	7	at	at	ADP
dpc-4338	64	8	the	the	DET
dpc-4338	64	9	time	time	NOUN
dpc-4338	64	10	of	of	ADP
dpc-4338	64	11	patch	patch	ADJ
dpc-4338	64	12	evaluation	evaluation	NOUN
dpc-4338	64	13	,	,	PUNCT
dpc-4338	64	14	two	two	NUM
dpc-4338	64	15	tape	tape	NOUN
dpc-4338	64	16	strips	strip	NOUN
dpc-4338	64	17	(	(	PUNCT
dpc-4338	64	18	standard	standard	ADJ
dpc-4338	64	19	d100	d100	PROPN
dpc-4338	64	20	squame	squame	NOUN
dpc-4338	64	21	discs	disc	NOUN
dpc-4338	64	22	,	,	PUNCT
dpc-4338	64	23	usa	usa	PROPN
dpc-4338	64	24	)	)	PUNCT
dpc-4338	64	25	were	be	AUX
dpc-4338	64	26	applied	apply	VERB
dpc-4338	64	27	to	to	ADP
dpc-4338	64	28	the	the	DET
dpc-4338	64	29	patients	patient	NOUN
dpc-4338	64	30	’	’	PART
dpc-4338	64	31	skin	skin	NOUN
dpc-4338	64	32	and	and	CCONJ
dpc-4338	64	33	stored	store	VERB
dpc-4338	64	34	at	at	ADP
dpc-4338	64	35	-20	-20	NUM
dpc-4338	64	36	°	°	NOUN
dpc-4338	64	37	c	c	NOUN
dpc-4338	64	38	.	.	PUNCT
dpc-4338	65	1	the	the	DET
dpc-4338	65	2	samples	sample	NOUN
dpc-4338	65	3	were	be	AUX
dpc-4338	65	4	then	then	ADV
dpc-4338	65	5	processed	process	VERB
dpc-4338	65	6	with	with	ADP
dpc-4338	65	7	500	500	NUM
dpc-4338	65	8	μl	μl	ADP
dpc-4338	65	9	of	of	ADP
dpc-4338	65	10	h2o	h2o	PROPN
dpc-4338	65	11	hplc	hplc	NOUN
dpc-4338	65	12	(	(	PUNCT
dpc-4338	65	13	fischer	fischer	PROPN
dpc-4338	65	14	chemical	chemical	PROPN
dpc-4338	65	15	u.k	u.k	PROPN
dpc-4338	65	16	.	.	PROPN
dpc-4338	65	17	limited	limited	PROPN
dpc-4338	65	18	)	)	PUNCT
dpc-4338	65	19	,	,	PUNCT
dpc-4338	65	20	200	200	NUM
dpc-4338	65	21	μl	μl	ADP
dpc-4338	65	22	of	of	ADP
dpc-4338	65	23	90	90	NUM
dpc-4338	65	24	%	%	NOUN
dpc-4338	65	25	meoh	meoh	NOUN
dpc-4338	65	26	(	(	PUNCT
dpc-4338	65	27	fischer	fischer	PROPN
dpc-4338	65	28	chemical	chemical	PROPN
dpc-4338	65	29	u.k	u.k	PROPN
dpc-4338	65	30	.	.	PROPN
dpc-4338	65	31	limited	limited	PROPN
dpc-4338	65	32	,	,	PUNCT
dpc-4338	65	33	bishop	bishop	NOUN
dpc-4338	65	34	meadow	meadow	NOUN
dpc-4338	65	35	)	)	PUNCT
dpc-4338	65	36	na2edtax2h2o	na2edtax2h2o	NOUN
dpc-4338	65	37	(	(	PUNCT
dpc-4338	65	38	lach	lach	NOUN
dpc-4338	65	39	-	-	PUNCT
dpc-4338	65	40	ner	ner	NOUN
dpc-4338	65	41	,	,	PUNCT
dpc-4338	65	42	s.r.o	s.r.o	PROPN
dpc-4338	65	43	.	.	PROPN
dpc-4338	65	44	,	,	PUNCT
dpc-4338	65	45	turkey	turkey	PROPN
dpc-4338	65	46	)	)	PUNCT
dpc-4338	65	47	,	,	PUNCT
dpc-4338	65	48	75	75	NUM
dpc-4338	65	49	μl	μl	NOUN
dpc-4338	65	50	of	of	ADP
dpc-4338	65	51	10	10	NUM
dpc-4338	65	52	mg	mg	NUM
dpc-4338	65	53	/	/	SYM
dpc-4338	65	54	ml	ml	NOUN
dpc-4338	65	55	bht	bht	PROPN
dpc-4338	65	56	(	(	PUNCT
dpc-4338	65	57	sigma	sigma	PROPN
dpc-4338	65	58	chemical	chemical	PROPN
dpc-4338	65	59	co.	co.	PROPN
dpc-4338	65	60	,	,	PUNCT
dpc-4338	65	61	usa	usa	PROPN
dpc-4338	65	62	)	)	PUNCT
dpc-4338	65	63	in	in	ADP
dpc-4338	65	64	ethanol	ethanol	NOUN
dpc-4338	65	65	hplc	hplc	NOUN
dpc-4338	65	66	(	(	PUNCT
dpc-4338	65	67	acros	acros	PROPN
dpc-4338	65	68	organics	organic	NOUN
dpc-4338	65	69	,	,	PUNCT
dpc-4338	65	70	germany	germany	PROPN
dpc-4338	65	71	)	)	PUNCT
dpc-4338	65	72	,	,	PUNCT
dpc-4338	65	73	and	and	CCONJ
dpc-4338	65	74	1.5	1.5	NUM
dpc-4338	65	75	μl	μl	NOUN
dpc-4338	65	76	of	of	ADP
dpc-4338	65	77	10	10	NUM
dpc-4338	65	78	mm	mm	PROPN
dpc-4338	65	79	desferal	desferal	NOUN
dpc-4338	65	80	(	(	PUNCT
dpc-4338	65	81	ciba	ciba	PROPN
dpc-4338	65	82	-	-	PUNCT
dpc-4338	65	83	geigy	geigy	PROPN
dpc-4338	65	84	switzerland	switzerland	PROPN
dpc-4338	65	85	)	)	PUNCT
dpc-4338	65	86	in	in	ADP
dpc-4338	65	87	h2o	h2o	PROPN
dpc-4338	65	88	hplc	hplc	NOUN
dpc-4338	65	89	.	.	PUNCT
dpc-4338	66	1	following	follow	VERB
dpc-4338	66	2	vortex	vortex	NOUN
dpc-4338	66	3	mixing	mixing	NOUN
dpc-4338	66	4	(	(	PUNCT
dpc-4338	66	5	msi	msi	PROPN
dpc-4338	66	6	minishaker	minishaker	PROPN
dpc-4338	66	7	ika	ika	PROPN
dpc-4338	66	8	,	,	PUNCT
dpc-4338	66	9	usa	usa	PROPN
dpc-4338	66	10	)	)	PUNCT
dpc-4338	66	11	at	at	ADP
dpc-4338	66	12	2,500	2,500	NUM
dpc-4338	66	13	rpm	rpm	NOUN
dpc-4338	66	14	for	for	ADP
dpc-4338	66	15	one	one	NUM
dpc-4338	66	16	minute	minute	NOUN
dpc-4338	66	17	and	and	CCONJ
dpc-4338	66	18	centrifugation	centrifugation	NOUN
dpc-4338	66	19	at	at	ADP
dpc-4338	66	20	9,000	9,000	NUM
dpc-4338	66	21	rpm	rpm	NOUN
dpc-4338	66	22	for	for	ADP
dpc-4338	66	23	eight	eight	NUM
dpc-4338	66	24	minutes	minute	NOUN
dpc-4338	66	25	at	at	ADP
dpc-4338	66	26	4	4	NUM
dpc-4338	66	27	°	°	NOUN
dpc-4338	66	28	c	c	NOUN
dpc-4338	66	29	,	,	PUNCT
dpc-4338	66	30	50	50	NUM
dpc-4338	66	31	μl	μl	ADV
dpc-4338	66	32	from	from	ADP
dpc-4338	66	33	each	each	DET
dpc-4338	66	34	vial	vial	ADJ
dpc-4338	66	35	solution	solution	NOUN
dpc-4338	66	36	and	and	CCONJ
dpc-4338	66	37	100	100	NUM
dpc-4338	66	38	μl	μl	ADP
dpc-4338	66	39	of	of	ADP
dpc-4338	66	40	saline	saline	NOUN
dpc-4338	66	41	were	be	AUX
dpc-4338	66	42	transferred	transfer	VERB
dpc-4338	66	43	to	to	ADP
dpc-4338	66	44	a	a	DET
dpc-4338	66	45	96	96	NUM
dpc-4338	66	46	-	-	PUNCT
dpc-4338	66	47	well	well	NOUN
dpc-4338	66	48	plate	plate	NOUN
dpc-4338	66	49	(	(	PUNCT
dpc-4338	66	50	costar	costar	NOUN
dpc-4338	66	51	–	–	PUNCT
dpc-4338	66	52	corning	corning	NOUN
dpc-4338	66	53	,	,	PUNCT
dpc-4338	66	54	usa	usa	PROPN
dpc-4338	66	55	)	)	PUNCT
dpc-4338	66	56	,	,	PUNCT
dpc-4338	66	57	with	with	ADP
dpc-4338	66	58	three	three	NUM
dpc-4338	66	59	wells	well	NOUN
dpc-4338	66	60	per	per	ADP
dpc-4338	66	61	solution	solution	NOUN
dpc-4338	66	62	.	.	PUNCT
dpc-4338	67	1	three	three	NUM
dpc-4338	67	2	wells	well	NOUN
dpc-4338	67	3	received	receive	VERB
dpc-4338	67	4	150	150	NUM
dpc-4338	67	5	μl	μl	ADP
dpc-4338	67	6	of	of	ADP
dpc-4338	67	7	saline	saline	NOUN
dpc-4338	67	8	as	as	ADP
dpc-4338	67	9	a	a	DET
dpc-4338	67	10	control	control	NOUN
dpc-4338	67	11	.	.	PUNCT
dpc-4338	68	1	subsequently	subsequently	ADV
dpc-4338	68	2	,	,	PUNCT
dpc-4338	68	3	10	10	NUM
dpc-4338	68	4	μl	μl	ADP
dpc-4338	68	5	of	of	ADP
dpc-4338	68	6	30	30	NUM
dpc-4338	68	7	μm	μm	NUM
dpc-4338	68	8	5-(and-6)-chloromethyl-2',7'-dichlorodihydrofluorescein	5-(and-6)-chloromethyl-2',7'-dichlorodihydrofluorescein	NUM
dpc-4338	68	9	diacetate	diacetate	ADJ
dpc-4338	68	10	,	,	PUNCT
dpc-4338	68	11	acetyl	acetyl	NOUN
dpc-4338	68	12	ester	ester	NOUN
dpc-4338	68	13	(	(	PUNCT
dpc-4338	68	14	cm	cm	NOUN
dpc-4338	68	15	-	-	PUNCT
dpc-4338	68	16	h2dcfda	h2dcfda	ADJ
dpc-4338	68	17	)	)	PUNCT
dpc-4338	68	18	ethanolic	ethanolic	ADJ
dpc-4338	68	19	solution	solution	NOUN
dpc-4338	68	20	(	(	PUNCT
dpc-4338	68	21	molecular	molecular	ADJ
dpc-4338	68	22	probes	probe	NOUN
dpc-4338	68	23	-thermo	-thermo	PROPN
dpc-4338	68	24	fisher	fisher	PROPN
dpc-4338	68	25	scientific	scientific	PROPN
dpc-4338	68	26	usa	usa	PROPN
dpc-4338	68	27	)	)	PUNCT
dpc-4338	68	28	was	be	AUX
dpc-4338	68	29	added	add	VERB
dpc-4338	68	30	to	to	ADP
dpc-4338	68	31	each	each	DET
dpc-4338	68	32	well	well	ADV
dpc-4338	68	33	.	.	PUNCT
dpc-4338	69	1	the	the	DET
dpc-4338	69	2	plate	plate	NOUN
dpc-4338	69	3	was	be	AUX
dpc-4338	69	4	then	then	ADV
dpc-4338	69	5	vortexed	vortexe	VERB
dpc-4338	69	6	at	at	ADP
dpc-4338	69	7	300	300	NUM
dpc-4338	69	8	rpm	rpm	NOUN
dpc-4338	69	9	for	for	ADP
dpc-4338	69	10	10	10	NUM
dpc-4338	69	11	minutes	minute	NOUN
dpc-4338	69	12	and	and	CCONJ
dpc-4338	69	13	placed	place	VERB
dpc-4338	69	14	in	in	ADP
dpc-4338	69	15	a	a	DET
dpc-4338	69	16	fluostar	fluostar	NOUN
dpc-4338	69	17	bmg	bmg	NOUN
dpc-4338	69	18	(	(	PUNCT
dpc-4338	69	19	germany	germany	PROPN
dpc-4338	69	20	)	)	PUNCT
dpc-4338	69	21	reader	reader	NOUN
dpc-4338	69	22	with	with	ADP
dpc-4338	69	23	the	the	DET
dpc-4338	69	24	excitation	excitation	NOUN
dpc-4338	69	25	filter	filter	NOUN
dpc-4338	69	26	set	set	VERB
dpc-4338	69	27	at	at	ADP
dpc-4338	69	28	485	485	NUM
dpc-4338	69	29	nm	nm	NOUN
dpc-4338	69	30	and	and	CCONJ
dpc-4338	69	31	emission	emission	NOUN
dpc-4338	69	32	at	at	ADP
dpc-4338	69	33	520	520	NUM
dpc-4338	69	34	nm	nm	NOUN
dpc-4338	69	35	,	,	PUNCT
dpc-4338	69	36	with	with	ADP
dpc-4338	69	37	a	a	DET
dpc-4338	69	38	gain	gain	NOUN
dpc-4338	69	39	of	of	ADP
dpc-4338	69	40	85	85	NUM
dpc-4338	69	41	.	.	PUNCT
dpc-4338	70	1	the	the	DET
dpc-4338	70	2	plate	plate	NOUN
dpc-4338	70	3	underwent	undergo	VERB
dpc-4338	70	4	incubation	incubation	NOUN
dpc-4338	70	5	at	at	ADP
dpc-4338	70	6	37	37	NUM
dpc-4338	70	7	°	°	ADP
dpc-4338	70	8	c	c	NOUN
dpc-4338	70	9	for	for	ADP
dpc-4338	70	10	50	50	NUM
dpc-4338	70	11	minutes	minute	NOUN
dpc-4338	70	12	prior	prior	ADV
dpc-4338	70	13	to	to	ADP
dpc-4338	70	14	measurements	measurement	NOUN
dpc-4338	70	15	.	.	PUNCT
dpc-4338	71	1	skin	skin	NOUN
dpc-4338	71	2	analysis	analysis	NOUN
dpc-4338	71	3	skin	skin	NOUN
dpc-4338	71	4	assessments	assessment	NOUN
dpc-4338	71	5	were	be	AUX
dpc-4338	71	6	conducted	conduct	VERB
dpc-4338	71	7	using	use	VERB
dpc-4338	71	8	an	an	DET
dpc-4338	71	9	antera	antera	NOUN
dpc-4338	71	10	®	®	NOUN
dpc-4338	71	11	3d	3d	PROPN
dpc-4338	71	12	camera	camera	NOUN
dpc-4338	71	13	(	(	PUNCT
dpc-4338	71	14	miravex	miravex	PROPN
dpc-4338	71	15	,	,	PUNCT
dpc-4338	71	16	dublin	dublin	PROPN
dpc-4338	71	17	,	,	PUNCT
dpc-4338	71	18	ireland	ireland	PROPN
dpc-4338	71	19	)	)	PUNCT
dpc-4338	71	20	at	at	ADP
dpc-4338	71	21	0	0	NUM
dpc-4338	71	22	hours	hour	NOUN
dpc-4338	71	23	and	and	CCONJ
dpc-4338	71	24	72	72	NUM
dpc-4338	71	25	hours	hour	NOUN
dpc-4338	71	26	in	in	ADP
dpc-4338	71	27	acd	acd	NOUN
dpc-4338	71	28	patients	patient	NOUN
dpc-4338	71	29	and	and	CCONJ
dpc-4338	71	30	at	at	ADP
dpc-4338	71	31	0	0	NUM
dpc-4338	71	32	hours	hour	NOUN
dpc-4338	71	33	and	and	CCONJ
dpc-4338	71	34	24	24	NUM
dpc-4338	71	35	hours	hour	NOUN
dpc-4338	71	36	in	in	ADP
dpc-4338	71	37	icd	icd	PROPN
dpc-4338	71	38	patients	patient	NOUN
dpc-4338	71	39	.	.	PUNCT
dpc-4338	72	1	hemoglobin	hemoglobin	NOUN
dpc-4338	72	2	concentration	concentration	NOUN
dpc-4338	72	3	and	and	CCONJ
dpc-4338	72	4	skin	skin	NOUN
dpc-4338	72	5	texture	texture	NOUN
dpc-4338	72	6	were	be	AUX
dpc-4338	72	7	evaluated	evaluate	VERB
dpc-4338	72	8	using	use	VERB
dpc-4338	72	9	antera	antera	NOUN
dpc-4338	72	10	®	®	NOUN
dpc-4338	72	11	3d	3d	PROPN
dpc-4338	72	12	software	software	NOUN
dpc-4338	72	13	(	(	PUNCT
dpc-4338	72	14	miravex	miravex	PROPN
dpc-4338	72	15	,	,	PUNCT
dpc-4338	72	16	dublin	dublin	PROPN
dpc-4338	72	17	,	,	PUNCT
dpc-4338	72	18	ireland	ireland	PROPN
dpc-4338	72	19	)	)	PUNCT
dpc-4338	72	20	.	.	PUNCT
dpc-4338	73	1	measurements	measurement	NOUN
dpc-4338	73	2	of	of	ADP
dpc-4338	73	3	skin	skin	NOUN
dpc-4338	73	4	biophysical	biophysical	ADJ
dpc-4338	73	5	parameters	parameter	NOUN
dpc-4338	73	6	in	in	ADP
dpc-4338	73	7	both	both	DET
dpc-4338	73	8	acd	acd	NOUN
dpc-4338	73	9	and	and	CCONJ
dpc-4338	73	10	icd	icd	PROPN
dpc-4338	73	11	patients	patient	NOUN
dpc-4338	73	12	,	,	PUNCT
dpc-4338	73	13	skin	skin	NOUN
dpc-4338	73	14	parameters	parameter	NOUN
dpc-4338	73	15	,	,	PUNCT
dpc-4338	73	16	including	include	VERB
dpc-4338	73	17	hydration	hydration	NOUN
dpc-4338	73	18	,	,	PUNCT
dpc-4338	73	19	tewl	tewl	NOUN
dpc-4338	73	20	,	,	PUNCT
dpc-4338	73	21	erythema	erythema	ADJ
dpc-4338	73	22	,	,	PUNCT
dpc-4338	73	23	and	and	CCONJ
dpc-4338	73	24	melanin	melanin	NOUN
dpc-4338	73	25	,	,	PUNCT
dpc-4338	73	26	were	be	AUX
dpc-4338	73	27	measured	measure	VERB
dpc-4338	73	28	using	use	VERB
dpc-4338	73	29	noninvasive	noninvasive	ADJ
dpc-4338	73	30	biophysical	biophysical	ADJ
dpc-4338	73	31	methods	method	NOUN
dpc-4338	73	32	at	at	ADP
dpc-4338	73	33	0	0	NUM
dpc-4338	73	34	hours	hour	NOUN
dpc-4338	73	35	and	and	CCONJ
dpc-4338	73	36	72	72	NUM
dpc-4338	73	37	  	  	SPACE
dpc-4338	73	38	hours	hour	NOUN
dpc-4338	73	39	and	and	CCONJ
dpc-4338	73	40	at	at	ADP
dpc-4338	73	41	0	0	NUM
dpc-4338	73	42	hours	hour	NOUN
dpc-4338	73	43	and	and	CCONJ
dpc-4338	73	44	24	24	NUM
dpc-4338	73	45	hours	hour	NOUN
dpc-4338	73	46	,	,	PUNCT
dpc-4338	73	47	respectively	respectively	ADV
dpc-4338	73	48	.	.	PUNCT
dpc-4338	74	1	hydration	hydration	NOUN
dpc-4338	74	2	levels	level	NOUN
dpc-4338	74	3	were	be	AUX
dpc-4338	74	4	gauged	gauge	VERB
dpc-4338	74	5	using	use	VERB
dpc-4338	74	6	a	a	DET
dpc-4338	74	7	corneometer	corneometer	NOUN
dpc-4338	74	8	cm	cm	NOUN
dpc-4338	74	9	820	820	NUM
dpc-4338	74	10	(	(	PUNCT
dpc-4338	74	11	courage	courage	NOUN
dpc-4338	74	12	+	+	CCONJ
dpc-4338	74	13	khazaka	khazaka	PROPN
dpc-4338	74	14	electronic	electronic	ADJ
dpc-4338	74	15	gmbh	gmbh	NOUN
dpc-4338	74	16	,	,	PUNCT
dpc-4338	74	17	cologne	cologne	NOUN
dpc-4338	74	18	,	,	PUNCT
dpc-4338	74	19	germany	germany	PROPN
dpc-4338	74	20	)	)	PUNCT
dpc-4338	74	21	,	,	PUNCT
dpc-4338	74	22	based	base	VERB
dpc-4338	74	23	on	on	ADP
dpc-4338	74	24	changes	change	NOUN
dpc-4338	74	25	in	in	ADP
dpc-4338	74	26	the	the	DET
dpc-4338	74	27	dielectric	dielectric	ADJ
dpc-4338	74	28	constant	constant	ADJ
dpc-4338	74	29	,	,	PUNCT
dpc-4338	74	30	with	with	ADP
dpc-4338	74	31	data	datum	NOUN
dpc-4338	74	32	table	table	NOUN
dpc-4338	74	33	1	1	NUM
dpc-4338	74	34	.	.	PUNCT
dpc-4338	75	1	characteristics	characteristic	NOUN
dpc-4338	75	2	of	of	ADP
dpc-4338	75	3	patients	patient	NOUN
dpc-4338	75	4	at	at	ADP
dpc-4338	75	5	baseline	baseline	NOUN
dpc-4338	75	6	.	.	PUNCT
dpc-4338	76	1	characteristics	characteristic	NOUN
dpc-4338	76	2	of	of	ADP
dpc-4338	76	3	 	 	SPACE
dpc-4338	76	4	patients	patient	NOUN
dpc-4338	76	5	allergic	allergic	ADJ
dpc-4338	76	6	contact	contact	NOUN
dpc-4338	76	7	dermatitis	dermatitis	NOUN
dpc-4338	76	8	irritant	irritant	VERB
dpc-4338	76	9	contact	contact	NOUN
dpc-4338	76	10	dermatitis	dermatitis	NOUN
dpc-4338	76	11	demographics	demographic	NOUN
dpc-4338	76	12	median	median	NOUN
dpc-4338	76	13	age	age	NOUN
dpc-4338	76	14	46	46	NUM
dpc-4338	76	15	50	50	NUM
dpc-4338	76	16	sex	sex	NOUN
dpc-4338	76	17	(	(	PUNCT
dpc-4338	76	18	%	%	INTJ
dpc-4338	76	19	)	)	PUNCT
dpc-4338	76	20	male	male	NOUN
dpc-4338	76	21	9.52	9.52	NUM
dpc-4338	76	22	9.52	9.52	NUM
dpc-4338	76	23	female	female	NOUN
dpc-4338	76	24	90.48	90.48	NUM
dpc-4338	76	25	90.48	90.48	NUM
dpc-4338	76	26	bmi	bmi	PROPN
dpc-4338	76	27	classification	classification	NOUN
dpc-4338	76	28	 	 	SPACE
dpc-4338	76	29	(	(	PUNCT
dpc-4338	76	30	%	%	INTJ
dpc-4338	76	31	)	)	PUNCT
dpc-4338	76	32	normal	normal	ADJ
dpc-4338	76	33	weight	weight	NOUN
dpc-4338	76	34	76.19	76.19	NUM
dpc-4338	76	35	66.67	66.67	NUM
dpc-4338	76	36	overweight	overweight	NOUN
dpc-4338	76	37	23.81	23.81	NUM
dpc-4338	76	38	23.81	23.81	NUM
dpc-4338	76	39	underweight	underweight	NOUN
dpc-4338	76	40	4.76	4.76	NUM
dpc-4338	76	41	morbid	morbid	NOUN
dpc-4338	76	42	obesity	obesity	NOUN
dpc-4338	76	43	4.76	4.76	NUM
dpc-4338	76	44	fitzpatrick	fitzpatrick	PROPN
dpc-4338	76	45	skin	skin	NOUN
dpc-4338	76	46	type	type	NOUN
dpc-4338	76	47	(	(	PUNCT
dpc-4338	76	48	%	%	INTJ
dpc-4338	76	49	)	)	PUNCT
dpc-4338	77	1	i	i	PRON
dpc-4338	77	2	4.76	4.76	NUM
dpc-4338	77	3	23.81	23.81	NUM
dpc-4338	77	4	ii	ii	PROPN
dpc-4338	77	5	57.14	57.14	NUM
dpc-4338	77	6	61.9	61.9	NUM
dpc-4338	77	7	iii	iii	NUM
dpc-4338	77	8	33.33	33.33	NUM
dpc-4338	77	9	14.29	14.29	NUM
dpc-4338	77	10	iv	iv	NUM
dpc-4338	77	11	4.76	4.76	NUM
dpc-4338	77	12	current	current	ADJ
dpc-4338	77	13	smoker	smoker	NOUN
dpc-4338	77	14	 	 	SPACE
dpc-4338	77	15	(	(	PUNCT
dpc-4338	77	16	%	%	NOUN
dpc-4338	77	17	)	)	PUNCT
dpc-4338	77	18	42.86	42.86	NUM
dpc-4338	77	19	38.1	38.1	NUM
dpc-4338	77	20	characteristics	characteristic	NOUN
dpc-4338	77	21	of	of	ADP
dpc-4338	77	22	disease	disease	NOUN
dpc-4338	77	23	patient	patient	ADJ
dpc-4338	77	24	atopic	atopic	NOUN
dpc-4338	77	25	dermatitis	dermatitis	NOUN
dpc-4338	77	26	history	history	NOUN
dpc-4338	77	27	 	 	SPACE
dpc-4338	77	28	(	(	PUNCT
dpc-4338	77	29	%	%	NOUN
dpc-4338	77	30	)	)	PUNCT
dpc-4338	77	31	47.62	47.62	NUM
dpc-4338	77	32	28.57	28.57	NUM
dpc-4338	77	33	family	family	NOUN
dpc-4338	77	34	atopic	atopic	NOUN
dpc-4338	77	35	dermatitis	dermatitis	NOUN
dpc-4338	77	36	history	history	NOUN
dpc-4338	77	37	 	 	SPACE
dpc-4338	77	38	(	(	PUNCT
dpc-4338	77	39	%	%	NOUN
dpc-4338	77	40	)	)	PUNCT
dpc-4338	77	41	28.57	28.57	NUM
dpc-4338	77	42	28.57	28.57	NUM
dpc-4338	77	43	disease	disease	NOUN
dpc-4338	77	44	(	(	PUNCT
dpc-4338	77	45	%	%	INTJ
dpc-4338	77	46	)	)	PUNCT
dpc-4338	77	47	primary	primary	NOUN
dpc-4338	77	48	(	(	PUNCT
dpc-4338	77	49	%	%	NOUN
dpc-4338	77	50	)	)	PUNCT
dpc-4338	77	51	9.52	9.52	NUM
dpc-4338	77	52	recurrence	recurrence	NOUN
dpc-4338	77	53	(	(	PUNCT
dpc-4338	77	54	%	%	INTJ
dpc-4338	77	55	)	)	PUNCT
dpc-4338	77	56	90.48	90.48	NUM
dpc-4338	77	57	exposure	exposure	NOUN
dpc-4338	77	58	to	to	PART
dpc-4338	77	59	contact	contact	VERB
dpc-4338	77	60	allergens	allergen	NOUN
dpc-4338	77	61	 	 	SPACE
dpc-4338	77	62	(	(	PUNCT
dpc-4338	77	63	%	%	NOUN
dpc-4338	77	64	)	)	PUNCT
dpc-4338	77	65	80.95	80.95	NUM
dpc-4338	77	66	abbreviation	abbreviation	NOUN
dpc-4338	77	67	:	:	PUNCT
dpc-4338	77	68	bmi	bmi	PROPN
dpc-4338	77	69	:	:	PUNCT
dpc-4338	77	70	body	body	NOUN
dpc-4338	77	71	mass	mass	PROPN
dpc-4338	77	72	index	index	NOUN
dpc-4338	77	73	.	.	PUNCT
dpc-4338	78	1	4	4	NUM
dpc-4338	78	2	original	original	ADJ
dpc-4338	78	3	article	article	NOUN
dpc-4338	78	4	|	|	ADV
dpc-4338	78	5	dermatol	dermatol	ADJ
dpc-4338	78	6	pract	pract	NOUN
dpc-4338	78	7	concept	concept	NOUN
dpc-4338	78	8	.	.	PUNCT
dpc-4338	79	1	2024;14(4):e2024231	2024;14(4):e2024231	NUM
dpc-4338	79	2	responsible	responsible	ADJ
dpc-4338	79	3	for	for	ADP
dpc-4338	79	4	19.05	19.05	NUM
dpc-4338	79	5	%	%	NOUN
dpc-4338	79	6	of	of	ADP
dpc-4338	79	7	reactions	reaction	NOUN
dpc-4338	79	8	and	and	CCONJ
dpc-4338	79	9	textile	textile	NOUN
dpc-4338	79	10	dye	dye	NOUN
dpc-4338	79	11	mix	mix	VERB
dpc-4338	79	12	6.6	6.6	NUM
dpc-4338	79	13	%	%	NOUN
dpc-4338	79	14	for	for	ADP
dpc-4338	79	15	14.29	14.29	NUM
dpc-4338	79	16	%	%	NOUN
dpc-4338	80	1	;	;	PUNCT
dpc-4338	80	2	thiuram	thiuram	NOUN
dpc-4338	80	3	mix	mix	NOUN
dpc-4338	80	4	1	1	NUM
dpc-4338	80	5	%	%	NOUN
dpc-4338	80	6	,	,	PUNCT
dpc-4338	80	7	fragrance	fragrance	NOUN
dpc-4338	80	8	mix	mix	NOUN
dpc-4338	80	9	i	i	PRON
dpc-4338	80	10	8	8	NUM
dpc-4338	80	11	%	%	NOUN
dpc-4338	80	12	,	,	PUNCT
dpc-4338	80	13	and	and	CCONJ
dpc-4338	80	14	ppd	ppd	PROPN
dpc-4338	80	15	1	1	NUM
dpc-4338	80	16	%	%	NOUN
dpc-4338	80	17	each	each	PRON
dpc-4338	80	18	accounted	account	VERB
dpc-4338	80	19	for	for	ADP
dpc-4338	80	20	9.52	9.52	NUM
dpc-4338	80	21	%	%	NOUN
dpc-4338	80	22	.	.	PUNCT
dpc-4338	81	1	cobalt	cobalt	NOUN
dpc-4338	81	2	chloride	chloride	NOUN
dpc-4338	81	3	1	1	NUM
dpc-4338	81	4	%	%	NOUN
dpc-4338	81	5	,	,	PUNCT
dpc-4338	81	6	4	4	NUM
dpc-4338	81	7	-	-	PUNCT
dpc-4338	81	8	aminoazobenzene	aminoazobenzene	NOUN
dpc-4338	81	9	1	1	NUM
dpc-4338	81	10	%	%	NOUN
dpc-4338	81	11	,	,	PUNCT
dpc-4338	81	12	thiomersal	thiomersal	ADJ
dpc-4338	81	13	0.1	0.1	NUM
dpc-4338	81	14	%	%	NOUN
dpc-4338	81	15	,	,	PUNCT
dpc-4338	81	16	amcinonide	amcinonide	ADV
dpc-4338	81	17	0.1	0.1	NUM
dpc-4338	81	18	%	%	NOUN
dpc-4338	81	19	,	,	PUNCT
dpc-4338	81	20	fragrance	fragrance	NOUN
dpc-4338	81	21	mix	mix	NOUN
dpc-4338	81	22	ii	ii	PROPN
dpc-4338	81	23	14	14	NUM
dpc-4338	81	24	%	%	NOUN
dpc-4338	81	25	,	,	PUNCT
dpc-4338	81	26	colophonium	colophonium	NOUN
dpc-4338	81	27	20	20	NUM
dpc-4338	81	28	%	%	NOUN
dpc-4338	81	29	,	,	PUNCT
dpc-4338	81	30	budesonide	budesonide	VERB
dpc-4338	81	31	0.01	0.01	NUM
dpc-4338	81	32	%	%	NOUN
dpc-4338	81	33	,	,	PUNCT
dpc-4338	81	34	and	and	CCONJ
dpc-4338	81	35	formaldehyde	formaldehyde	NOUN
dpc-4338	81	36	2	2	NUM
dpc-4338	81	37	%	%	NOUN
dpc-4338	81	38	each	each	PRON
dpc-4338	81	39	contributed	contribute	VERB
dpc-4338	81	40	to	to	ADP
dpc-4338	81	41	4.76	4.76	NUM
dpc-4338	81	42	%	%	NOUN
dpc-4338	81	43	of	of	ADP
dpc-4338	81	44	reactions	reaction	NOUN
dpc-4338	81	45	(	(	PUNCT
dpc-4338	81	46	figure	figure	NOUN
dpc-4338	81	47	1b	1b	NUM
dpc-4338	81	48	)	)	PUNCT
dpc-4338	81	49	.	.	PUNCT
dpc-4338	82	1	oxidative	oxidative	ADJ
dpc-4338	82	2	stress	stress	NOUN
dpc-4338	82	3	oxidative	oxidative	ADJ
dpc-4338	82	4	stress	stress	NOUN
dpc-4338	82	5	,	,	PUNCT
dpc-4338	82	6	indicated	indicate	VERB
dpc-4338	82	7	by	by	ADP
dpc-4338	82	8	increased	increase	VERB
dpc-4338	82	9	fluorescence	fluorescence	NOUN
dpc-4338	82	10	intensity	intensity	NOUN
dpc-4338	82	11	,	,	PUNCT
dpc-4338	82	12	was	be	AUX
dpc-4338	82	13	significantly	significantly	ADV
dpc-4338	82	14	elevated	elevate	VERB
dpc-4338	82	15	in	in	ADP
dpc-4338	82	16	both	both	CCONJ
dpc-4338	82	17	icd	icd	PROPN
dpc-4338	82	18	(	(	PUNCT
dpc-4338	82	19	p	p	X
dpc-4338	82	20	<	<	X
dpc-4338	82	21	0.001	0.001	NUM
dpc-4338	82	22	)	)	PUNCT
dpc-4338	82	23	and	and	CCONJ
dpc-4338	82	24	acd	acd	NOUN
dpc-4338	82	25	(	(	PUNCT
dpc-4338	82	26	p	p	X
dpc-4338	82	27	<	<	X
dpc-4338	82	28	0.001	0.001	NUM
dpc-4338	82	29	)	)	PUNCT
dpc-4338	82	30	patients	patient	NOUN
dpc-4338	82	31	(	(	PUNCT
dpc-4338	82	32	figure	figure	NOUN
dpc-4338	82	33	2	2	NUM
dpc-4338	82	34	)	)	PUNCT
dpc-4338	82	35	.	.	PUNCT
dpc-4338	83	1	the	the	DET
dpc-4338	83	2	mean	mean	ADJ
dpc-4338	83	3	fluorescence	fluorescence	NOUN
dpc-4338	83	4	increase	increase	NOUN
dpc-4338	83	5	in	in	ADP
dpc-4338	83	6	icd	icd	PROPN
dpc-4338	83	7	patients	patient	NOUN
dpc-4338	83	8	was	be	AUX
dpc-4338	83	9	6.586	6.586	NUM
dpc-4338	83	10	%	%	NOUN
dpc-4338	83	11	,	,	PUNCT
dpc-4338	83	12	while	while	SCONJ
dpc-4338	83	13	in	in	ADP
dpc-4338	83	14	acd	acd	NOUN
dpc-4338	83	15	patients	patient	NOUN
dpc-4338	83	16	,	,	PUNCT
dpc-4338	83	17	it	it	PRON
dpc-4338	83	18	was	be	AUX
dpc-4338	83	19	5.515	5.515	NUM
dpc-4338	83	20	%	%	NOUN
dpc-4338	83	21	.	.	PUNCT
dpc-4338	84	1	there	there	PRON
dpc-4338	84	2	were	be	VERB
dpc-4338	84	3	no	no	DET
dpc-4338	84	4	significant	significant	ADJ
dpc-4338	84	5	differences	difference	NOUN
dpc-4338	84	6	between	between	ADP
dpc-4338	84	7	the	the	DET
dpc-4338	84	8	two	two	NUM
dpc-4338	84	9	groups	group	NOUN
dpc-4338	84	10	at	at	ADP
dpc-4338	84	11	the	the	DET
dpc-4338	84	12	time	time	NOUN
dpc-4338	84	13	of	of	ADP
dpc-4338	84	14	evaluation	evaluation	NOUN
dpc-4338	84	15	.	.	PUNCT
dpc-4338	85	1	all	all	DET
dpc-4338	85	2	allergens	allergen	NOUN
dpc-4338	85	3	led	lead	VERB
dpc-4338	85	4	to	to	ADP
dpc-4338	85	5	a	a	DET
dpc-4338	85	6	significant	significant	ADJ
dpc-4338	85	7	rise	rise	NOUN
dpc-4338	85	8	in	in	ADP
dpc-4338	85	9	oxidative	oxidative	ADJ
dpc-4338	85	10	stress	stress	NOUN
dpc-4338	85	11	,	,	PUNCT
dpc-4338	85	12	with	with	ADP
dpc-4338	85	13	the	the	DET
dpc-4338	85	14	most	most	ADV
dpc-4338	85	15	substantial	substantial	ADJ
dpc-4338	85	16	increases	increase	NOUN
dpc-4338	85	17	observed	observe	VERB
dpc-4338	85	18	for	for	ADP
dpc-4338	85	19	amcinonide	amcinonide	NOUN
dpc-4338	85	20	,	,	PUNCT
dpc-4338	85	21	nickel	nickel	NOUN
dpc-4338	85	22	sulfate	sulfate	NOUN
dpc-4338	85	23	,	,	PUNCT
dpc-4338	85	24	cobalt	cobalt	NOUN
dpc-4338	85	25	chloride	chloride	NOUN
dpc-4338	85	26	,	,	PUNCT
dpc-4338	85	27	budesonide	budesonide	NOUN
dpc-4338	85	28	,	,	PUNCT
dpc-4338	85	29	ppd	ppd	NOUN
dpc-4338	85	30	,	,	PUNCT
dpc-4338	85	31	and	and	CCONJ
dpc-4338	85	32	thiuram	thiuram	NOUN
dpc-4338	85	33	mix	mix	NOUN
dpc-4338	85	34	allergens	allergen	NOUN
dpc-4338	85	35	(	(	PUNCT
dpc-4338	85	36	table	table	NOUN
dpc-4338	85	37	2	2	NUM
dpc-4338	85	38	)	)	PUNCT
dpc-4338	85	39	.	.	PUNCT
dpc-4338	86	1	antera	antera	NOUN
dpc-4338	86	2	®	®	NOUN
dpc-4338	86	3	measurements	measurement	VERB
dpc-4338	86	4	analysis	analysis	NOUN
dpc-4338	86	5	using	use	VERB
dpc-4338	86	6	antera	antera	NOUN
dpc-4338	86	7	®	®	NOUN
dpc-4338	86	8	3d	3d	PROPN
dpc-4338	86	9	software	software	NOUN
dpc-4338	86	10	(	(	PUNCT
dpc-4338	86	11	figure	figure	NOUN
dpc-4338	86	12	3	3	NUM
dpc-4338	86	13	)	)	PUNCT
dpc-4338	86	14	revealed	reveal	VERB
dpc-4338	86	15	pronounced	pronounce	VERB
dpc-4338	86	16	inflammatory	inflammatory	ADJ
dpc-4338	86	17	activity	activity	NOUN
dpc-4338	86	18	in	in	ADP
dpc-4338	86	19	both	both	CCONJ
dpc-4338	86	20	icd	icd	PROPN
dpc-4338	86	21	and	and	CCONJ
dpc-4338	86	22	acd	acd	NOUN
dpc-4338	86	23	patients	patient	NOUN
dpc-4338	86	24	.	.	PUNCT
dpc-4338	87	1	all	all	DET
dpc-4338	87	2	antera	antera	NOUN
dpc-4338	87	3	®	®	NOUN
dpc-4338	87	4	3d	3d	NOUN
dpc-4338	87	5	parameters	parameter	NOUN
dpc-4338	87	6	,	,	PUNCT
dpc-4338	87	7	including	include	VERB
dpc-4338	87	8	hemoglobin	hemoglobin	NOUN
dpc-4338	87	9	concentration	concentration	NOUN
dpc-4338	87	10	,	,	PUNCT
dpc-4338	87	11	skin	skin	NOUN
dpc-4338	87	12	texture	texture	NOUN
dpc-4338	87	13	,	,	PUNCT
dpc-4338	87	14	and	and	CCONJ
dpc-4338	87	15	volume	volume	NOUN
dpc-4338	87	16	values	value	NOUN
dpc-4338	87	17	,	,	PUNCT
dpc-4338	87	18	were	be	AUX
dpc-4338	87	19	significantly	significantly	ADV
dpc-4338	87	20	higher	high	ADJ
dpc-4338	87	21	in	in	ADP
dpc-4338	87	22	icd	icd	PROPN
dpc-4338	87	23	patients	patient	NOUN
dpc-4338	87	24	within	within	ADP
dpc-4338	87	25	24	24	NUM
dpc-4338	87	26	hours	hour	NOUN
dpc-4338	87	27	(	(	PUNCT
dpc-4338	87	28	figure	figure	NOUN
dpc-4338	87	29	4	4	NUM
dpc-4338	87	30	,	,	PUNCT
dpc-4338	87	31	p	p	X
dpc-4338	87	32	<	<	X
dpc-4338	87	33	0.001	0.001	NUM
dpc-4338	87	34	)	)	PUNCT
dpc-4338	87	35	.	.	PUNCT
dpc-4338	88	1	likewise	likewise	ADV
dpc-4338	88	2	,	,	PUNCT
dpc-4338	88	3	these	these	DET
dpc-4338	88	4	parameters	parameter	NOUN
dpc-4338	88	5	were	be	AUX
dpc-4338	88	6	significantly	significantly	ADV
dpc-4338	88	7	elevated	elevate	VERB
dpc-4338	88	8	at	at	ADP
dpc-4338	88	9	72	72	NUM
dpc-4338	88	10	hours	hour	NOUN
dpc-4338	88	11	in	in	ADP
dpc-4338	88	12	acd	acd	NOUN
dpc-4338	88	13	patients	patient	NOUN
dpc-4338	88	14	(	(	PUNCT
dpc-4338	88	15	figure	figure	NOUN
dpc-4338	88	16	4	4	NUM
dpc-4338	88	17	,	,	PUNCT
dpc-4338	88	18	p	p	X
dpc-4338	88	19	<	<	X
dpc-4338	88	20	0.001	0.001	NUM
dpc-4338	88	21	)	)	PUNCT
dpc-4338	88	22	.	.	PUNCT
dpc-4338	89	1	the	the	DET
dpc-4338	89	2	median	median	ADJ
dpc-4338	89	3	hemoglobin	hemoglobin	NOUN
dpc-4338	89	4	concentration	concentration	NOUN
dpc-4338	89	5	,	,	PUNCT
dpc-4338	89	6	skin	skin	NOUN
dpc-4338	89	7	texture	texture	NOUN
dpc-4338	89	8	,	,	PUNCT
dpc-4338	89	9	and	and	CCONJ
dpc-4338	89	10	volume	volume	NOUN
dpc-4338	89	11	increased	increase	VERB
dpc-4338	89	12	in	in	ADP
dpc-4338	89	13	both	both	DET
dpc-4338	89	14	groups	group	NOUN
dpc-4338	89	15	as	as	SCONJ
dpc-4338	89	16	the	the	DET
dpc-4338	89	17	intensity	intensity	NOUN
dpc-4338	89	18	of	of	ADP
dpc-4338	89	19	inflammation	inflammation	NOUN
dpc-4338	89	20	escalated	escalate	VERB
dpc-4338	89	21	.	.	PUNCT
dpc-4338	90	1	the	the	DET
dpc-4338	90	2	percentage	percentage	NOUN
dpc-4338	90	3	difference	difference	NOUN
dpc-4338	90	4	in	in	ADP
dpc-4338	90	5	median	median	ADJ
dpc-4338	90	6	hemoglobin	hemoglobin	NOUN
dpc-4338	90	7	concentration	concentration	NOUN
dpc-4338	90	8	was	be	AUX
dpc-4338	90	9	94.95	94.95	NUM
dpc-4338	90	10	%	%	NOUN
dpc-4338	90	11	in	in	ADP
dpc-4338	90	12	acd	acd	NOUN
dpc-4338	90	13	and	and	CCONJ
dpc-4338	90	14	47.14	47.14	NUM
dpc-4338	90	15	%	%	NOUN
dpc-4338	90	16	in	in	ADP
dpc-4338	90	17	icd	icd	PROPN
dpc-4338	90	18	patients	patient	NOUN
dpc-4338	90	19	.	.	PUNCT
dpc-4338	91	1	notably	notably	ADV
dpc-4338	91	2	,	,	PUNCT
dpc-4338	91	3	significant	significant	ADJ
dpc-4338	91	4	differences	difference	NOUN
dpc-4338	91	5	were	be	AUX
dpc-4338	91	6	observed	observe	VERB
dpc-4338	91	7	between	between	ADP
dpc-4338	91	8	acd	acd	NOUN
dpc-4338	91	9	and	and	CCONJ
dpc-4338	91	10	icd	icd	PROPN
dpc-4338	91	11	patients	patient	NOUN
dpc-4338	91	12	at	at	ADP
dpc-4338	91	13	72	72	NUM
dpc-4338	91	14	hours	hour	NOUN
dpc-4338	91	15	and	and	CCONJ
dpc-4338	91	16	24	24	NUM
dpc-4338	91	17	hours	hour	NOUN
dpc-4338	91	18	,	,	PUNCT
dpc-4338	91	19	respectively	respectively	ADV
dpc-4338	91	20	(	(	PUNCT
dpc-4338	91	21	figure	figure	NOUN
dpc-4338	91	22	4a	4a	NOUN
dpc-4338	91	23	,	,	PUNCT
dpc-4338	91	24	p	p	X
dpc-4338	91	25	<	<	X
dpc-4338	91	26	0.001	0.001	NUM
dpc-4338	91	27	)	)	PUNCT
dpc-4338	91	28	.	.	PUNCT
dpc-4338	92	1	the	the	DET
dpc-4338	92	2	percentage	percentage	NOUN
dpc-4338	92	3	difference	difference	NOUN
dpc-4338	92	4	in	in	ADP
dpc-4338	92	5	the	the	DET
dpc-4338	92	6	median	median	ADJ
dpc-4338	92	7	texture	texture	NOUN
dpc-4338	92	8	value	value	NOUN
dpc-4338	92	9	was	be	AUX
dpc-4338	92	10	66.39	66.39	NUM
dpc-4338	92	11	%	%	NOUN
dpc-4338	92	12	in	in	ADP
dpc-4338	92	13	acd	acd	NOUN
dpc-4338	92	14	compared	compare	VERB
dpc-4338	92	15	to	to	ADP
dpc-4338	92	16	37.73	37.73	NUM
dpc-4338	92	17	%	%	NOUN
dpc-4338	92	18	in	in	ADP
dpc-4338	92	19	icd	icd	PROPN
dpc-4338	92	20	patients	patient	NOUN
dpc-4338	92	21	.	.	PUNCT
dpc-4338	93	1	the	the	DET
dpc-4338	93	2	distinction	distinction	NOUN
dpc-4338	93	3	between	between	ADP
dpc-4338	93	4	acd	acd	NOUN
dpc-4338	93	5	and	and	CCONJ
dpc-4338	93	6	icd	icd	PROPN
dpc-4338	93	7	patients	patient	NOUN
dpc-4338	93	8	at	at	ADP
dpc-4338	93	9	the	the	DET
dpc-4338	93	10	time	time	NOUN
dpc-4338	93	11	of	of	ADP
dpc-4338	93	12	evaluation	evaluation	NOUN
dpc-4338	93	13	was	be	AUX
dpc-4338	93	14	statistically	statistically	ADV
dpc-4338	93	15	significant	significant	ADJ
dpc-4338	93	16	(	(	PUNCT
dpc-4338	93	17	figure	figure	NOUN
dpc-4338	93	18	4b	4b	PROPN
dpc-4338	93	19	,	,	PUNCT
dpc-4338	93	20	p	p	X
dpc-4338	93	21	<	<	X
dpc-4338	93	22	0.05	0.05	NUM
dpc-4338	93	23	)	)	PUNCT
dpc-4338	93	24	.	.	PUNCT
dpc-4338	94	1	similarly	similarly	ADV
dpc-4338	94	2	,	,	PUNCT
dpc-4338	94	3	significant	significant	ADJ
dpc-4338	94	4	differences	difference	NOUN
dpc-4338	94	5	were	be	AUX
dpc-4338	94	6	noted	note	VERB
dpc-4338	94	7	between	between	ADP
dpc-4338	94	8	acd	acd	NOUN
dpc-4338	94	9	and	and	CCONJ
dpc-4338	94	10	icd	icd	PROPN
dpc-4338	94	11	patients	patient	NOUN
dpc-4338	94	12	in	in	ADP
dpc-4338	94	13	terms	term	NOUN
dpc-4338	94	14	of	of	ADP
dpc-4338	94	15	volume	volume	NOUN
dpc-4338	94	16	(	(	PUNCT
dpc-4338	94	17	figure	figure	NOUN
dpc-4338	94	18	4c	4c	NOUN
dpc-4338	94	19	,	,	PUNCT
dpc-4338	94	20	p	p	X
dpc-4338	94	21	<	<	X
dpc-4338	94	22	0.05	0.05	NUM
dpc-4338	94	23	)	)	PUNCT
dpc-4338	94	24	.	.	PUNCT
dpc-4338	95	1	biophysical	biophysical	ADJ
dpc-4338	95	2	measurements	measurement	NOUN
dpc-4338	95	3	transepidermal	transepidermal	ADJ
dpc-4338	95	4	water	water	NOUN
dpc-4338	95	5	loss	loss	NOUN
dpc-4338	95	6	(	(	PUNCT
dpc-4338	95	7	tewl	tewl	NOUN
dpc-4338	95	8	)	)	PUNCT
dpc-4338	95	9	is	be	AUX
dpc-4338	95	10	directly	directly	ADV
dpc-4338	95	11	associated	associate	VERB
dpc-4338	95	12	with	with	ADP
dpc-4338	95	13	skin	skin	NOUN
dpc-4338	95	14	barrier	barrier	NOUN
dpc-4338	95	15	functionality	functionality	NOUN
dpc-4338	95	16	and	and	CCONJ
dpc-4338	95	17	indirectly	indirectly	ADV
dpc-4338	95	18	with	with	ADP
dpc-4338	95	19	the	the	DET
dpc-4338	95	20	intensity	intensity	NOUN
dpc-4338	95	21	of	of	ADP
dpc-4338	95	22	inflammation	inflammation	NOUN
dpc-4338	95	23	.	.	PUNCT
dpc-4338	96	1	significantly	significantly	ADV
dpc-4338	96	2	higher	high	ADJ
dpc-4338	96	3	tewl	tewl	NOUN
dpc-4338	96	4	levels	level	NOUN
dpc-4338	96	5	were	be	AUX
dpc-4338	96	6	noted	note	VERB
dpc-4338	96	7	in	in	ADP
dpc-4338	96	8	icd	icd	PROPN
dpc-4338	96	9	patients	patient	NOUN
dpc-4338	96	10	at	at	ADP
dpc-4338	96	11	24	24	NUM
dpc-4338	96	12	hours	hour	NOUN
dpc-4338	96	13	and	and	CCONJ
dpc-4338	96	14	in	in	ADP
dpc-4338	96	15	acd	acd	NOUN
dpc-4338	96	16	patients	patient	NOUN
dpc-4338	96	17	at	at	ADP
dpc-4338	96	18	72	72	NUM
dpc-4338	96	19	hours	hour	NOUN
dpc-4338	96	20	(	(	PUNCT
dpc-4338	96	21	figure	figure	NOUN
dpc-4338	96	22	5	5	NUM
dpc-4338	96	23	,	,	PUNCT
dpc-4338	96	24	p	p	X
dpc-4338	96	25	<	<	X
dpc-4338	96	26	0.001	0.001	NUM
dpc-4338	96	27	)	)	PUNCT
dpc-4338	96	28	.	.	PUNCT
dpc-4338	97	1	the	the	DET
dpc-4338	97	2	median	median	ADJ
dpc-4338	97	3	tewl	tewl	NOUN
dpc-4338	97	4	showed	show	VERB
dpc-4338	97	5	a	a	DET
dpc-4338	97	6	20	20	NUM
dpc-4338	97	7	%	%	NOUN
dpc-4338	97	8	increase	increase	NOUN
dpc-4338	97	9	in	in	ADP
dpc-4338	97	10	acd	acd	NOUN
dpc-4338	97	11	and	and	CCONJ
dpc-4338	97	12	a	a	DET
dpc-4338	97	13	406.42	406.42	NUM
dpc-4338	97	14	%	%	NOUN
dpc-4338	97	15	increase	increase	NOUN
dpc-4338	97	16	in	in	ADP
dpc-4338	97	17	icd	icd	PROPN
dpc-4338	97	18	patients	patient	NOUN
dpc-4338	97	19	.	.	PUNCT
dpc-4338	98	1	noteworthy	noteworthy	ADJ
dpc-4338	98	2	differences	difference	NOUN
dpc-4338	98	3	were	be	AUX
dpc-4338	98	4	identified	identify	VERB
dpc-4338	98	5	between	between	ADP
dpc-4338	98	6	acd	acd	NOUN
dpc-4338	98	7	and	and	CCONJ
dpc-4338	98	8	icd	icd	PROPN
dpc-4338	98	9	patients	patient	NOUN
dpc-4338	98	10	at	at	ADP
dpc-4338	98	11	the	the	DET
dpc-4338	98	12	time	time	NOUN
dpc-4338	98	13	of	of	ADP
dpc-4338	98	14	analysis	analysis	NOUN
dpc-4338	98	15	(	(	PUNCT
dpc-4338	98	16	figure	figure	NOUN
dpc-4338	98	17	5	5	NUM
dpc-4338	98	18	,	,	PUNCT
dpc-4338	98	19	p	p	X
dpc-4338	98	20	<	<	X
dpc-4338	98	21	0.05	0.05	NUM
dpc-4338	98	22	)	)	PUNCT
dpc-4338	98	23	.	.	PUNCT
dpc-4338	99	1	recorded	record	VERB
dpc-4338	99	2	in	in	ADP
dpc-4338	99	3	arbitrary	arbitrary	ADJ
dpc-4338	99	4	units	unit	NOUN
dpc-4338	99	5	.	.	PUNCT
dpc-4338	100	1	the	the	DET
dpc-4338	100	2	skin	skin	NOUN
dpc-4338	100	3	barrier	barrier	NOUN
dpc-4338	100	4	function	function	NOUN
dpc-4338	100	5	(	(	PUNCT
dpc-4338	100	6	tewl	tewl	NOUN
dpc-4338	100	7	)	)	PUNCT
dpc-4338	100	8	was	be	AUX
dpc-4338	100	9	evaluated	evaluate	VERB
dpc-4338	100	10	using	use	VERB
dpc-4338	100	11	a	a	DET
dpc-4338	100	12	tewameter	tewameter	NOUN
dpc-4338	100	13	tm	tm	ADP
dpc-4338	100	14	210	210	NUM
dpc-4338	100	15	(	(	PUNCT
dpc-4338	100	16	courage	courage	NOUN
dpc-4338	100	17	+	+	CCONJ
dpc-4338	100	18	khazaka	khazaka	PROPN
dpc-4338	100	19	electronic	electronic	ADJ
dpc-4338	100	20	gmbh	gmbh	NOUN
dpc-4338	100	21	,	,	PUNCT
dpc-4338	100	22	cologne	cologne	NOUN
dpc-4338	100	23	,	,	PUNCT
dpc-4338	100	24	germany	germany	PROPN
dpc-4338	100	25	)	)	PUNCT
dpc-4338	100	26	by	by	ADP
dpc-4338	100	27	measuring	measure	VERB
dpc-4338	100	28	the	the	DET
dpc-4338	100	29	density	density	NOUN
dpc-4338	100	30	gradient	gradient	NOUN
dpc-4338	100	31	of	of	ADP
dpc-4338	100	32	water	water	NOUN
dpc-4338	100	33	evaporation	evaporation	NOUN
dpc-4338	100	34	from	from	ADP
dpc-4338	100	35	the	the	DET
dpc-4338	100	36	skin	skin	NOUN
dpc-4338	100	37	,	,	PUNCT
dpc-4338	100	38	with	with	ADP
dpc-4338	100	39	estimations	estimation	NOUN
dpc-4338	100	40	based	base	VERB
dpc-4338	100	41	on	on	ADP
dpc-4338	100	42	the	the	DET
dpc-4338	100	43	mean	mean	ADJ
dpc-4338	100	44	value	value	NOUN
dpc-4338	100	45	of	of	ADP
dpc-4338	100	46	the	the	DET
dpc-4338	100	47	flux	flux	NOUN
dpc-4338	100	48	density	density	NOUN
dpc-4338	100	49	of	of	ADP
dpc-4338	100	50	water	water	NOUN
dpc-4338	100	51	(	(	PUNCT
dpc-4338	100	52	in	in	ADP
dpc-4338	100	53	g	g	PROPN
dpc-4338	100	54	/	/	SYM
dpc-4338	100	55	m2	m2	PROPN
dpc-4338	100	56	/	/	SYM
dpc-4338	100	57	h	h	NOUN
dpc-4338	100	58	)	)	PUNCT
dpc-4338	100	59	.	.	PUNCT
dpc-4338	101	1	erythema	erythema	ADJ
dpc-4338	101	2	and	and	CCONJ
dpc-4338	101	3	melanin	melanin	NOUN
dpc-4338	101	4	levels	level	NOUN
dpc-4338	101	5	were	be	AUX
dpc-4338	101	6	quantified	quantify	VERB
dpc-4338	101	7	using	use	VERB
dpc-4338	101	8	a	a	DET
dpc-4338	101	9	mexameter	mexameter	NOUN
dpc-4338	101	10	mx	mx	PROPN
dpc-4338	101	11	18	18	NUM
dpc-4338	101	12	(	(	PUNCT
dpc-4338	101	13	courage	courage	NOUN
dpc-4338	101	14	+	+	CCONJ
dpc-4338	101	15	khazaka	khazaka	PROPN
dpc-4338	101	16	electronic	electronic	ADJ
dpc-4338	101	17	gmbh	gmbh	NOUN
dpc-4338	101	18	,	,	PUNCT
dpc-4338	101	19	cologne	cologne	NOUN
dpc-4338	101	20	,	,	PUNCT
dpc-4338	101	21	germany	germany	PROPN
dpc-4338	101	22	)	)	PUNCT
dpc-4338	101	23	,	,	PUNCT
dpc-4338	101	24	with	with	SCONJ
dpc-4338	101	25	data	datum	NOUN
dpc-4338	101	26	also	also	ADV
dpc-4338	101	27	recorded	record	VERB
dpc-4338	101	28	in	in	ADP
dpc-4338	101	29	arbitrary	arbitrary	ADJ
dpc-4338	101	30	units	unit	NOUN
dpc-4338	101	31	.	.	PUNCT
dpc-4338	102	1	before	before	ADP
dpc-4338	102	2	each	each	DET
dpc-4338	102	3	measurement	measurement	NOUN
dpc-4338	102	4	,	,	PUNCT
dpc-4338	102	5	the	the	DET
dpc-4338	102	6	treated	treat	VERB
dpc-4338	102	7	area	area	NOUN
dpc-4338	102	8	was	be	AUX
dpc-4338	102	9	cleansed	cleanse	VERB
dpc-4338	102	10	with	with	ADP
dpc-4338	102	11	0.9	0.9	NUM
dpc-4338	102	12	%	%	NOUN
dpc-4338	102	13	sodium	sodium	NOUN
dpc-4338	102	14	chloride	chloride	NOUN
dpc-4338	102	15	solution	solution	NOUN
dpc-4338	102	16	and	and	CCONJ
dpc-4338	102	17	dried	dry	VERB
dpc-4338	102	18	with	with	ADP
dpc-4338	102	19	sterile	sterile	ADJ
dpc-4338	102	20	gauze	gauze	NOUN
dpc-4338	102	21	.	.	PUNCT
dpc-4338	103	1	statistical	statistical	ADJ
dpc-4338	103	2	analysis	analysis	NOUN
dpc-4338	103	3	the	the	DET
dpc-4338	103	4	statistical	statistical	ADJ
dpc-4338	103	5	analysis	analysis	NOUN
dpc-4338	103	6	commenced	commence	VERB
dpc-4338	103	7	with	with	ADP
dpc-4338	103	8	the	the	DET
dpc-4338	103	9	determination	determination	NOUN
dpc-4338	103	10	of	of	ADP
dpc-4338	103	11	descriptive	descriptive	ADJ
dpc-4338	103	12	criteria	criterion	NOUN
dpc-4338	103	13	and	and	CCONJ
dpc-4338	103	14	estimation	estimation	NOUN
dpc-4338	103	15	of	of	ADP
dpc-4338	103	16	scatter	scatter	NOUN
dpc-4338	103	17	metrics	metric	NOUN
dpc-4338	103	18	.	.	PUNCT
dpc-4338	104	1	normality	normality	NOUN
dpc-4338	104	2	testing	testing	NOUN
dpc-4338	104	3	was	be	AUX
dpc-4338	104	4	performed	perform	VERB
dpc-4338	104	5	prior	prior	ADV
dpc-4338	104	6	to	to	ADP
dpc-4338	104	7	statistical	statistical	ADJ
dpc-4338	104	8	comparisons	comparison	NOUN
dpc-4338	104	9	among	among	ADP
dpc-4338	104	10	two	two	NUM
dpc-4338	104	11	or	or	CCONJ
dpc-4338	104	12	more	more	ADJ
dpc-4338	104	13	groups	group	NOUN
dpc-4338	104	14	.	.	PUNCT
dpc-4338	105	1	the	the	DET
dpc-4338	105	2	shapiro	shapiro	PROPN
dpc-4338	105	3	-	-	PUNCT
dpc-4338	105	4	wilk	wilk	NOUN
dpc-4338	105	5	test	test	NOUN
dpc-4338	105	6	was	be	AUX
dpc-4338	105	7	utilized	utilize	VERB
dpc-4338	105	8	to	to	PART
dpc-4338	105	9	assess	assess	VERB
dpc-4338	105	10	the	the	DET
dpc-4338	105	11	normality	normality	NOUN
dpc-4338	105	12	of	of	ADP
dpc-4338	105	13	data	datum	NOUN
dpc-4338	105	14	distribution	distribution	NOUN
dpc-4338	105	15	.	.	PUNCT
dpc-4338	106	1	upon	upon	SCONJ
dpc-4338	106	2	rejection	rejection	NOUN
dpc-4338	106	3	of	of	ADP
dpc-4338	106	4	the	the	DET
dpc-4338	106	5	nominal	nominal	ADJ
dpc-4338	106	6	normality	normality	NOUN
dpc-4338	106	7	hypothesis	hypothesis	NOUN
dpc-4338	106	8	,	,	PUNCT
dpc-4338	106	9	the	the	DET
dpc-4338	106	10	data	datum	NOUN
dpc-4338	106	11	were	be	AUX
dpc-4338	106	12	deemed	deem	VERB
dpc-4338	106	13	to	to	PART
dpc-4338	106	14	deviate	deviate	VERB
dpc-4338	106	15	from	from	ADP
dpc-4338	106	16	a	a	DET
dpc-4338	106	17	normal	normal	ADJ
dpc-4338	106	18	distribution	distribution	NOUN
dpc-4338	106	19	.	.	PUNCT
dpc-4338	107	1	when	when	SCONJ
dpc-4338	107	2	data	datum	NOUN
dpc-4338	107	3	appeared	appear	VERB
dpc-4338	107	4	normally	normally	ADV
dpc-4338	107	5	distributed	distribute	VERB
dpc-4338	107	6	,	,	PUNCT
dpc-4338	107	7	parametric	parametric	ADJ
dpc-4338	107	8	procedures	procedure	NOUN
dpc-4338	107	9	were	be	AUX
dpc-4338	107	10	employed	employ	VERB
dpc-4338	107	11	.	.	PUNCT
dpc-4338	108	1	however	however	ADV
dpc-4338	108	2	,	,	PUNCT
dpc-4338	108	3	in	in	ADP
dpc-4338	108	4	all	all	DET
dpc-4338	108	5	instances	instance	NOUN
dpc-4338	108	6	within	within	ADP
dpc-4338	108	7	this	this	DET
dpc-4338	108	8	study	study	NOUN
dpc-4338	108	9	,	,	PUNCT
dpc-4338	108	10	as	as	SCONJ
dpc-4338	108	11	the	the	DET
dpc-4338	108	12	data	datum	NOUN
dpc-4338	108	13	were	be	AUX
dpc-4338	108	14	found	find	VERB
dpc-4338	108	15	not	not	PART
dpc-4338	108	16	to	to	PART
dpc-4338	108	17	be	be	AUX
dpc-4338	108	18	normally	normally	ADV
dpc-4338	108	19	distributed	distribute	VERB
dpc-4338	108	20	,	,	PUNCT
dpc-4338	108	21	non	non	X
dpc-4338	108	22	parametric	parametric	ADJ
dpc-4338	108	23	methods	method	NOUN
dpc-4338	108	24	were	be	AUX
dpc-4338	108	25	applied	apply	VERB
dpc-4338	108	26	.	.	PUNCT
dpc-4338	109	1	the	the	DET
dpc-4338	109	2	mann	mann	PROPN
dpc-4338	109	3	-	-	PUNCT
dpc-4338	109	4	whitney	whitney	PROPN
dpc-4338	109	5	u	u	PROPN
dpc-4338	109	6	test	test	NOUN
dpc-4338	109	7	was	be	AUX
dpc-4338	109	8	employed	employ	VERB
dpc-4338	109	9	for	for	ADP
dpc-4338	109	10	comparisons	comparison	NOUN
dpc-4338	109	11	between	between	ADP
dpc-4338	109	12	two	two	NUM
dpc-4338	109	13	independent	independent	ADJ
dpc-4338	109	14	groups	group	NOUN
dpc-4338	109	15	,	,	PUNCT
dpc-4338	109	16	for	for	ADP
dpc-4338	109	17	instance	instance	NOUN
dpc-4338	109	18	,	,	PUNCT
dpc-4338	109	19	to	to	PART
dpc-4338	109	20	evaluate	evaluate	VERB
dpc-4338	109	21	the	the	DET
dpc-4338	109	22	effect	effect	NOUN
dpc-4338	109	23	of	of	ADP
dpc-4338	109	24	sex	sex	NOUN
dpc-4338	109	25	.	.	PUNCT
dpc-4338	110	1	for	for	ADP
dpc-4338	110	2	pairwise	pairwise	NOUN
dpc-4338	110	3	comparisons	comparison	NOUN
dpc-4338	110	4	between	between	ADP
dpc-4338	110	5	groups	group	NOUN
dpc-4338	110	6	,	,	PUNCT
dpc-4338	110	7	such	such	ADJ
dpc-4338	110	8	as	as	ADP
dpc-4338	110	9	the	the	DET
dpc-4338	110	10	comparison	comparison	NOUN
dpc-4338	110	11	of	of	ADP
dpc-4338	110	12	skin	skin	NOUN
dpc-4338	110	13	biophysical	biophysical	ADJ
dpc-4338	110	14	parameters	parameter	NOUN
dpc-4338	110	15	across	across	ADP
dpc-4338	110	16	two	two	NUM
dpc-4338	110	17	different	different	ADJ
dpc-4338	110	18	time	time	NOUN
dpc-4338	110	19	points	point	NOUN
dpc-4338	110	20	,	,	PUNCT
dpc-4338	110	21	the	the	DET
dpc-4338	110	22	wilcoxon	wilcoxon	ADJ
dpc-4338	110	23	signed	sign	VERB
dpc-4338	110	24	-	-	PUNCT
dpc-4338	110	25	rank	rank	NOUN
dpc-4338	110	26	test	test	NOUN
dpc-4338	110	27	was	be	AUX
dpc-4338	110	28	used	use	VERB
dpc-4338	110	29	.	.	PUNCT
dpc-4338	111	1	the	the	DET
dpc-4338	111	2	type	type	NOUN
dpc-4338	111	3	i	i	PRON
dpc-4338	111	4	error	error	NOUN
dpc-4338	111	5	(	(	PUNCT
dpc-4338	111	6	significance	significance	NOUN
dpc-4338	111	7	level	level	NOUN
dpc-4338	111	8	)	)	PUNCT
dpc-4338	111	9	was	be	AUX
dpc-4338	111	10	set	set	VERB
dpc-4338	111	11	at	at	ADP
dpc-4338	111	12	5	5	NUM
dpc-4338	111	13	%	%	NOUN
dpc-4338	111	14	for	for	ADP
dpc-4338	111	15	all	all	DET
dpc-4338	111	16	analyses	analysis	NOUN
dpc-4338	111	17	within	within	ADP
dpc-4338	111	18	this	this	DET
dpc-4338	111	19	study	study	NOUN
dpc-4338	111	20	.	.	PUNCT
dpc-4338	112	1	a	a	DET
dpc-4338	112	2	result	result	NOUN
dpc-4338	112	3	was	be	AUX
dpc-4338	112	4	deemed	deem	VERB
dpc-4338	112	5	significant	significant	ADJ
dpc-4338	112	6	if	if	SCONJ
dpc-4338	112	7	the	the	DET
dpc-4338	112	8	estimated	estimate	VERB
dpc-4338	112	9	p	p	NOUN
dpc-4338	112	10	-	-	PUNCT
dpc-4338	112	11	value	value	NOUN
dpc-4338	112	12	(	(	PUNCT
dpc-4338	112	13	p	p	NOUN
dpc-4338	112	14	)	)	PUNCT
dpc-4338	112	15	was	be	AUX
dpc-4338	112	16	less	less	ADJ
dpc-4338	112	17	than	than	ADP
dpc-4338	112	18	the	the	DET
dpc-4338	112	19	significance	significance	NOUN
dpc-4338	112	20	level	level	NOUN
dpc-4338	112	21	,	,	PUNCT
dpc-4338	112	22	with	with	ADP
dpc-4338	112	23	p	p	NOUN
dpc-4338	112	24	-	-	PUNCT
dpc-4338	112	25	values	value	NOUN
dpc-4338	112	26	of	of	ADP
dpc-4338	112	27	<	<	X
dpc-4338	112	28	0.05	0.05	NUM
dpc-4338	112	29	denoted	denote	VERB
dpc-4338	112	30	as	as	ADP
dpc-4338	112	31	statistically	statistically	ADV
dpc-4338	112	32	significant	significant	ADJ
dpc-4338	112	33	and	and	CCONJ
dpc-4338	112	34	indicated	indicate	VERB
dpc-4338	112	35	by	by	ADP
dpc-4338	112	36	the	the	DET
dpc-4338	112	37	symbols	symbol	NOUN
dpc-4338	112	38	(	(	PUNCT
dpc-4338	112	39	*	*	NOUN
dpc-4338	112	40	)	)	PUNCT
dpc-4338	112	41	for	for	ADP
dpc-4338	112	42	p	p	NOUN
dpc-4338	112	43	<	<	X
dpc-4338	112	44	0.05	0.05	NUM
dpc-4338	112	45	,	,	PUNCT
dpc-4338	112	46	(	(	PUNCT
dpc-4338	112	47	*	*	PUNCT
dpc-4338	112	48	*	*	PUNCT
dpc-4338	112	49	)	)	PUNCT
dpc-4338	112	50	for	for	ADP
dpc-4338	112	51	p	p	NOUN
dpc-4338	112	52	<	<	X
dpc-4338	112	53	0.01	0.01	NUM
dpc-4338	112	54	,	,	PUNCT
dpc-4338	112	55	(	(	PUNCT
dpc-4338	112	56	*	*	PUNCT
dpc-4338	112	57	*	*	PUNCT
dpc-4338	112	58	*	*	PUNCT
dpc-4338	112	59	)	)	PUNCT
dpc-4338	112	60	for	for	ADP
dpc-4338	112	61	p	p	X
dpc-4338	112	62	 	 	SPACE
dpc-4338	112	63	<	<	X
dpc-4338	112	64	0.001	0.001	NUM
dpc-4338	112	65	,	,	PUNCT
dpc-4338	112	66	and	and	CCONJ
dpc-4338	112	67	(	(	PUNCT
dpc-4338	112	68	*	*	PUNCT
dpc-4338	112	69	*	*	PUNCT
dpc-4338	112	70	*	*	PUNCT
dpc-4338	112	71	*	*	PUNCT
dpc-4338	112	72	)	)	PUNCT
dpc-4338	112	73	for	for	ADP
dpc-4338	112	74	p	p	NOUN
dpc-4338	112	75	<	<	X
dpc-4338	112	76	0.0001	0.0001	NUM
dpc-4338	112	77	.	.	PUNCT
dpc-4338	113	1	all	all	DET
dpc-4338	113	2	statistical	statistical	ADJ
dpc-4338	113	3	analyses	analysis	NOUN
dpc-4338	113	4	were	be	AUX
dpc-4338	113	5	conducted	conduct	VERB
dpc-4338	113	6	using	use	VERB
dpc-4338	113	7	spss	spss	PROPN
dpc-4338	113	8	®	®	NOUN
dpc-4338	113	9	(	(	PUNCT
dpc-4338	113	10	v.25	v.25	PROPN
dpc-4338	113	11	,	,	PUNCT
dpc-4338	113	12	ibm	ibm	PROPN
dpc-4338	113	13	,	,	PUNCT
dpc-4338	113	14	chicago	chicago	PROPN
dpc-4338	113	15	,	,	PUNCT
dpc-4338	113	16	il	il	PROPN
dpc-4338	113	17	,	,	PUNCT
dpc-4338	113	18	usa	usa	PROPN
dpc-4338	113	19	)	)	PUNCT
dpc-4338	113	20	.	.	PUNCT
dpc-4338	114	1	results	result	VERB
dpc-4338	114	2	clinical	clinical	ADJ
dpc-4338	114	3	assessment	assessment	NOUN
dpc-4338	114	4	icd	icd	PROPN
dpc-4338	114	5	patients	patient	NOUN
dpc-4338	114	6	all	all	DET
dpc-4338	114	7	patients	patient	NOUN
dpc-4338	114	8	exhibited	exhibit	VERB
dpc-4338	114	9	erythema	erythema	ADJ
dpc-4338	114	10	at	at	ADP
dpc-4338	114	11	the	the	DET
dpc-4338	114	12	time	time	NOUN
dpc-4338	114	13	of	of	ADP
dpc-4338	114	14	evaluation	evaluation	NOUN
dpc-4338	114	15	(	(	PUNCT
dpc-4338	114	16	24	24	NUM
dpc-4338	114	17	hours	hour	NOUN
dpc-4338	114	18	)	)	PUNCT
dpc-4338	114	19	.	.	PUNCT
dpc-4338	115	1	acd	acd	NOUN
dpc-4338	115	2	patients	patient	NOUN
dpc-4338	115	3	the	the	DET
dpc-4338	115	4	clinical	clinical	ADJ
dpc-4338	115	5	assessment	assessment	NOUN
dpc-4338	115	6	of	of	ADP
dpc-4338	115	7	acd	acd	NOUN
dpc-4338	115	8	patients	patient	NOUN
dpc-4338	115	9	at	at	ADP
dpc-4338	115	10	72	72	NUM
dpc-4338	115	11	hours	hour	NOUN
dpc-4338	115	12	,	,	PUNCT
dpc-4338	115	13	based	base	VERB
dpc-4338	115	14	on	on	ADP
dpc-4338	115	15	the	the	DET
dpc-4338	115	16	icdrg	icdrg	NOUN
dpc-4338	115	17	criteria	criterion	NOUN
dpc-4338	115	18	,	,	PUNCT
dpc-4338	115	19	is	be	AUX
dpc-4338	115	20	illustrated	illustrate	VERB
dpc-4338	115	21	in	in	ADP
dpc-4338	115	22	figure	figure	NOUN
dpc-4338	115	23	1	1	NUM
dpc-4338	115	24	.	.	PUNCT
dpc-4338	116	1	strong	strong	ADJ
dpc-4338	116	2	reaction	reaction	NOUN
dpc-4338	116	3	(	(	PUNCT
dpc-4338	116	4	+	+	PUNCT
dpc-4338	116	5	+	+	CCONJ
dpc-4338	116	6	+	+	X
dpc-4338	116	7	)	)	PUNCT
dpc-4338	116	8	according	accord	VERB
dpc-4338	116	9	to	to	ADP
dpc-4338	116	10	the	the	DET
dpc-4338	116	11	icdrg	icdrg	ADJ
dpc-4338	116	12	scale	scale	NOUN
dpc-4338	116	13	was	be	AUX
dpc-4338	116	14	presented	present	VERB
dpc-4338	116	15	by	by	ADP
dpc-4338	116	16	ppd	ppd	PROPN
dpc-4338	116	17	1	1	NUM
dpc-4338	116	18	%	%	NOUN
dpc-4338	116	19	,	,	PUNCT
dpc-4338	116	20	textile	textile	NOUN
dpc-4338	116	21	dye	dye	NOUN
dpc-4338	116	22	mix	mix	NOUN
dpc-4338	116	23	6.6	6.6	NUM
dpc-4338	116	24	%	%	NOUN
dpc-4338	116	25	,	,	PUNCT
dpc-4338	116	26	and	and	CCONJ
dpc-4338	116	27	4	4	NUM
dpc-4338	116	28	aminoazobenzene	aminoazobenzene	NOUN
dpc-4338	116	29	1	1	NUM
dpc-4338	116	30	%	%	NOUN
dpc-4338	116	31	(	(	PUNCT
dpc-4338	116	32	figure	figure	NOUN
dpc-4338	116	33	1a	1a	NOUN
dpc-4338	116	34	)	)	PUNCT
dpc-4338	116	35	.	.	PUNCT
dpc-4338	117	1	nickel	nickel	NOUN
dpc-4338	117	2	sulfate	sulfate	NOUN
dpc-4338	117	3	5	5	NUM
dpc-4338	117	4	%	%	NOUN
dpc-4338	117	5	w	w	PROPN
dpc-4338	117	6	/	/	SYM
dpc-4338	117	7	w	w	NOUN
dpc-4338	117	8	solution	solution	NOUN
dpc-4338	117	9	was	be	AUX
dpc-4338	117	10	original	original	ADJ
dpc-4338	117	11	article	article	NOUN
dpc-4338	117	12	|	|	ADV
dpc-4338	117	13	dermatol	dermatol	ADJ
dpc-4338	117	14	pract	pract	NOUN
dpc-4338	117	15	concept	concept	NOUN
dpc-4338	117	16	.	.	PUNCT
dpc-4338	118	1	2024;14(4):e2024231	2024;14(4):e2024231	NUM
dpc-4338	118	2	5	5	NUM
dpc-4338	118	3	icdrg	icdrg	NOUN
dpc-4338	118	4	scale	scale	NOUN
dpc-4338	118	5	[	[	X
dpc-4338	118	6	13	13	NUM
dpc-4338	118	7	]	]	PUNCT
dpc-4338	118	8	.	.	PUNCT
dpc-4338	119	1	the	the	DET
dpc-4338	119	2	findings	finding	NOUN
dpc-4338	119	3	highlight	highlight	VERB
dpc-4338	119	4	nickel	nickel	NOUN
dpc-4338	119	5	sulfate	sulfate	NOUN
dpc-4338	119	6	(	(	PUNCT
dpc-4338	119	7	figure	figure	NOUN
dpc-4338	119	8	1b	1b	NUM
dpc-4338	119	9	)	)	PUNCT
dpc-4338	119	10	as	as	ADP
dpc-4338	119	11	the	the	DET
dpc-4338	119	12	most	most	ADV
dpc-4338	119	13	prevalent	prevalent	ADJ
dpc-4338	119	14	sensitizer	sensitizer	NOUN
dpc-4338	119	15	,	,	PUNCT
dpc-4338	119	16	aligning	align	VERB
dpc-4338	119	17	with	with	ADP
dpc-4338	119	18	observations	observation	NOUN
dpc-4338	119	19	made	make	VERB
dpc-4338	119	20	by	by	ADP
dpc-4338	119	21	dekoven	dekoven	ADJ
dpc-4338	119	22	et	et	PROPN
dpc-4338	119	23	al	al	PROPN
dpc-4338	119	24	.	.	PUNCT
dpc-4338	120	1	[	[	X
dpc-4338	120	2	17,19	17,19	NUM
dpc-4338	120	3	]	]	PUNCT
dpc-4338	120	4	.	.	PUNCT
dpc-4338	121	1	fluorescence	fluorescence	NOUN
dpc-4338	121	2	-	-	PUNCT
dpc-4338	121	3	based	base	VERB
dpc-4338	121	4	oxidative	oxidative	ADJ
dpc-4338	121	5	stress	stress	NOUN
dpc-4338	121	6	assessment	assessment	NOUN
dpc-4338	121	7	revealed	reveal	VERB
dpc-4338	121	8	no	no	DET
dpc-4338	121	9	significant	significant	ADJ
dpc-4338	121	10	differences	difference	NOUN
dpc-4338	121	11	between	between	ADP
dpc-4338	121	12	acd	acd	NOUN
dpc-4338	121	13	and	and	CCONJ
dpc-4338	121	14	icd	icd	PROPN
dpc-4338	121	15	patients	patient	NOUN
dpc-4338	121	16	(	(	PUNCT
dpc-4338	121	17	figure	figure	NOUN
dpc-4338	121	18	2	2	NUM
dpc-4338	121	19	)	)	PUNCT
dpc-4338	121	20	.	.	PUNCT
dpc-4338	122	1	however	however	ADV
dpc-4338	122	2	,	,	PUNCT
dpc-4338	122	3	oxidative	oxidative	ADJ
dpc-4338	122	4	stress	stress	NOUN
dpc-4338	122	5	levels	level	NOUN
dpc-4338	122	6	increased	increase	VERB
dpc-4338	122	7	in	in	ADP
dpc-4338	122	8	icd	icd	PROPN
dpc-4338	122	9	patients	patient	NOUN
dpc-4338	122	10	after	after	ADP
dpc-4338	122	11	24	24	NUM
dpc-4338	122	12	hours	hour	NOUN
dpc-4338	122	13	and	and	CCONJ
dpc-4338	122	14	in	in	ADP
dpc-4338	122	15	acd	acd	NOUN
dpc-4338	122	16	patients	patient	NOUN
dpc-4338	122	17	after	after	ADP
dpc-4338	122	18	72	72	NUM
dpc-4338	122	19	hours	hour	NOUN
dpc-4338	122	20	(	(	PUNCT
dpc-4338	122	21	p	p	X
dpc-4338	122	22	<	<	X
dpc-4338	122	23	0.05	0.05	NUM
dpc-4338	122	24	)	)	PUNCT
dpc-4338	122	25	,	,	PUNCT
dpc-4338	122	26	with	with	ADP
dpc-4338	122	27	significant	significant	ADJ
dpc-4338	122	28	elevations	elevation	NOUN
dpc-4338	122	29	observed	observe	VERB
dpc-4338	122	30	in	in	ADP
dpc-4338	122	31	response	response	NOUN
dpc-4338	122	32	to	to	ADP
dpc-4338	122	33	moderate	moderate	ADJ
dpc-4338	122	34	sensitizers	sensitizer	NOUN
dpc-4338	122	35	such	such	ADJ
dpc-4338	122	36	as	as	ADP
dpc-4338	122	37	amcinonide	amcinonide	NOUN
dpc-4338	122	38	and	and	CCONJ
dpc-4338	122	39	budesonide	budesonide	VERB
dpc-4338	122	40	and	and	CCONJ
dpc-4338	122	41	to	to	ADP
dpc-4338	122	42	strong	strong	ADJ
dpc-4338	122	43	sensitizers	sensitizer	NOUN
dpc-4338	122	44	like	like	ADP
dpc-4338	122	45	cobalt	cobalt	NOUN
dpc-4338	122	46	chloride	chloride	NOUN
dpc-4338	122	47	,	,	PUNCT
dpc-4338	122	48	nickel	nickel	NOUN
dpc-4338	122	49	sulfate	sulfate	NOUN
dpc-4338	122	50	,	,	PUNCT
dpc-4338	122	51	ppd	ppd	NOUN
dpc-4338	122	52	,	,	PUNCT
dpc-4338	122	53	and	and	CCONJ
dpc-4338	122	54	thiuram	thiuram	NOUN
dpc-4338	122	55	mix	mix	NOUN
dpc-4338	122	56	allergens	allergen	NOUN
dpc-4338	122	57	(	(	PUNCT
dpc-4338	122	58	table	table	NOUN
dpc-4338	122	59	2	2	NUM
dpc-4338	122	60	)	)	PUNCT
dpc-4338	123	1	[	[	X
dpc-4338	123	2	20	20	NUM
dpc-4338	123	3	-	-	SYM
dpc-4338	123	4	23	23	NUM
dpc-4338	123	5	]	]	PUNCT
dpc-4338	123	6	.	.	PUNCT
dpc-4338	124	1	ppd	ppd	PROPN
dpc-4338	124	2	,	,	PUNCT
dpc-4338	124	3	commonly	commonly	ADV
dpc-4338	124	4	found	find	VERB
dpc-4338	124	5	in	in	ADP
dpc-4338	124	6	hair	hair	NOUN
dpc-4338	124	7	dyes	dye	NOUN
dpc-4338	124	8	and	and	CCONJ
dpc-4338	124	9	black	black	ADJ
dpc-4338	124	10	henna	henna	NOUN
dpc-4338	124	11	tattoos	tattoo	NOUN
dpc-4338	124	12	,	,	PUNCT
dpc-4338	124	13	enhances	enhance	VERB
dpc-4338	124	14	the	the	DET
dpc-4338	124	15	formation	formation	NOUN
dpc-4338	124	16	of	of	ADP
dpc-4338	124	17	reactive	reactive	ADJ
dpc-4338	124	18	oxygen	oxygen	NOUN
dpc-4338	124	19	species	specie	NOUN
dpc-4338	124	20	(	(	PUNCT
dpc-4338	124	21	table	table	NOUN
dpc-4338	124	22	2	2	NUM
dpc-4338	124	23	)	)	PUNCT
dpc-4338	124	24	,	,	PUNCT
dpc-4338	124	25	thereby	thereby	ADV
dpc-4338	124	26	elevating	elevate	VERB
dpc-4338	124	27	oxidative	oxidative	ADJ
dpc-4338	124	28	stress	stress	NOUN
dpc-4338	124	29	in	in	ADP
dpc-4338	124	30	human	human	ADJ
dpc-4338	124	31	keratinocytes	keratinocyte	NOUN
dpc-4338	124	32	,	,	PUNCT
dpc-4338	124	33	a	a	DET
dpc-4338	124	34	finding	finding	NOUN
dpc-4338	124	35	consistent	consistent	ADJ
dpc-4338	124	36	with	with	ADP
dpc-4338	124	37	our	our	PRON
dpc-4338	124	38	results	result	NOUN
dpc-4338	124	39	[	[	X
dpc-4338	124	40	24,25	24,25	NUM
dpc-4338	124	41	]	]	PUNCT
dpc-4338	124	42	.	.	PUNCT
dpc-4338	125	1	discussion	discussion	NOUN
dpc-4338	125	2	all	all	DET
dpc-4338	125	3	participants	participant	NOUN
dpc-4338	125	4	in	in	ADP
dpc-4338	125	5	this	this	DET
dpc-4338	125	6	study	study	NOUN
dpc-4338	125	7	exhibited	exhibit	VERB
dpc-4338	125	8	signs	sign	NOUN
dpc-4338	125	9	of	of	ADP
dpc-4338	125	10	skin	skin	NOUN
dpc-4338	125	11	inflammation	inflammation	NOUN
dpc-4338	125	12	.	.	PUNCT
dpc-4338	126	1	in	in	ADP
dpc-4338	126	2	patients	patient	NOUN
dpc-4338	126	3	with	with	ADP
dpc-4338	126	4	icd	icd	PROPN
dpc-4338	126	5	,	,	PUNCT
dpc-4338	126	6	the	the	DET
dpc-4338	126	7	inflammatory	inflammatory	ADJ
dpc-4338	126	8	response	response	NOUN
dpc-4338	126	9	significantly	significantly	ADV
dpc-4338	126	10	subsided	subside	VERB
dpc-4338	126	11	48	48	NUM
dpc-4338	126	12	hours	hour	NOUN
dpc-4338	126	13	following	follow	VERB
dpc-4338	126	14	the	the	DET
dpc-4338	126	15	application	application	NOUN
dpc-4338	126	16	of	of	ADP
dpc-4338	126	17	sls	sls	PROPN
dpc-4338	126	18	,	,	PUNCT
dpc-4338	126	19	indicative	indicative	ADJ
dpc-4338	126	20	of	of	ADP
dpc-4338	126	21	icd	icd	PROPN
dpc-4338	126	22	’s	’s	PART
dpc-4338	126	23	characteristic	characteristic	ADJ
dpc-4338	126	24	direct	direct	ADJ
dpc-4338	126	25	harm	harm	NOUN
dpc-4338	126	26	to	to	ADP
dpc-4338	126	27	keratinocytes	keratinocyte	NOUN
dpc-4338	126	28	,	,	PUNCT
dpc-4338	126	29	which	which	PRON
dpc-4338	126	30	promptly	promptly	ADV
dpc-4338	126	31	triggers	trigger	VERB
dpc-4338	126	32	the	the	DET
dpc-4338	126	33	innate	innate	ADJ
dpc-4338	126	34	immune	immune	ADJ
dpc-4338	126	35	response	response	NOUN
dpc-4338	126	36	[	[	X
dpc-4338	126	37	18	18	NUM
dpc-4338	126	38	]	]	PUNCT
dpc-4338	126	39	.	.	PUNCT
dpc-4338	127	1	conversely	conversely	ADV
dpc-4338	127	2	,	,	PUNCT
dpc-4338	127	3	the	the	DET
dpc-4338	127	4	reaction	reaction	NOUN
dpc-4338	127	5	to	to	ADP
dpc-4338	127	6	allergens	allergen	NOUN
dpc-4338	127	7	in	in	ADP
dpc-4338	127	8	acd	acd	NOUN
dpc-4338	127	9	is	be	AUX
dpc-4338	127	10	typically	typically	ADV
dpc-4338	127	11	not	not	PART
dpc-4338	127	12	instantaneous	instantaneous	ADJ
dpc-4338	127	13	.	.	PUNCT
dpc-4338	128	1	despite	despite	SCONJ
dpc-4338	128	2	acd	acd	NOUN
dpc-4338	128	3	’s	’s	PART
dpc-4338	128	4	more	more	ADV
dpc-4338	128	5	severe	severe	ADJ
dpc-4338	128	6	clinical	clinical	ADJ
dpc-4338	128	7	presentation	presentation	NOUN
dpc-4338	128	8	compared	compare	VERB
dpc-4338	128	9	to	to	ADP
dpc-4338	128	10	icd	icd	PROPN
dpc-4338	128	11	,	,	PUNCT
dpc-4338	128	12	the	the	DET
dpc-4338	128	13	response	response	NOUN
dpc-4338	128	14	is	be	AUX
dpc-4338	128	15	delayed	delay	VERB
dpc-4338	128	16	,	,	PUNCT
dpc-4338	128	17	often	often	ADV
dpc-4338	128	18	taking	take	VERB
dpc-4338	128	19	up	up	ADP
dpc-4338	128	20	to	to	PART
dpc-4338	128	21	72	72	NUM
dpc-4338	128	22	hours	hour	NOUN
dpc-4338	128	23	to	to	PART
dpc-4338	128	24	manifest	manifest	VERB
dpc-4338	128	25	[	[	X
dpc-4338	128	26	18	18	NUM
dpc-4338	128	27	]	]	PUNCT
dpc-4338	128	28	.	.	PUNCT
dpc-4338	129	1	according	accord	VERB
dpc-4338	129	2	to	to	ADP
dpc-4338	129	3	the	the	DET
dpc-4338	129	4	icdrg	icdrg	NOUN
dpc-4338	129	5	criteria	criterion	NOUN
dpc-4338	129	6	,	,	PUNCT
dpc-4338	129	7	allergens	allergen	NOUN
dpc-4338	129	8	are	be	AUX
dpc-4338	129	9	categorized	categorize	VERB
dpc-4338	129	10	based	base	VERB
dpc-4338	129	11	on	on	ADP
dpc-4338	129	12	the	the	DET
dpc-4338	129	13	degree	degree	NOUN
dpc-4338	129	14	of	of	ADP
dpc-4338	129	15	reaction	reaction	NOUN
dpc-4338	129	16	within	within	ADP
dpc-4338	129	17	72	72	NUM
dpc-4338	129	18	hours	hour	NOUN
dpc-4338	129	19	(	(	PUNCT
dpc-4338	129	20	figure	figure	NOUN
dpc-4338	129	21	1a	1a	NOUN
dpc-4338	129	22	)	)	PUNCT
dpc-4338	129	23	.	.	PUNCT
dpc-4338	130	1	ppd	ppd	PROPN
dpc-4338	130	2	,	,	PUNCT
dpc-4338	130	3	textile	textile	ADJ
dpc-4338	130	4	dye	dye	NOUN
dpc-4338	130	5	mixtures	mixture	NOUN
dpc-4338	130	6	,	,	PUNCT
dpc-4338	130	7	and	and	CCONJ
dpc-4338	130	8	4	4	NUM
dpc-4338	130	9	-	-	PUNCT
dpc-4338	130	10	aminoazobenzene	aminoazobenzene	NOUN
dpc-4338	130	11	elicited	elicit	VERB
dpc-4338	130	12	the	the	DET
dpc-4338	130	13	most	most	ADV
dpc-4338	130	14	potent	potent	ADJ
dpc-4338	130	15	reactions	reaction	NOUN
dpc-4338	130	16	,	,	PUNCT
dpc-4338	130	17	corroborating	corroborate	VERB
dpc-4338	130	18	the	the	DET
dpc-4338	130	19	figure	figure	NOUN
dpc-4338	130	20	1	1	NUM
dpc-4338	130	21	.	.	PUNCT
dpc-4338	131	1	(	(	PUNCT
dpc-4338	131	2	a	a	X
dpc-4338	131	3	)	)	PUNCT
dpc-4338	131	4	clinical	clinical	ADJ
dpc-4338	131	5	assessment	assessment	NOUN
dpc-4338	131	6	of	of	ADP
dpc-4338	131	7	acd	acd	NOUN
dpc-4338	131	8	patients	patient	NOUN
dpc-4338	131	9	after	after	ADP
dpc-4338	131	10	72	72	NUM
dpc-4338	131	11	hours	hour	NOUN
dpc-4338	131	12	.	.	PUNCT
dpc-4338	132	1	incidents	incident	NOUN
dpc-4338	132	2	presented	present	VERB
dpc-4338	132	3	(	(	PUNCT
dpc-4338	132	4	+	+	NOUN
dpc-4338	132	5	)	)	PUNCT
dpc-4338	132	6	4.76	4.76	NUM
dpc-4338	132	7	%	%	NOUN
dpc-4338	132	8	,	,	PUNCT
dpc-4338	132	9	(	(	PUNCT
dpc-4338	132	10	+	+	NOUN
dpc-4338	132	11	+	+	NOUN
dpc-4338	132	12	)	)	PUNCT
dpc-4338	132	13	71.43	71.43	NUM
dpc-4338	132	14	%	%	NOUN
dpc-4338	132	15	and	and	CCONJ
dpc-4338	132	16	(	(	PUNCT
dpc-4338	132	17	+	+	ADJ
dpc-4338	132	18	+	+	NOUN
dpc-4338	132	19	+	+	NOUN
dpc-4338	132	20	)	)	PUNCT
dpc-4338	132	21	23.81	23.81	NUM
dpc-4338	132	22	%	%	NOUN
dpc-4338	132	23	.	.	PUNCT
dpc-4338	133	1	(	(	PUNCT
dpc-4338	133	2	b	b	X
dpc-4338	133	3	)	)	PUNCT
dpc-4338	133	4	the	the	DET
dpc-4338	133	5	most	most	ADV
dpc-4338	133	6	common	common	ADJ
dpc-4338	133	7	allergens	allergen	NOUN
dpc-4338	133	8	were	be	AUX
dpc-4338	133	9	,	,	PUNCT
dpc-4338	133	10	in	in	ADP
dpc-4338	133	11	order	order	NOUN
dpc-4338	133	12	,	,	PUNCT
dpc-4338	133	13	nickel	nickel	NOUN
dpc-4338	133	14	sulfate	sulfate	NOUN
dpc-4338	133	15	solution	solution	NOUN
dpc-4338	133	16	5	5	NUM
dpc-4338	133	17	%	%	NOUN
dpc-4338	133	18	w	w	PROPN
dpc-4338	133	19	/	/	SYM
dpc-4338	133	20	w	w	NOUN
dpc-4338	133	21	and	and	CCONJ
dpc-4338	133	22	textile	textile	ADJ
dpc-4338	133	23	dye	dye	NOUN
dpc-4338	133	24	mix	mix	NOUN
dpc-4338	133	25	6.6	6.6	NUM
dpc-4338	133	26	%	%	NOUN
dpc-4338	133	27	w	w	PROPN
dpc-4338	133	28	/	/	SYM
dpc-4338	133	29	w.	w.	NOUN
dpc-4338	133	30	6	6	NUM
dpc-4338	133	31	original	original	ADJ
dpc-4338	133	32	article	article	NOUN
dpc-4338	133	33	|	|	ADV
dpc-4338	133	34	dermatol	dermatol	ADJ
dpc-4338	133	35	pract	pract	NOUN
dpc-4338	133	36	concept	concept	NOUN
dpc-4338	133	37	.	.	PUNCT
dpc-4338	134	1	2024;14(4):e2024231	2024;14(4):e2024231	NUM
dpc-4338	135	1	our	our	PRON
dpc-4338	135	2	observation	observation	NOUN
dpc-4338	135	3	regarding	regard	VERB
dpc-4338	135	4	the	the	DET
dpc-4338	135	5	increase	increase	NOUN
dpc-4338	135	6	in	in	ADP
dpc-4338	135	7	oxidative	oxidative	ADJ
dpc-4338	135	8	stress	stress	NOUN
dpc-4338	135	9	caused	cause	VERB
dpc-4338	135	10	by	by	ADP
dpc-4338	135	11	nickel	nickel	NOUN
dpc-4338	135	12	sulfate	sulfate	NOUN
dpc-4338	135	13	(	(	PUNCT
dpc-4338	135	14	table	table	NOUN
dpc-4338	135	15	2	2	NUM
dpc-4338	135	16	)	)	PUNCT
dpc-4338	135	17	also	also	ADV
dpc-4338	135	18	supports	support	VERB
dpc-4338	135	19	the	the	DET
dpc-4338	135	20	notion	notion	NOUN
dpc-4338	135	21	of	of	ADP
dpc-4338	135	22	enhanced	enhanced	ADJ
dpc-4338	135	23	lipid	lipid	NOUN
dpc-4338	135	24	peroxidation	peroxidation	NOUN
dpc-4338	135	25	,	,	PUNCT
dpc-4338	135	26	as	as	SCONJ
dpc-4338	135	27	evidenced	evidence	VERB
dpc-4338	135	28	in	in	ADP
dpc-4338	135	29	previous	previous	ADJ
dpc-4338	135	30	studies	study	NOUN
dpc-4338	135	31	[	[	X
dpc-4338	135	32	27	27	NUM
dpc-4338	135	33	-	-	SYM
dpc-4338	135	34	29	29	NUM
dpc-4338	135	35	]	]	PUNCT
dpc-4338	135	36	.	.	PUNCT
dpc-4338	136	1	the	the	DET
dpc-4338	136	2	antera	antera	PROPN
dpc-4338	136	3	®	®	NOUN
dpc-4338	136	4	3d	3d	PROPN
dpc-4338	136	5	camera	camera	NOUN
dpc-4338	136	6	facilitated	facilitate	VERB
dpc-4338	136	7	the	the	DET
dpc-4338	136	8	evaluation	evaluation	NOUN
dpc-4338	136	9	of	of	ADP
dpc-4338	136	10	inflammation	inflammation	ADJ
dpc-4338	136	11	intensity	intensity	NOUN
dpc-4338	136	12	in	in	ADP
dpc-4338	136	13	icd	icd	PROPN
dpc-4338	136	14	and	and	CCONJ
dpc-4338	136	15	acd	acd	NOUN
dpc-4338	136	16	,	,	PUNCT
dpc-4338	136	17	demonstrating	demonstrate	VERB
dpc-4338	136	18	that	that	PRON
dpc-4338	136	19	mean	mean	VERB
dpc-4338	136	20	hemoglobin	hemoglobin	NOUN
dpc-4338	136	21	concentration	concentration	NOUN
dpc-4338	136	22	and	and	CCONJ
dpc-4338	136	23	skin	skin	NOUN
dpc-4338	136	24	texture	texture	ADJ
dpc-4338	136	25	values	value	NOUN
dpc-4338	136	26	figure	figure	VERB
dpc-4338	136	27	2	2	NUM
dpc-4338	136	28	.	.	PUNCT
dpc-4338	136	29	mean	mean	ADJ
dpc-4338	136	30	value	value	NOUN
dpc-4338	136	31	of	of	ADP
dpc-4338	136	32	fluorescence	fluorescence	NOUN
dpc-4338	136	33	for	for	ADP
dpc-4338	136	34	icd	icd	PROPN
dpc-4338	136	35	and	and	CCONJ
dpc-4338	136	36	acd	acd	NOUN
dpc-4338	136	37	patients	patient	NOUN
dpc-4338	136	38	.	.	PUNCT
dpc-4338	137	1	fluorescence	fluorescence	ADJ
dpc-4338	137	2	values	value	NOUN
dpc-4338	137	3	were	be	AUX
dpc-4338	137	4	significantly	significantly	ADV
dpc-4338	137	5	increased	increase	VERB
dpc-4338	137	6	for	for	ADP
dpc-4338	137	7	both	both	DET
dpc-4338	137	8	groups	group	NOUN
dpc-4338	137	9	at	at	ADP
dpc-4338	137	10	the	the	DET
dpc-4338	137	11	time	time	NOUN
dpc-4338	137	12	of	of	ADP
dpc-4338	137	13	evaluation	evaluation	NOUN
dpc-4338	137	14	(	(	PUNCT
dpc-4338	137	15	*	*	PUNCT
dpc-4338	137	16	*	*	PUNCT
dpc-4338	137	17	*	*	PUNCT
dpc-4338	137	18	p	p	X
dpc-4338	137	19	<	<	X
dpc-4338	137	20	0.001	0.001	NUM
dpc-4338	137	21	)	)	PUNCT
dpc-4338	137	22	.	.	PUNCT
dpc-4338	138	1	figure	figure	VERB
dpc-4338	138	2	3	3	NUM
dpc-4338	138	3	.	.	PUNCT
dpc-4338	138	4	antera	antera	NOUN
dpc-4338	138	5	®	®	NOUN
dpc-4338	138	6	3d	3d	NOUN
dpc-4338	138	7	images	image	NOUN
dpc-4338	138	8	of	of	ADP
dpc-4338	138	9	acd	acd	NOUN
dpc-4338	138	10	and	and	CCONJ
dpc-4338	138	11	icd	icd	PROPN
dpc-4338	138	12	patients	patient	NOUN
dpc-4338	138	13	.	.	PUNCT
dpc-4338	139	1	(	(	PUNCT
dpc-4338	139	2	a	a	X
dpc-4338	139	3	)	)	PUNCT
dpc-4338	139	4	textile	textile	NOUN
dpc-4338	139	5	dye	dye	NOUN
dpc-4338	139	6	mixture	mixture	NOUN
dpc-4338	139	7	:	:	PUNCT
dpc-4338	139	8	a	a	DET
dpc-4338	139	9	21	21	NUM
dpc-4338	139	10	-	-	PUNCT
dpc-4338	139	11	year	year	NOUN
dpc-4338	139	12	-	-	PUNCT
dpc-4338	139	13	old	old	ADJ
dpc-4338	139	14	female	female	ADJ
dpc-4338	139	15	patient	patient	NOUN
dpc-4338	139	16	with	with	ADP
dpc-4338	139	17	allergic	allergic	ADJ
dpc-4338	139	18	contact	contact	NOUN
dpc-4338	139	19	dermatitis	dermatitis	NOUN
dpc-4338	139	20	.	.	PUNCT
dpc-4338	140	1	(	(	PUNCT
dpc-4338	140	2	b	b	X
dpc-4338	140	3	)	)	PUNCT
dpc-4338	140	4	ppd	ppd	NOUN
dpc-4338	140	5	:	:	PUNCT
dpc-4338	140	6	a	a	DET
dpc-4338	140	7	21	21	NUM
dpc-4338	140	8	-	-	PUNCT
dpc-4338	140	9	year	year	NOUN
dpc-4338	140	10	-	-	PUNCT
dpc-4338	140	11	old	old	ADJ
dpc-4338	140	12	female	female	ADJ
dpc-4338	140	13	patient	patient	NOUN
dpc-4338	140	14	with	with	ADP
dpc-4338	140	15	allergic	allergic	ADJ
dpc-4338	140	16	contact	contact	NOUN
dpc-4338	140	17	dermatitis	dermatitis	NOUN
dpc-4338	140	18	.	.	PUNCT
dpc-4338	141	1	(	(	PUNCT
dpc-4338	141	2	c	c	X
dpc-4338	141	3	)	)	PUNCT
dpc-4338	141	4	a	a	DET
dpc-4338	141	5	45	45	NUM
dpc-4338	141	6	-	-	PUNCT
dpc-4338	141	7	year	year	NOUN
dpc-4338	141	8	-	-	PUNCT
dpc-4338	141	9	old	old	ADJ
dpc-4338	141	10	female	female	ADJ
dpc-4338	141	11	patient	patient	NOUN
dpc-4338	141	12	irritated	irritated	ADJ
dpc-4338	141	13	with	with	ADP
dpc-4338	141	14	sls	sls	PROPN
dpc-4338	141	15	6	6	NUM
dpc-4338	141	16	%	%	NOUN
dpc-4338	141	17	in	in	ADP
dpc-4338	141	18	the	the	DET
dpc-4338	141	19	forearm	forearm	NOUN
dpc-4338	141	20	.	.	PUNCT
dpc-4338	142	1	(	(	PUNCT
dpc-4338	142	2	d	d	X
dpc-4338	142	3	)	)	PUNCT
dpc-4338	142	4	a	a	DET
dpc-4338	142	5	55	55	NUM
dpc-4338	142	6	-	-	PUNCT
dpc-4338	142	7	year	year	NOUN
dpc-4338	142	8	-	-	PUNCT
dpc-4338	142	9	old	old	ADJ
dpc-4338	142	10	female	female	ADJ
dpc-4338	142	11	patient	patient	NOUN
dpc-4338	142	12	irritated	irritated	ADJ
dpc-4338	142	13	with	with	ADP
dpc-4338	142	14	sls	sls	PROPN
dpc-4338	142	15	6	6	NUM
dpc-4338	142	16	%	%	NOUN
dpc-4338	142	17	in	in	ADP
dpc-4338	142	18	the	the	DET
dpc-4338	142	19	forearm	forearm	NOUN
dpc-4338	142	20	.	.	PUNCT
dpc-4338	143	1	table	table	NOUN
dpc-4338	143	2	2	2	NUM
dpc-4338	143	3	.	.	X
dpc-4338	143	4	increase	increase	VERB
dpc-4338	143	5	in	in	ADP
dpc-4338	143	6	allergen	allergen	NOUN
dpc-4338	143	7	oxidative	oxidative	ADJ
dpc-4338	143	8	stress	stress	NOUN
dpc-4338	143	9	at	at	ADP
dpc-4338	143	10	72	72	NUM
dpc-4338	143	11	hours	hour	NOUN
dpc-4338	143	12	expressed	express	VERB
dpc-4338	143	13	in	in	ADP
dpc-4338	143	14	fluorescence	fluorescence	ADJ
dpc-4338	143	15	units	unit	NOUN
dpc-4338	143	16	.	.	PUNCT
dpc-4338	144	1	allergens	allergen	NOUN
dpc-4338	144	2	mean	mean	VERB
dpc-4338	144	3	increase	increase	NOUN
dpc-4338	144	4	in	in	ADP
dpc-4338	144	5	fluorescence	fluorescence	ADJ
dpc-4338	144	6	units	unit	NOUN
dpc-4338	144	7	formaldehyde	formaldehyde	NOUN
dpc-4338	144	8	2	2	NUM
dpc-4338	144	9	%	%	NOUN
dpc-4338	144	10	420	420	NUM
dpc-4338	144	11	thiuram	thiuram	NOUN
dpc-4338	144	12	mix	mix	NOUN
dpc-4338	144	13	1	1	NUM
dpc-4338	144	14	%	%	NOUN
dpc-4338	144	15	1537	1537	NUM
dpc-4338	144	16	nickel	nickel	NOUN
dpc-4338	144	17	sulfate	sulfate	NOUN
dpc-4338	144	18	5	5	NUM
dpc-4338	144	19	%	%	NOUN
dpc-4338	144	20	0	0	NUM
dpc-4338	144	21	budesonide	budesonide	VERB
dpc-4338	144	22	0.01	0.01	NUM
dpc-4338	144	23	%	%	NOUN
dpc-4338	144	24	2936	2936	NUM
dpc-4338	144	25	amcinonide	amcinonide	ADV
dpc-4338	144	26	0.1	0.1	NUM
dpc-4338	144	27	%	%	NOUN
dpc-4338	144	28	2677	2677	NUM
dpc-4338	144	29	colophonium	colophonium	NOUN
dpc-4338	144	30	20	20	NUM
dpc-4338	144	31	%	%	NOUN
dpc-4338	144	32	0	0	NUM
dpc-4338	144	33	thiomersal	thiomersal	ADJ
dpc-4338	144	34	0.1	0.1	NUM
dpc-4338	144	35	%	%	NOUN
dpc-4338	144	36	2155	2155	NUM
dpc-4338	144	37	ppd	ppd	NOUN
dpc-4338	144	38	1	1	NUM
dpc-4338	144	39	%	%	NOUN
dpc-4338	144	40	2046	2046	NUM
dpc-4338	144	41	textile	textile	NOUN
dpc-4338	144	42	dye	dye	NOUN
dpc-4338	144	43	mix	mix	NOUN
dpc-4338	144	44	6.6	6.6	NUM
dpc-4338	144	45	%	%	NOUN
dpc-4338	144	46	1323	1323	NUM
dpc-4338	144	47	textile	textile	NOUN
dpc-4338	144	48	dye	dye	NOUN
dpc-4338	144	49	mix	mix	NOUN
dpc-4338	144	50	6.6	6.6	NUM
dpc-4338	144	51	%	%	NOUN
dpc-4338	144	52	1528	1528	NUM
dpc-4338	144	53	fragrance	fragrance	NOUN
dpc-4338	144	54	mix	mix	NOUN
dpc-4338	144	55	ii	ii	NOUN
dpc-4338	144	56	14	14	NUM
dpc-4338	144	57	%	%	NOUN
dpc-4338	144	58	1195	1195	NUM
dpc-4338	144	59	fragrance	fragrance	NOUN
dpc-4338	144	60	mix	mix	NOUN
dpc-4338	144	61	i	i	PRON
dpc-4338	144	62	8	8	NUM
dpc-4338	144	63	%	%	NOUN
dpc-4338	144	64	576	576	NUM
dpc-4338	144	65	nickel	nickel	NOUN
dpc-4338	144	66	sulfate	sulfate	NOUN
dpc-4338	144	67	5	5	NUM
dpc-4338	144	68	%	%	NOUN
dpc-4338	144	69	3049	3049	NUM
dpc-4338	144	70	cobalt	cobalt	NOUN
dpc-4338	144	71	chloride	chloride	NOUN
dpc-4338	144	72	1	1	NUM
dpc-4338	144	73	%	%	NOUN
dpc-4338	144	74	3703	3703	NUM
dpc-4338	144	75	ppd	ppd	NOUN
dpc-4338	144	76	1	1	NUM
dpc-4338	144	77	%	%	NOUN
dpc-4338	144	78	1576	1576	NUM
dpc-4338	144	79	textile	textile	NOUN
dpc-4338	144	80	dye	dye	NOUN
dpc-4338	144	81	mix	mix	NOUN
dpc-4338	144	82	6.6	6.6	NUM
dpc-4338	144	83	%	%	NOUN
dpc-4338	144	84	463	463	NUM
dpc-4338	144	85	4	4	NUM
dpc-4338	144	86	-	-	PUNCT
dpc-4338	144	87	aminoazobenzene	aminoazobenzene	NOUN
dpc-4338	144	88	1	1	NUM
dpc-4338	144	89	%	%	NOUN
dpc-4338	144	90	598	598	NUM
dpc-4338	144	91	nickel	nickel	NOUN
dpc-4338	144	92	sulfate	sulfate	NOUN
dpc-4338	144	93	5	5	NUM
dpc-4338	144	94	%	%	NOUN
dpc-4338	144	95	2965	2965	NUM
dpc-4338	144	96	thiuram	thiuram	NOUN
dpc-4338	144	97	mix	mix	NOUN
dpc-4338	144	98	1	1	NUM
dpc-4338	144	99	%	%	NOUN
dpc-4338	144	100	4990	4990	NUM
dpc-4338	144	101	nickel	nickel	NOUN
dpc-4338	144	102	sulfate	sulfate	NOUN
dpc-4338	144	103	5	5	NUM
dpc-4338	144	104	%	%	NOUN
dpc-4338	144	105	3936	3936	NUM
dpc-4338	144	106	fragrance	fragrance	NOUN
dpc-4338	144	107	mix	mix	NOUN
dpc-4338	144	108	i	i	PRON
dpc-4338	144	109	8	8	NUM
dpc-4338	144	110	%	%	NOUN
dpc-4338	144	111	0	0	NUM
dpc-4338	144	112	original	original	ADJ
dpc-4338	144	113	article	article	NOUN
dpc-4338	144	114	|	|	ADV
dpc-4338	144	115	dermatol	dermatol	ADJ
dpc-4338	144	116	pract	pract	NOUN
dpc-4338	144	117	concept	concept	NOUN
dpc-4338	144	118	.	.	PUNCT
dpc-4338	145	1	2024;14(4):e2024231	2024;14(4):e2024231	NUM
dpc-4338	145	2	7	7	NUM
dpc-4338	145	3	limitations	limitation	NOUN
dpc-4338	145	4	given	give	VERB
dpc-4338	145	5	the	the	DET
dpc-4338	145	6	limited	limited	ADJ
dpc-4338	145	7	sample	sample	NOUN
dpc-4338	145	8	size	size	NOUN
dpc-4338	145	9	of	of	ADP
dpc-4338	145	10	21	21	NUM
dpc-4338	145	11	patients	patient	NOUN
dpc-4338	145	12	each	each	PRON
dpc-4338	145	13	for	for	ADP
dpc-4338	145	14	acd	acd	NOUN
dpc-4338	145	15	and	and	CCONJ
dpc-4338	145	16	icd	icd	NOUN
dpc-4338	145	17	,	,	PUNCT
dpc-4338	145	18	further	further	ADJ
dpc-4338	145	19	research	research	NOUN
dpc-4338	145	20	is	be	AUX
dpc-4338	145	21	necessary	necessary	ADJ
dpc-4338	145	22	to	to	PART
dpc-4338	145	23	definitively	definitively	ADV
dpc-4338	145	24	ascertain	ascertain	VERB
dpc-4338	145	25	whether	whether	SCONJ
dpc-4338	145	26	biophysical	biophysical	ADJ
dpc-4338	145	27	measurements	measurement	NOUN
dpc-4338	145	28	,	,	PUNCT
dpc-4338	145	29	antera	antera	NOUN
dpc-4338	145	30	®	®	NOUN
dpc-4338	145	31	3d	3d	PROPN
dpc-4338	145	32	camera	camera	NOUN
dpc-4338	145	33	imaging	imaging	NOUN
dpc-4338	145	34	,	,	PUNCT
dpc-4338	145	35	and	and	CCONJ
dpc-4338	145	36	oxidative	oxidative	ADJ
dpc-4338	145	37	stress	stress	NOUN
dpc-4338	145	38	analysis	analysis	NOUN
dpc-4338	145	39	can	can	AUX
dpc-4338	145	40	distinguish	distinguish	VERB
dpc-4338	145	41	between	between	ADP
dpc-4338	145	42	icd	icd	PROPN
dpc-4338	145	43	and	and	CCONJ
dpc-4338	145	44	acd	acd	NOUN
dpc-4338	145	45	inflammation	inflammation	NOUN
dpc-4338	145	46	effectively	effectively	ADV
dpc-4338	145	47	.	.	PUNCT
dpc-4338	146	1	conclusions	conclusion	NOUN
dpc-4338	146	2	numerous	numerous	ADJ
dpc-4338	146	3	distinctions	distinction	NOUN
dpc-4338	146	4	were	be	AUX
dpc-4338	146	5	identified	identify	VERB
dpc-4338	146	6	between	between	ADP
dpc-4338	146	7	acd	acd	NOUN
dpc-4338	146	8	and	and	CCONJ
dpc-4338	146	9	icd	icd	PROPN
dpc-4338	146	10	responses	response	NOUN
dpc-4338	146	11	.	.	PUNCT
dpc-4338	147	1	icd	icd	PROPN
dpc-4338	147	2	prompts	prompt	VERB
dpc-4338	147	3	an	an	DET
dpc-4338	147	4	almost	almost	ADV
dpc-4338	147	5	immediate	immediate	ADJ
dpc-4338	147	6	inflammatory	inflammatory	ADJ
dpc-4338	147	7	reaction	reaction	NOUN
dpc-4338	147	8	(	(	PUNCT
dpc-4338	147	9	peaking	peak	VERB
dpc-4338	147	10	at	at	ADP
dpc-4338	147	11	24	24	NUM
dpc-4338	147	12	hours	hour	NOUN
dpc-4338	147	13	)	)	PUNCT
dpc-4338	147	14	,	,	PUNCT
dpc-4338	147	15	whereas	whereas	SCONJ
dpc-4338	147	16	acd	acd	NOUN
dpc-4338	147	17	incites	incite	VERB
dpc-4338	147	18	a	a	DET
dpc-4338	147	19	delayed	delay	VERB
dpc-4338	147	20	response	response	NOUN
dpc-4338	147	21	(	(	PUNCT
dpc-4338	147	22	72	72	NUM
dpc-4338	147	23	hours	hour	NOUN
dpc-4338	147	24	)	)	PUNCT
dpc-4338	147	25	.	.	PUNCT
dpc-4338	148	1	the	the	DET
dpc-4338	148	2	reduction	reduction	NOUN
dpc-4338	148	3	in	in	ADP
dpc-4338	148	4	skin	skin	NOUN
dpc-4338	148	5	barrier	barrier	NOUN
dpc-4338	148	6	function	function	NOUN
dpc-4338	148	7	was	be	AUX
dpc-4338	148	8	substantially	substantially	ADV
dpc-4338	148	9	greater	great	ADJ
dpc-4338	148	10	in	in	ADP
dpc-4338	148	11	icd	icd	PROPN
dpc-4338	148	12	than	than	ADP
dpc-4338	148	13	in	in	ADP
dpc-4338	148	14	acd	acd	NOUN
dpc-4338	148	15	.	.	PUNCT
dpc-4338	149	1	all	all	DET
dpc-4338	149	2	antera	antera	NOUN
dpc-4338	149	3	®	®	NOUN
dpc-4338	149	4	3d	3d	NUM
dpc-4338	149	5	parameters	parameter	NOUN
dpc-4338	149	6	(	(	PUNCT
dpc-4338	149	7	hemoglobin	hemoglobin	NOUN
dpc-4338	149	8	concentration	concentration	NOUN
dpc-4338	149	9	,	,	PUNCT
dpc-4338	149	10	skin	skin	NOUN
dpc-4338	149	11	texture	texture	NOUN
dpc-4338	149	12	,	,	PUNCT
dpc-4338	149	13	and	and	CCONJ
dpc-4338	149	14	volume	volume	NOUN
dpc-4338	149	15	)	)	PUNCT
dpc-4338	149	16	were	be	AUX
dpc-4338	149	17	significantly	significantly	ADV
dpc-4338	149	18	elevated	elevate	VERB
dpc-4338	149	19	in	in	ADP
dpc-4338	149	20	acd	acd	NOUN
dpc-4338	149	21	compared	compare	VERB
dpc-4338	149	22	to	to	ADP
dpc-4338	149	23	icd	icd	PROPN
dpc-4338	149	24	patients	patient	NOUN
dpc-4338	149	25	.	.	PUNCT
dpc-4338	150	1	no	no	DET
dpc-4338	150	2	statistically	statistically	ADV
dpc-4338	150	3	significant	significant	ADJ
dpc-4338	150	4	differences	difference	NOUN
dpc-4338	150	5	in	in	ADP
dpc-4338	150	6	oxidative	oxidative	ADJ
dpc-4338	150	7	stress	stress	NOUN
dpc-4338	150	8	were	be	AUX
dpc-4338	150	9	noted	note	VERB
dpc-4338	150	10	between	between	ADP
dpc-4338	150	11	acd	acd	NOUN
dpc-4338	150	12	and	and	CCONJ
dpc-4338	150	13	icd	icd	PROPN
dpc-4338	150	14	patients	patient	NOUN
dpc-4338	150	15	.	.	PUNCT
dpc-4338	151	1	nickel	nickel	NOUN
dpc-4338	151	2	sulfate	sulfate	NOUN
dpc-4338	151	3	emerged	emerge	VERB
dpc-4338	151	4	as	as	ADP
dpc-4338	151	5	the	the	DET
dpc-4338	151	6	most	most	ADV
dpc-4338	151	7	common	common	ADJ
dpc-4338	151	8	sensitizer	sensitizer	NOUN
dpc-4338	151	9	,	,	PUNCT
dpc-4338	151	10	while	while	SCONJ
dpc-4338	151	11	ppd	ppd	NOUN
dpc-4338	151	12	,	,	PUNCT
dpc-4338	151	13	textile	textile	ADJ
dpc-4338	151	14	dye	dye	NOUN
dpc-4338	151	15	mix	mix	NOUN
dpc-4338	151	16	,	,	PUNCT
dpc-4338	151	17	and	and	CCONJ
dpc-4338	151	18	4	4	NUM
dpc-4338	151	19	-	-	PUNCT
dpc-4338	151	20	aminoazobenzene	aminoazobenzene	NOUN
dpc-4338	151	21	triggered	trigger	VERB
dpc-4338	151	22	the	the	DET
dpc-4338	151	23	most	most	ADV
dpc-4338	151	24	severe	severe	ADJ
dpc-4338	151	25	inflammatory	inflammatory	ADJ
dpc-4338	151	26	responses	response	NOUN
dpc-4338	151	27	.	.	PUNCT
dpc-4338	152	1	allergens	allergen	NOUN
dpc-4338	152	2	such	such	ADJ
dpc-4338	152	3	as	as	ADP
dpc-4338	152	4	amcinonide	amcinonide	ADJ
dpc-4338	152	5	,	,	PUNCT
dpc-4338	152	6	nickel	nickel	NOUN
dpc-4338	152	7	sulfate	sulfate	NOUN
dpc-4338	152	8	,	,	PUNCT
dpc-4338	152	9	cobalt	cobalt	NOUN
dpc-4338	152	10	chloride	chloride	NOUN
dpc-4338	152	11	,	,	PUNCT
dpc-4338	152	12	budesonide	budesonide	NOUN
dpc-4338	152	13	,	,	PUNCT
dpc-4338	152	14	ppd	ppd	NOUN
dpc-4338	152	15	,	,	PUNCT
dpc-4338	152	16	and	and	CCONJ
dpc-4338	152	17	thiuram	thiuram	NOUN
dpc-4338	152	18	mix	mix	NOUN
dpc-4338	152	19	were	be	AUX
dpc-4338	152	20	found	find	VERB
dpc-4338	152	21	to	to	PART
dpc-4338	152	22	induce	induce	VERB
dpc-4338	152	23	significant	significant	ADJ
dpc-4338	152	24	oxidative	oxidative	ADJ
dpc-4338	152	25	stress	stress	NOUN
dpc-4338	152	26	.	.	PUNCT
dpc-4338	153	1	acknowledgments	acknowledgment	NOUN
dpc-4338	153	2	the	the	DET
dpc-4338	153	3	authors	author	NOUN
dpc-4338	153	4	would	would	AUX
dpc-4338	153	5	like	like	VERB
dpc-4338	153	6	to	to	PART
dpc-4338	153	7	acknowledge	acknowledge	VERB
dpc-4338	153	8	mrs	mrs	PROPN
dpc-4338	153	9	lagiokapa	lagiokapa	PROPN
dpc-4338	153	10	polyxeni	polyxeni	PROPN
dpc-4338	153	11	,	,	PUNCT
dpc-4338	153	12	pesli	pesli	PROPN
dpc-4338	153	13	maria	maria	PROPN
dpc-4338	153	14	and	and	CCONJ
dpc-4338	153	15	kostaki	kostaki	PROPN
dpc-4338	153	16	maria	maria	PROPN
dpc-4338	153	17	for	for	ADP
dpc-4338	153	18	their	their	PRON
dpc-4338	153	19	valuable	valuable	ADJ
dpc-4338	153	20	help	help	NOUN
dpc-4338	153	21	.	.	PUNCT
dpc-4338	154	1	references	reference	NOUN
dpc-4338	154	2	1	1	NUM
dpc-4338	154	3	.	.	PUNCT
dpc-4338	155	1	thyssen	thyssen	PROPN
dpc-4338	155	2	jp	jp	PROPN
dpc-4338	155	3	,	,	PUNCT
dpc-4338	155	4	johansen	johansen	PROPN
dpc-4338	155	5	jd	jd	PROPN
dpc-4338	155	6	,	,	PUNCT
dpc-4338	155	7	linneberg	linneberg	PROPN
dpc-4338	155	8	a	a	INTJ
dpc-4338	155	9	,	,	PUNCT
dpc-4338	155	10	menné	menné	NOUN
dpc-4338	155	11	t.	t.	VERB
dpc-4338	155	12	the	the	DET
dpc-4338	155	13	epidemiology	epidemiology	NOUN
dpc-4338	155	14	of	of	ADP
dpc-4338	155	15	hand	hand	NOUN
dpc-4338	155	16	eczema	eczema	NOUN
dpc-4338	155	17	in	in	ADP
dpc-4338	155	18	the	the	DET
dpc-4338	155	19	general	general	ADJ
dpc-4338	155	20	population	population	NOUN
dpc-4338	155	21	—	—	PUNCT
dpc-4338	155	22	prevalence	prevalence	NOUN
dpc-4338	155	23	and	and	CCONJ
dpc-4338	155	24	main	main	ADJ
dpc-4338	155	25	findings	finding	NOUN
dpc-4338	155	26	.	.	PUNCT
dpc-4338	156	1	contact	contact	PROPN
dpc-4338	156	2	dermatitis	dermatitis	NOUN
dpc-4338	156	3	.	.	PUNCT
dpc-4338	157	1	2010	2010	NUM
dpc-4338	157	2	feb;62(2):75	feb;62(2):75	PROPN
dpc-4338	157	3	-	-	PUNCT
dpc-4338	157	4	87	87	NUM
dpc-4338	157	5	.	.	PUNCT
dpc-4338	158	1	doi	doi	NOUN
dpc-4338	158	2	:	:	PUNCT
dpc-4338	158	3	10.1111	10.1111	NUM
dpc-4338	158	4	/	/	SYM
dpc-4338	158	5	j.1600	j.1600	NOUN
dpc-4338	158	6	-	-	PUNCT
dpc-4338	158	7	0536.2009.01669.x	0536.2009.01669.x	PROPN
dpc-4338	158	8	.	.	PUNCT
dpc-4338	159	1	pmid	pmid	NOUN
dpc-4338	159	2	:	:	PUNCT
dpc-4338	159	3	20136890	20136890	NUM
dpc-4338	159	4	.	.	PUNCT
dpc-4338	160	1	rise	rise	VERB
dpc-4338	160	2	in	in	ADP
dpc-4338	160	3	tandem	tandem	NOUN
dpc-4338	160	4	with	with	ADP
dpc-4338	160	5	inflammation	inflammation	ADJ
dpc-4338	160	6	severity	severity	NOUN
dpc-4338	160	7	(	(	PUNCT
dpc-4338	160	8	figures	figure	NOUN
dpc-4338	160	9	4a	4a	NUM
dpc-4338	160	10	,	,	PUNCT
dpc-4338	160	11	4b	4b	X
dpc-4338	160	12	,	,	PUNCT
dpc-4338	160	13	p	p	X
dpc-4338	160	14	<	<	X
dpc-4338	160	15	0.001	0.001	NUM
dpc-4338	160	16	)	)	PUNCT
dpc-4338	160	17	,	,	PUNCT
dpc-4338	160	18	a	a	DET
dpc-4338	160	19	fact	fact	NOUN
dpc-4338	160	20	previously	previously	ADV
dpc-4338	160	21	established	establish	VERB
dpc-4338	160	22	[	[	PUNCT
dpc-4338	160	23	30	30	NUM
dpc-4338	160	24	]	]	PUNCT
dpc-4338	160	25	.	.	PUNCT
dpc-4338	161	1	additionally	additionally	ADV
dpc-4338	161	2	,	,	PUNCT
dpc-4338	161	3	volume	volume	NOUN
dpc-4338	161	4	,	,	PUNCT
dpc-4338	161	5	as	as	SCONJ
dpc-4338	161	6	measured	measure	VERB
dpc-4338	161	7	by	by	ADP
dpc-4338	161	8	the	the	DET
dpc-4338	161	9	antera	antera	NOUN
dpc-4338	161	10	®	®	NOUN
dpc-4338	161	11	3d	3d	PROPN
dpc-4338	161	12	camera	camera	NOUN
dpc-4338	161	13	,	,	PUNCT
dpc-4338	161	14	augmented	augment	VERB
dpc-4338	161	15	with	with	ADP
dpc-4338	161	16	inflammation	inflammation	NOUN
dpc-4338	161	17	(	(	PUNCT
dpc-4338	161	18	figure	figure	NOUN
dpc-4338	161	19	4c	4c	NOUN
dpc-4338	161	20	,	,	PUNCT
dpc-4338	161	21	p	p	X
dpc-4338	161	22	<	<	X
dpc-4338	161	23	0.001	0.001	NUM
dpc-4338	161	24	)	)	PUNCT
dpc-4338	161	25	.	.	PUNCT
dpc-4338	162	1	significantly	significantly	ADV
dpc-4338	162	2	higher	high	ADJ
dpc-4338	162	3	values	value	NOUN
dpc-4338	162	4	of	of	ADP
dpc-4338	162	5	all	all	DET
dpc-4338	162	6	antera	antera	NOUN
dpc-4338	162	7	®	®	NOUN
dpc-4338	162	8	3d	3d	NUM
dpc-4338	162	9	parameters	parameter	NOUN
dpc-4338	162	10	were	be	AUX
dpc-4338	162	11	observed	observe	VERB
dpc-4338	162	12	in	in	ADP
dpc-4338	162	13	both	both	CCONJ
dpc-4338	162	14	icd	icd	PROPN
dpc-4338	162	15	and	and	CCONJ
dpc-4338	162	16	acd	acd	NOUN
dpc-4338	162	17	patients	patient	NOUN
dpc-4338	162	18	(	(	PUNCT
dpc-4338	162	19	figure	figure	NOUN
dpc-4338	162	20	4	4	NUM
dpc-4338	162	21	,	,	PUNCT
dpc-4338	162	22	p	p	X
dpc-4338	162	23	<	<	X
dpc-4338	162	24	0.001	0.001	NUM
dpc-4338	162	25	)	)	PUNCT
dpc-4338	162	26	,	,	PUNCT
dpc-4338	162	27	with	with	ADP
dpc-4338	162	28	acd	acd	NOUN
dpc-4338	162	29	patients	patient	NOUN
dpc-4338	162	30	showing	show	VERB
dpc-4338	162	31	a	a	DET
dpc-4338	162	32	more	more	ADV
dpc-4338	162	33	pronounced	pronounced	ADJ
dpc-4338	162	34	increase	increase	NOUN
dpc-4338	162	35	in	in	ADP
dpc-4338	162	36	antera	antera	NOUN
dpc-4338	162	37	®	®	NOUN
dpc-4338	162	38	3d	3d	NOUN
dpc-4338	162	39	values	value	NOUN
dpc-4338	162	40	compared	compare	VERB
dpc-4338	162	41	to	to	ADP
dpc-4338	162	42	icd	icd	PROPN
dpc-4338	162	43	patients	patient	NOUN
dpc-4338	162	44	(	(	PUNCT
dpc-4338	162	45	figure	figure	NOUN
dpc-4338	162	46	4	4	NUM
dpc-4338	162	47	,	,	PUNCT
dpc-4338	162	48	p	p	X
dpc-4338	162	49	<	<	X
dpc-4338	162	50	0.05	0.05	NUM
dpc-4338	162	51	)	)	PUNCT
dpc-4338	162	52	.	.	PUNCT
dpc-4338	163	1	thus	thus	ADV
dpc-4338	163	2	,	,	PUNCT
dpc-4338	163	3	antera	antera	NOUN
dpc-4338	163	4	®	®	NOUN
dpc-4338	163	5	3d	3d	PROPN
dpc-4338	163	6	camera	camera	NOUN
dpc-4338	163	7	measurements	measurement	NOUN
dpc-4338	163	8	appear	appear	VERB
dpc-4338	163	9	to	to	PART
dpc-4338	163	10	be	be	AUX
dpc-4338	163	11	a	a	DET
dpc-4338	163	12	valuable	valuable	ADJ
dpc-4338	163	13	tool	tool	NOUN
dpc-4338	163	14	for	for	ADP
dpc-4338	163	15	distinguishing	distinguish	VERB
dpc-4338	163	16	between	between	ADP
dpc-4338	163	17	icd	icd	PROPN
dpc-4338	163	18	and	and	CCONJ
dpc-4338	163	19	acd	acd	NOUN
dpc-4338	163	20	inflammation	inflammation	NOUN
dpc-4338	163	21	.	.	PUNCT
dpc-4338	164	1	tewl	tewl	NOUN
dpc-4338	164	2	in	in	ADP
dpc-4338	164	3	icd	icd	PROPN
dpc-4338	164	4	patients	patient	NOUN
dpc-4338	164	5	increased	increase	VERB
dpc-4338	164	6	by	by	ADP
dpc-4338	164	7	an	an	DET
dpc-4338	164	8	average	average	NOUN
dpc-4338	164	9	of	of	ADP
dpc-4338	164	10	406.42	406.42	NUM
dpc-4338	164	11	%	%	NOUN
dpc-4338	164	12	,	,	PUNCT
dpc-4338	164	13	while	while	SCONJ
dpc-4338	164	14	in	in	ADP
dpc-4338	164	15	acd	acd	NOUN
dpc-4338	164	16	patients	patient	NOUN
dpc-4338	164	17	it	it	PRON
dpc-4338	164	18	rose	rise	VERB
dpc-4338	164	19	by	by	ADP
dpc-4338	164	20	20	20	NUM
dpc-4338	164	21	%	%	NOUN
dpc-4338	164	22	(	(	PUNCT
dpc-4338	164	23	figure	figure	NOUN
dpc-4338	164	24	5	5	NUM
dpc-4338	164	25	,	,	PUNCT
dpc-4338	164	26	p	p	X
dpc-4338	164	27	<	<	X
dpc-4338	164	28	0.05	0.05	NUM
dpc-4338	164	29	)	)	PUNCT
dpc-4338	164	30	,	,	PUNCT
dpc-4338	164	31	indicating	indicate	VERB
dpc-4338	164	32	a	a	DET
dpc-4338	164	33	roughly	roughly	ADV
dpc-4338	164	34	twentyfold	twentyfold	VERB
dpc-4338	164	35	greater	great	ADJ
dpc-4338	164	36	decrease	decrease	NOUN
dpc-4338	164	37	in	in	ADP
dpc-4338	164	38	skin	skin	NOUN
dpc-4338	164	39	barrier	barrier	NOUN
dpc-4338	164	40	function	function	NOUN
dpc-4338	164	41	in	in	ADP
dpc-4338	164	42	icd	icd	PROPN
dpc-4338	164	43	patients	patient	NOUN
dpc-4338	164	44	compared	compare	VERB
dpc-4338	164	45	to	to	ADP
dpc-4338	164	46	acd	acd	PROPN
dpc-4338	164	47	.	.	PUNCT
dpc-4338	165	1	tewl	tewl	PROPN
dpc-4338	165	2	,	,	PUNCT
dpc-4338	165	3	a	a	DET
dpc-4338	165	4	direct	direct	ADJ
dpc-4338	165	5	indicator	indicator	NOUN
dpc-4338	165	6	of	of	ADP
dpc-4338	165	7	skin	skin	NOUN
dpc-4338	165	8	barrier	barrier	NOUN
dpc-4338	165	9	integrity	integrity	NOUN
dpc-4338	165	10	and	and	CCONJ
dpc-4338	165	11	thus	thus	ADV
dpc-4338	165	12	inflammation	inflammation	NOUN
dpc-4338	165	13	[	[	X
dpc-4338	165	14	30,31	30,31	NUM
dpc-4338	165	15	]	]	PUNCT
dpc-4338	165	16	,	,	PUNCT
dpc-4338	165	17	could	could	AUX
dpc-4338	165	18	significantly	significantly	ADV
dpc-4338	165	19	aid	aid	VERB
dpc-4338	165	20	in	in	ADP
dpc-4338	165	21	differentiating	differentiate	VERB
dpc-4338	165	22	between	between	ADP
dpc-4338	165	23	icd	icd	PROPN
dpc-4338	165	24	and	and	CCONJ
dpc-4338	165	25	acd	acd	VERB
dpc-4338	165	26	inflammatory	inflammatory	ADJ
dpc-4338	165	27	responses	response	NOUN
dpc-4338	165	28	.	.	PUNCT
dpc-4338	166	1	figure	figure	NOUN
dpc-4338	166	2	4	4	NUM
dpc-4338	166	3	.	.	PUNCT
dpc-4338	167	1	(	(	PUNCT
dpc-4338	167	2	a	a	X
dpc-4338	167	3	)	)	PUNCT
dpc-4338	167	4	hemoglobin	hemoglobin	NOUN
dpc-4338	167	5	concentration	concentration	NOUN
dpc-4338	167	6	,	,	PUNCT
dpc-4338	167	7	(	(	PUNCT
dpc-4338	167	8	b	b	NOUN
dpc-4338	167	9	)	)	PUNCT
dpc-4338	167	10	skin	skin	NOUN
dpc-4338	167	11	texture	texture	NOUN
dpc-4338	167	12	,	,	PUNCT
dpc-4338	167	13	and	and	CCONJ
dpc-4338	167	14	(	(	PUNCT
dpc-4338	167	15	c	c	NOUN
dpc-4338	167	16	)	)	PUNCT
dpc-4338	167	17	mean	mean	NOUN
dpc-4338	167	18	volume	volume	NOUN
dpc-4338	167	19	values	value	NOUN
dpc-4338	167	20	at	at	ADP
dpc-4338	167	21	the	the	DET
dpc-4338	167	22	time	time	NOUN
dpc-4338	167	23	of	of	ADP
dpc-4338	167	24	evaluation	evaluation	NOUN
dpc-4338	167	25	for	for	ADP
dpc-4338	167	26	icd	icd	PROPN
dpc-4338	167	27	and	and	CCONJ
dpc-4338	167	28	acd	acd	NOUN
dpc-4338	167	29	patients	patient	NOUN
dpc-4338	167	30	.	.	PUNCT
dpc-4338	168	1	significant	significant	ADJ
dpc-4338	168	2	differences	difference	NOUN
dpc-4338	168	3	were	be	AUX
dpc-4338	168	4	observed	observe	VERB
dpc-4338	168	5	at	at	ADP
dpc-4338	168	6	0	0	NUM
dpc-4338	168	7	h	h	NOUN
dpc-4338	168	8	compared	compare	VERB
dpc-4338	168	9	to	to	ADP
dpc-4338	168	10	at	at	ADP
dpc-4338	168	11	the	the	DET
dpc-4338	168	12	time	time	NOUN
dpc-4338	168	13	of	of	ADP
dpc-4338	168	14	evaluation	evaluation	NOUN
dpc-4338	168	15	.	.	PUNCT
dpc-4338	169	1	(	(	PUNCT
dpc-4338	169	2	*	*	PUNCT
dpc-4338	169	3	*	*	PUNCT
dpc-4338	169	4	*	*	PUNCT
dpc-4338	169	5	p	p	X
dpc-4338	169	6	<	<	X
dpc-4338	169	7	0.001	0.001	NUM
dpc-4338	169	8	)	)	PUNCT
dpc-4338	169	9	.	.	PUNCT
dpc-4338	170	1	figure	figure	NOUN
dpc-4338	170	2	5	5	NUM
dpc-4338	170	3	.	.	PUNCT
dpc-4338	171	1	mean	mean	ADJ
dpc-4338	171	2	values	value	NOUN
dpc-4338	171	3	of	of	ADP
dpc-4338	171	4	tewl	tewl	NOUN
dpc-4338	171	5	for	for	ADP
dpc-4338	171	6	icd	icd	PROPN
dpc-4338	171	7	and	and	CCONJ
dpc-4338	171	8	acd	acd	NOUN
dpc-4338	171	9	patients	patient	NOUN
dpc-4338	171	10	.	.	PUNCT
dpc-4338	172	1	significant	significant	ADJ
dpc-4338	172	2	differences	difference	NOUN
dpc-4338	172	3	were	be	AUX
dpc-4338	172	4	observed	observe	VERB
dpc-4338	172	5	at	at	ADP
dpc-4338	172	6	0	0	NUM
dpc-4338	172	7	hours	hour	NOUN
dpc-4338	172	8	compared	compare	VERB
dpc-4338	172	9	to	to	ADP
dpc-4338	172	10	at	at	ADP
dpc-4338	172	11	the	the	DET
dpc-4338	172	12	time	time	NOUN
dpc-4338	172	13	of	of	ADP
dpc-4338	172	14	evaluation	evaluation	NOUN
dpc-4338	172	15	(	(	PUNCT
dpc-4338	172	16	*	*	PUNCT
dpc-4338	172	17	*	*	PUNCT
dpc-4338	172	18	*	*	PUNCT
dpc-4338	172	19	p	p	X
dpc-4338	172	20	<	<	X
dpc-4338	172	21	0.001	0.001	NUM
dpc-4338	172	22	)	)	PUNCT
dpc-4338	172	23	.	.	PUNCT
dpc-4338	173	1	8	8	NUM
dpc-4338	173	2	original	original	ADJ
dpc-4338	173	3	article	article	NOUN
dpc-4338	173	4	|	|	ADV
dpc-4338	173	5	dermatol	dermatol	ADJ
dpc-4338	173	6	pract	pract	NOUN
dpc-4338	173	7	concept	concept	NOUN
dpc-4338	173	8	.	.	PUNCT
dpc-4338	174	1	2024;14(4):e2024231	2024;14(4):e2024231	NUM
dpc-4338	174	2	15	15	NUM
dpc-4338	174	3	.	.	PUNCT
dpc-4338	175	1	nijhawan	nijhawan	PROPN
dpc-4338	175	2	ri	ri	PROPN
dpc-4338	175	3	,	,	PUNCT
dpc-4338	175	4	matiz	matiz	PROPN
dpc-4338	175	5	c	c	PROPN
dpc-4338	175	6	,	,	PUNCT
dpc-4338	175	7	jacob	jacob	PROPN
dpc-4338	175	8	se	se	PROPN
dpc-4338	175	9	.	.	PUNCT
dpc-4338	176	1	contact	contact	PROPN
dpc-4338	176	2	dermatitis	dermatitis	PROPN
dpc-4338	176	3	:	:	PUNCT
dpc-4338	176	4	from	from	ADP
dpc-4338	176	5	basics	basic	NOUN
dpc-4338	176	6	to	to	ADP
dpc-4338	176	7	allergodromes	allergodrome	NOUN
dpc-4338	176	8	.	.	PUNCT
dpc-4338	177	1	pediatr	pediatr	PROPN
dpc-4338	177	2	ann	ann	PROPN
dpc-4338	177	3	.	.	PROPN
dpc-4338	177	4	2009	2009	NUM
dpc-4338	177	5	feb;38(2):99	feb;38(2):99	PROPN
dpc-4338	177	6	-	-	PUNCT
dpc-4338	177	7	108	108	NUM
dpc-4338	177	8	.	.	PUNCT
dpc-4338	178	1	doi	doi	NOUN
dpc-4338	178	2	:	:	PUNCT
dpc-4338	178	3	10.3928/00904481	10.3928/00904481	NUM
dpc-4338	178	4	-	-	SYM
dpc-4338	178	5	20090201	20090201	NUM
dpc-4338	178	6	-	-	SYM
dpc-4338	178	7	07	07	NUM
dpc-4338	178	8	.	.	PUNCT
dpc-4338	179	1	pmid	pmid	NOUN
dpc-4338	179	2	:	:	PUNCT
dpc-4338	179	3	19263785	19263785	NUM
dpc-4338	179	4	.	.	PUNCT
dpc-4338	180	1	16	16	NUM
dpc-4338	180	2	.	.	PUNCT
dpc-4338	181	1	riemann	riemann	PROPN
dpc-4338	181	2	h	h	PROPN
dpc-4338	181	3	,	,	PUNCT
dpc-4338	181	4	schwarz	schwarz	PROPN
dpc-4338	181	5	t	t	PROPN
dpc-4338	181	6	,	,	PUNCT
dpc-4338	181	7	grabbe	grabbe	PROPN
dpc-4338	181	8	s.	s.	PROPN
dpc-4338	181	9	pathomechanismen	pathomechanismen	PROPN
dpc-4338	181	10	der	der	PROPN
dpc-4338	181	11	auslösephase	auslösephase	VERB
dpc-4338	181	12	der	der	NOUN
dpc-4338	181	13	allergischen	allergischen	ADV
dpc-4338	181	14	kontaktdermatitis	kontaktdermatitis	PROPN
dpc-4338	181	15	[	[	PRON
dpc-4338	181	16	pathomechanisms	pathomechanism	NOUN
dpc-4338	181	17	of	of	ADP
dpc-4338	181	18	the	the	DET
dpc-4338	181	19	elicitation	elicitation	NOUN
dpc-4338	181	20	phase	phase	NOUN
dpc-4338	181	21	of	of	ADP
dpc-4338	181	22	allergic	allergic	ADJ
dpc-4338	181	23	contact	contact	NOUN
dpc-4338	181	24	dermatitis	dermatitis	NOUN
dpc-4338	181	25	]	]	PUNCT
dpc-4338	181	26	.	.	PUNCT
dpc-4338	182	1	j	j	PROPN
dpc-4338	182	2	dtsch	dtsch	PROPN
dpc-4338	182	3	dermatol	dermatol	NOUN
dpc-4338	182	4	ges	ge	NOUN
dpc-4338	182	5	.	.	PROPN
dpc-4338	182	6	2003	2003	NUM
dpc-4338	182	7	aug;1(8):613	aug;1(8):613	PROPN
dpc-4338	182	8	-	-	PUNCT
dpc-4338	182	9	9	9	NUM
dpc-4338	182	10	.	.	PUNCT
dpc-4338	182	11	german	german	NOUN
dpc-4338	182	12	.	.	PUNCT
dpc-4338	183	1	pmid	pmid	NOUN
dpc-4338	183	2	:	:	PUNCT
dpc-4338	183	3	16296151	16296151	NUM
dpc-4338	183	4	.	.	PUNCT
dpc-4338	184	1	17	17	NUM
dpc-4338	184	2	.	.	PUNCT
dpc-4338	185	1	dekoven	dekoven	PROPN
dpc-4338	185	2	jg	jg	PROPN
dpc-4338	185	3	,	,	PUNCT
dpc-4338	185	4	warshaw	warshaw	VERB
dpc-4338	185	5	em	em	PRON
dpc-4338	185	6	,	,	PUNCT
dpc-4338	185	7	zug	zug	PROPN
dpc-4338	185	8	ka	ka	PROPN
dpc-4338	185	9	,	,	PUNCT
dpc-4338	185	10	et	et	PROPN
dpc-4338	185	11	al	al	PROPN
dpc-4338	185	12	.	.	PROPN
dpc-4338	186	1	north	north	PROPN
dpc-4338	186	2	american	american	PROPN
dpc-4338	186	3	contact	contact	PROPN
dpc-4338	186	4	dermatitis	dermatitis	PROPN
dpc-4338	186	5	group	group	PROPN
dpc-4338	186	6	patch	patch	PROPN
dpc-4338	186	7	test	test	NOUN
dpc-4338	186	8	results	result	NOUN
dpc-4338	186	9	:	:	PUNCT
dpc-4338	186	10	2015	2015	NUM
dpc-4338	186	11	-	-	SYM
dpc-4338	186	12	2016	2016	NUM
dpc-4338	186	13	.	.	PUNCT
dpc-4338	187	1	dermatitis	dermatitis	NOUN
dpc-4338	187	2	.	.	PUNCT
dpc-4338	188	1	2018	2018	NUM
dpc-4338	188	2	nov	nov	PROPN
dpc-4338	188	3	/	/	SYM
dpc-4338	188	4	dec;29(6):297	dec;29(6):297	PROPN
dpc-4338	188	5	-	-	PUNCT
dpc-4338	188	6	309	309	NUM
dpc-4338	188	7	.	.	PUNCT
dpc-4338	189	1	doi	doi	NOUN
dpc-4338	189	2	:	:	PUNCT
dpc-4338	189	3	10.1097/	10.1097/	NUM
dpc-4338	189	4	der.0000000000000417	der.0000000000000417	NOUN
dpc-4338	189	5	.	.	PUNCT
dpc-4338	190	1	pmid	pmid	NOUN
dpc-4338	190	2	:	:	PUNCT
dpc-4338	190	3	30422882	30422882	NUM
dpc-4338	190	4	.	.	PUNCT
dpc-4338	191	1	18	18	NUM
dpc-4338	191	2	.	.	X
dpc-4338	191	3	nassau	nassau	PROPN
dpc-4338	191	4	s	s	PROPN
dpc-4338	191	5	,	,	PUNCT
dpc-4338	191	6	fonacier	fonacier	NOUN
dpc-4338	191	7	l.	l.	PROPN
dpc-4338	191	8	allergic	allergic	PROPN
dpc-4338	191	9	contact	contact	PROPN
dpc-4338	191	10	dermatitis	dermatitis	PROPN
dpc-4338	191	11	.	.	PUNCT
dpc-4338	192	1	med	med	PROPN
dpc-4338	192	2	clin	clin	PROPN
dpc-4338	192	3	north	north	PROPN
dpc-4338	192	4	am	am	PROPN
dpc-4338	192	5	.	.	PUNCT
dpc-4338	193	1	2020	2020	NUM
dpc-4338	193	2	jan;104(1):61	jan;104(1):61	NOUN
dpc-4338	193	3	-	-	PUNCT
dpc-4338	193	4	76	76	NUM
dpc-4338	193	5	.	.	PUNCT
dpc-4338	194	1	doi	doi	NOUN
dpc-4338	194	2	:	:	PUNCT
dpc-4338	194	3	10.1016	10.1016	NUM
dpc-4338	194	4	/	/	SYM
dpc-4338	194	5	j.	j.	PROPN
dpc-4338	194	6	mcna.2019.08.012	mcna.2019.08.012	PROPN
dpc-4338	194	7	.	.	PUNCT
dpc-4338	195	1	epub	epub	PROPN
dpc-4338	195	2	2019	2019	NUM
dpc-4338	195	3	oct	oct	PROPN
dpc-4338	195	4	28	28	NUM
dpc-4338	195	5	.	.	PUNCT
dpc-4338	196	1	pmid	pmid	NOUN
dpc-4338	196	2	:	:	PUNCT
dpc-4338	196	3	31757238	31757238	NUM
dpc-4338	196	4	.	.	PUNCT
dpc-4338	197	1	19	19	NUM
dpc-4338	197	2	.	.	X
dpc-4338	197	3	tagka	tagka	PROPN
dpc-4338	197	4	a	a	PROPN
dpc-4338	197	5	,	,	PUNCT
dpc-4338	197	6	stratigos	stratigos	PROPN
dpc-4338	197	7	a	a	PRON
dpc-4338	197	8	,	,	PUNCT
dpc-4338	197	9	lambrou	lambrou	NOUN
dpc-4338	197	10	gi	gi	NOUN
dpc-4338	197	11	,	,	PUNCT
dpc-4338	197	12	et	et	PROPN
dpc-4338	197	13	al	al	PROPN
dpc-4338	197	14	.	.	PUNCT
dpc-4338	198	1	prevalence	prevalence	NOUN
dpc-4338	198	2	of	of	ADP
dpc-4338	198	3	contact	contact	NOUN
dpc-4338	198	4	dermatitis	dermatitis	NOUN
dpc-4338	198	5	in	in	ADP
dpc-4338	198	6	the	the	DET
dpc-4338	198	7	greek	greek	ADJ
dpc-4338	198	8	population	population	NOUN
dpc-4338	198	9	:	:	PUNCT
dpc-4338	198	10	a	a	DET
dpc-4338	198	11	retrospective	retrospective	ADJ
dpc-4338	198	12	observational	observational	ADJ
dpc-4338	198	13	study	study	NOUN
dpc-4338	198	14	.	.	PUNCT
dpc-4338	199	1	contact	contact	PROPN
dpc-4338	199	2	dermatitis	dermatitis	PROPN
dpc-4338	199	3	.	.	PUNCT
dpc-4338	200	1	2019	2019	NUM
dpc-4338	200	2	dec;81(6):460	dec;81(6):460	PROPN
dpc-4338	200	3	-	-	PUNCT
dpc-4338	200	4	462	462	PROPN
dpc-4338	200	5	.	.	PUNCT
dpc-4338	201	1	doi	doi	NOUN
dpc-4338	201	2	:	:	PUNCT
dpc-4338	201	3	10.1111	10.1111	NUM
dpc-4338	201	4	/	/	SYM
dpc-4338	201	5	cod.13364	cod.13364	NOUN
dpc-4338	201	6	.	.	PUNCT
dpc-4338	202	1	epub	epub	PROPN
dpc-4338	202	2	2019	2019	NUM
dpc-4338	202	3	aug	aug	PROPN
dpc-4338	202	4	8	8	NUM
dpc-4338	202	5	.	.	PUNCT
dpc-4338	203	1	pmid	pmid	NOUN
dpc-4338	203	2	:	:	PUNCT
dpc-4338	203	3	31347179	31347179	NUM
dpc-4338	203	4	.	.	PUNCT
dpc-4338	204	1	20	20	NUM
dpc-4338	204	2	.	.	X
dpc-4338	204	3	uter	uter	PROPN
dpc-4338	204	4	w	w	PROPN
dpc-4338	204	5	,	,	PUNCT
dpc-4338	204	6	de	de	PROPN
dpc-4338	204	7	pádua	pádua	PROPN
dpc-4338	204	8	cm	cm	PROPN
dpc-4338	204	9	,	,	PUNCT
dpc-4338	204	10	pfahlberg	pfahlberg	VERB
dpc-4338	204	11	a	a	DET
dpc-4338	204	12	,	,	PUNCT
dpc-4338	204	13	nink	nink	NOUN
dpc-4338	204	14	k	k	NOUN
dpc-4338	204	15	,	,	PUNCT
dpc-4338	204	16	schnuch	schnuch	VERB
dpc-4338	204	17	a	a	PRON
dpc-4338	204	18	,	,	PUNCT
dpc-4338	204	19	lessmann	lessmann	PROPN
dpc-4338	204	20	h.	h.	PROPN
dpc-4338	204	21	contact	contact	PROPN
dpc-4338	204	22	allergy	allergy	NOUN
dpc-4338	204	23	to	to	ADP
dpc-4338	204	24	topical	topical	ADJ
dpc-4338	204	25	corticosteroids	corticosteroid	NOUN
dpc-4338	204	26	--	--	PUNCT
dpc-4338	204	27	results	result	NOUN
dpc-4338	204	28	from	from	ADP
dpc-4338	204	29	the	the	DET
dpc-4338	204	30	ivdk	ivdk	NOUN
dpc-4338	204	31	and	and	CCONJ
dpc-4338	204	32	epidemiological	epidemiological	ADJ
dpc-4338	204	33	risk	risk	NOUN
dpc-4338	204	34	assessment	assessment	NOUN
dpc-4338	204	35	.	.	PUNCT
dpc-4338	205	1	j	j	PROPN
dpc-4338	205	2	dtsch	dtsch	PROPN
dpc-4338	205	3	dermatol	dermatol	NOUN
dpc-4338	205	4	ges	ges	PROPN
dpc-4338	205	5	.	.	PROPN
dpc-4338	205	6	2009	2009	NUM
dpc-4338	205	7	jan;7(1):34	jan;7(1):34	NOUN
dpc-4338	205	8	-	-	PUNCT
dpc-4338	205	9	41	41	NUM
dpc-4338	205	10	,	,	PUNCT
dpc-4338	205	11	34	34	NUM
dpc-4338	205	12	-	-	SYM
dpc-4338	205	13	42	42	NUM
dpc-4338	205	14	.	.	PUNCT
dpc-4338	206	1	english	english	PROPN
dpc-4338	206	2	,	,	PUNCT
dpc-4338	206	3	german	german	ADJ
dpc-4338	206	4	.	.	PUNCT
dpc-4338	207	1	doi	doi	NOUN
dpc-4338	207	2	:	:	PUNCT
dpc-4338	207	3	10.1111	10.1111	NUM
dpc-4338	207	4	/	/	SYM
dpc-4338	207	5	j.1610	j.1610	NOUN
dpc-4338	207	6	-	-	NOUN
dpc-4338	207	7	0387.2008.06844.x	0387.2008.06844.x	NUM
dpc-4338	207	8	.	.	PUNCT
dpc-4338	208	1	epub	epub	PROPN
dpc-4338	208	2	2008	2008	NUM
dpc-4338	208	3	aug	aug	PROPN
dpc-4338	208	4	28	28	NUM
dpc-4338	208	5	.	.	PUNCT
dpc-4338	209	1	pmid	pmid	NOUN
dpc-4338	209	2	:	:	PUNCT
dpc-4338	209	3	18761609	18761609	NUM
dpc-4338	209	4	.	.	PUNCT
dpc-4338	210	1	21	21	NUM
dpc-4338	210	2	.	.	X
dpc-4338	211	1	arslan	arslan	PROPN
dpc-4338	211	2	s	s	PROPN
dpc-4338	211	3	,	,	PUNCT
dpc-4338	211	4	aksan	aksan	PROPN
dpc-4338	211	5	s	s	PROPN
dpc-4338	211	6	,	,	PUNCT
dpc-4338	211	7	ucar	ucar	PROPN
dpc-4338	211	8	r	r	PROPN
dpc-4338	211	9	,	,	PUNCT
dpc-4338	211	10	caliskaner	caliskaner	PROPN
dpc-4338	211	11	az	az	PROPN
dpc-4338	211	12	.	.	PUNCT
dpc-4338	212	1	contact	contact	PROPN
dpc-4338	212	2	dermatitis	dermatitis	PROPN
dpc-4338	212	3	to	to	PART
dpc-4338	212	4	cobalt	cobalt	VERB
dpc-4338	212	5	chloride	chloride	NOUN
dpc-4338	212	6	with	with	ADP
dpc-4338	212	7	an	an	DET
dpc-4338	212	8	unusual	unusual	ADJ
dpc-4338	212	9	mechanism	mechanism	NOUN
dpc-4338	212	10	.	.	PUNCT
dpc-4338	213	1	prosthet	prosthet	PROPN
dpc-4338	213	2	orthot	orthot	NUM
dpc-4338	213	3	int	int	NOUN
dpc-4338	213	4	.	.	PUNCT
dpc-4338	214	1	2015	2015	NUM
dpc-4338	214	2	oct;39(5):419	oct;39(5):419	NUM
dpc-4338	214	3	-	-	SYM
dpc-4338	214	4	21	21	NUM
dpc-4338	214	5	.	.	PUNCT
dpc-4338	215	1	doi	doi	NOUN
dpc-4338	215	2	:	:	PUNCT
dpc-4338	215	3	10.1177/0309364614534293	10.1177/0309364614534293	NUM
dpc-4338	215	4	.	.	PUNCT
dpc-4338	216	1	epub	epub	NOUN
dpc-4338	216	2	2014	2014	NUM
dpc-4338	216	3	may	may	PROPN
dpc-4338	216	4	29	29	NUM
dpc-4338	216	5	.	.	PUNCT
dpc-4338	217	1	pmid	pmid	NOUN
dpc-4338	217	2	:	:	PUNCT
dpc-4338	217	3	24876170	24876170	NUM
dpc-4338	217	4	.	.	PUNCT
dpc-4338	218	1	22	22	NUM
dpc-4338	218	2	.	.	PUNCT
dpc-4338	219	1	goldenberg	goldenberg	PROPN
dpc-4338	219	2	a	a	PROPN
dpc-4338	219	3	,	,	PUNCT
dpc-4338	219	4	matiz	matiz	PROPN
dpc-4338	219	5	c	c	PROPN
dpc-4338	219	6	,	,	PUNCT
dpc-4338	219	7	eichenfield	eichenfield	PROPN
dpc-4338	219	8	lf	lf	PROPN
dpc-4338	219	9	.	.	PUNCT
dpc-4338	219	10	religious	religious	ADJ
dpc-4338	219	11	allergic	allergic	ADJ
dpc-4338	219	12	contact	contact	NOUN
dpc-4338	219	13	dermatitis	dermatitis	NOUN
dpc-4338	219	14	.	.	PUNCT
dpc-4338	220	1	pediatr	pediatr	ADJ
dpc-4338	220	2	dermatol	dermatol	NOUN
dpc-4338	220	3	.	.	PUNCT
dpc-4338	221	1	2015	2015	NUM
dpc-4338	221	2	jul	jul	PROPN
dpc-4338	221	3	-	-	PUNCT
dpc-4338	221	4	aug;32(4):e191	aug;32(4):e191	PROPN
dpc-4338	221	5	-	-	PUNCT
dpc-4338	221	6	2	2	PROPN
dpc-4338	221	7	.	.	PUNCT
dpc-4338	221	8	doi	doi	NOUN
dpc-4338	221	9	:	:	PUNCT
dpc-4338	221	10	10.1111	10.1111	NUM
dpc-4338	221	11	/	/	SYM
dpc-4338	221	12	pde.12613	pde.12613	PROPN
dpc-4338	221	13	.	.	PUNCT
dpc-4338	222	1	epub	epub	PROPN
dpc-4338	222	2	2015	2015	NUM
dpc-4338	222	3	may	may	PROPN
dpc-4338	222	4	13	13	NUM
dpc-4338	222	5	.	.	PUNCT
dpc-4338	223	1	pmid	pmid	NOUN
dpc-4338	223	2	:	:	PUNCT
dpc-4338	223	3	25968562	25968562	NUM
dpc-4338	223	4	.	.	PUNCT
dpc-4338	224	1	23	23	NUM
dpc-4338	224	2	.	.	X
dpc-4338	224	3	tang	tang	PROPN
dpc-4338	224	4	b	b	PROPN
dpc-4338	224	5	,	,	PUNCT
dpc-4338	224	6	williams	williams	PROPN
dpc-4338	224	7	pl	pl	PROPN
dpc-4338	224	8	,	,	PUNCT
dpc-4338	224	9	xue	xue	PROPN
dpc-4338	224	10	ks	ks	PROPN
dpc-4338	224	11	,	,	PUNCT
dpc-4338	224	12	wang	wang	PROPN
dpc-4338	224	13	js	js	PROPN
dpc-4338	224	14	,	,	PUNCT
dpc-4338	224	15	tang	tang	PROPN
dpc-4338	224	16	l.	l.	PROPN
dpc-4338	224	17	detoxification	detoxification	NOUN
dpc-4338	224	18	mechanisms	mechanism	NOUN
dpc-4338	224	19	of	of	ADP
dpc-4338	224	20	nickel	nickel	NOUN
dpc-4338	224	21	sulfate	sulfate	NOUN
dpc-4338	224	22	in	in	ADP
dpc-4338	224	23	nematode	nematode	ADJ
dpc-4338	224	24	caenorhabditis	caenorhabditis	NOUN
dpc-4338	224	25	elegans	elegan	NOUN
dpc-4338	224	26	.	.	PUNCT
dpc-4338	225	1	chemosphere	chemosphere	PROPN
dpc-4338	225	2	.	.	PUNCT
dpc-4338	226	1	2020	2020	NUM
dpc-4338	227	1	dec;260:127627	dec;260:127627	PROPN
dpc-4338	227	2	.	.	PUNCT
dpc-4338	228	1	doi	doi	NOUN
dpc-4338	228	2	:	:	PUNCT
dpc-4338	228	3	10.1016	10.1016	NUM
dpc-4338	228	4	/	/	SYM
dpc-4338	228	5	j.chemosphere.2020.127627	j.chemosphere.2020.127627	ADJ
dpc-4338	228	6	.	.	PUNCT
dpc-4338	229	1	epub	epub	PROPN
dpc-4338	229	2	2020	2020	NUM
dpc-4338	229	3	jul	jul	PROPN
dpc-4338	229	4	10	10	NUM
dpc-4338	229	5	.	.	PUNCT
dpc-4338	230	1	pmid	pmid	NOUN
dpc-4338	230	2	:	:	PUNCT
dpc-4338	230	3	32673864	32673864	NUM
dpc-4338	230	4	.	.	PUNCT
dpc-4338	231	1	24	24	NUM
dpc-4338	231	2	.	.	PUNCT
dpc-4338	231	3	schnuch	schnuch	PROPN
dpc-4338	231	4	a	a	PRON
dpc-4338	231	5	,	,	PUNCT
dpc-4338	231	6	lessmann	lessmann	PROPN
dpc-4338	231	7	h	h	NOUN
dpc-4338	231	8	,	,	PUNCT
dpc-4338	231	9	frosch	frosch	PROPN
dpc-4338	231	10	pj	pj	PROPN
dpc-4338	231	11	,	,	PUNCT
dpc-4338	231	12	uter	uter	PROPN
dpc-4338	231	13	w.	w.	PROPN
dpc-4338	231	14	para	para	PROPN
dpc-4338	231	15	phenylenediamine	phenylenediamine	PROPN
dpc-4338	231	16	:	:	PUNCT
dpc-4338	231	17	the	the	DET
dpc-4338	231	18	profile	profile	NOUN
dpc-4338	231	19	of	of	ADP
dpc-4338	231	20	an	an	DET
dpc-4338	231	21	important	important	ADJ
dpc-4338	231	22	allergen	allergen	NOUN
dpc-4338	231	23	.	.	PUNCT
dpc-4338	232	1	results	result	NOUN
dpc-4338	232	2	of	of	ADP
dpc-4338	232	3	the	the	DET
dpc-4338	232	4	ivdk	ivdk	NOUN
dpc-4338	232	5	.	.	PUNCT
dpc-4338	233	1	br	br	PROPN
dpc-4338	233	2	j	j	PROPN
dpc-4338	233	3	dermatol	dermatol	NOUN
dpc-4338	233	4	.	.	PUNCT
dpc-4338	234	1	2008	2008	NUM
dpc-4338	234	2	aug;159(2):379	aug;159(2):379	PROPN
dpc-4338	234	3	-	-	PUNCT
dpc-4338	234	4	86	86	NUM
dpc-4338	234	5	.	.	PUNCT
dpc-4338	235	1	doi	doi	NOUN
dpc-4338	235	2	:	:	PUNCT
dpc-4338	235	3	10.1111	10.1111	NUM
dpc-4338	235	4	/	/	SYM
dpc-4338	235	5	j.1365	j.1365	NOUN
dpc-4338	235	6	-	-	PUNCT
dpc-4338	235	7	2133.2008.08644.x	2133.2008.08644.x	NUM
dpc-4338	235	8	.	.	PUNCT
dpc-4338	236	1	epub	epub	PROPN
dpc-4338	236	2	2008	2008	NUM
dpc-4338	236	3	may	may	PROPN
dpc-4338	236	4	28	28	NUM
dpc-4338	236	5	.	.	PUNCT
dpc-4338	237	1	erratum	erratum	PROPN
dpc-4338	237	2	in	in	ADP
dpc-4338	237	3	:	:	PUNCT
dpc-4338	237	4	br	br	PROPN
dpc-4338	237	5	j	j	PROPN
dpc-4338	237	6	dermatol	dermatol	NOUN
dpc-4338	237	7	.	.	PUNCT
dpc-4338	238	1	2008	2008	NUM
dpc-4338	238	2	sep;159(3):772	sep;159(3):772	NOUN
dpc-4338	238	3	.	.	PUNCT
dpc-4338	239	1	pmid	pmid	NOUN
dpc-4338	239	2	:	:	PUNCT
dpc-4338	239	3	18510664	18510664	NUM
dpc-4338	239	4	.	.	PUNCT
dpc-4338	240	1	25	25	NUM
dpc-4338	240	2	.	.	PUNCT
dpc-4338	240	3	zapolanski	zapolanski	PROPN
dpc-4338	240	4	t	t	PROPN
dpc-4338	240	5	,	,	PUNCT
dpc-4338	240	6	jacob	jacob	PROPN
dpc-4338	240	7	se	se	PROPN
dpc-4338	240	8	.	.	PUNCT
dpc-4338	240	9	para	para	NOUN
dpc-4338	240	10	-	-	PUNCT
dpc-4338	240	11	phenylenediamine	phenylenediamine	NOUN
dpc-4338	240	12	.	.	PUNCT
dpc-4338	241	1	dermatitis	dermatitis	NOUN
dpc-4338	241	2	.	.	PUNCT
dpc-4338	242	1	2008	2008	NUM
dpc-4338	242	2	may	may	PROPN
dpc-4338	242	3	-	-	PUNCT
dpc-4338	242	4	jun;19(3):e20	jun;19(3):e20	NOUN
dpc-4338	242	5	-	-	PUNCT
dpc-4338	242	6	1	1	NUM
dpc-4338	242	7	.	.	PUNCT
dpc-4338	243	1	pmid	pmid	NOUN
dpc-4338	243	2	:	:	PUNCT
dpc-4338	243	3	18627681	18627681	NUM
dpc-4338	243	4	.	.	PUNCT
dpc-4338	244	1	26	26	NUM
dpc-4338	244	2	.	.	PUNCT
dpc-4338	244	3	zanoni	zanoni	PROPN
dpc-4338	244	4	tb	tb	PROPN
dpc-4338	244	5	,	,	PUNCT
dpc-4338	244	6	hudari	hudari	PROPN
dpc-4338	244	7	f	f	PROPN
dpc-4338	244	8	,	,	PUNCT
dpc-4338	244	9	munnia	munnia	PROPN
dpc-4338	244	10	a	a	NOUN
dpc-4338	244	11	,	,	PUNCT
dpc-4338	244	12	et	et	PROPN
dpc-4338	244	13	al	al	PROPN
dpc-4338	244	14	.	.	PUNCT
dpc-4338	245	1	the	the	DET
dpc-4338	245	2	oxidation	oxidation	NOUN
dpc-4338	245	3	of	of	ADP
dpc-4338	245	4	pphenylenediamine	pphenylenediamine	NOUN
dpc-4338	245	5	,	,	PUNCT
dpc-4338	245	6	an	an	DET
dpc-4338	245	7	ingredient	ingredient	NOUN
dpc-4338	245	8	used	use	VERB
dpc-4338	245	9	for	for	ADP
dpc-4338	245	10	permanent	permanent	ADJ
dpc-4338	245	11	hair	hair	NOUN
dpc-4338	245	12	dyeing	dyeing	NOUN
dpc-4338	245	13	purposes	purpose	NOUN
dpc-4338	245	14	,	,	PUNCT
dpc-4338	245	15	leads	lead	VERB
dpc-4338	245	16	to	to	ADP
dpc-4338	245	17	the	the	DET
dpc-4338	245	18	formation	formation	NOUN
dpc-4338	245	19	of	of	ADP
dpc-4338	245	20	hydroxyl	hydroxyl	NOUN
dpc-4338	245	21	radicals	radical	NOUN
dpc-4338	245	22	:	:	PUNCT
dpc-4338	245	23	oxidative	oxidative	ADJ
dpc-4338	245	24	stress	stress	NOUN
dpc-4338	245	25	and	and	CCONJ
dpc-4338	245	26	dna	dna	NOUN
dpc-4338	245	27	damage	damage	NOUN
dpc-4338	245	28	in	in	ADP
dpc-4338	245	29	human	human	ADJ
dpc-4338	245	30	immortalized	immortalize	VERB
dpc-4338	245	31	keratinocytes	keratinocyte	NOUN
dpc-4338	245	32	.	.	PUNCT
dpc-4338	246	1	toxicol	toxicol	PROPN
dpc-4338	246	2	lett	lett	PROPN
dpc-4338	246	3	.	.	PROPN
dpc-4338	247	1	2015	2015	NUM
dpc-4338	247	2	dec	dec	PROPN
dpc-4338	247	3	15;239(3):194	15;239(3):194	PROPN
dpc-4338	247	4	-	-	PUNCT
dpc-4338	247	5	204	204	NUM
dpc-4338	247	6	.	.	PUNCT
dpc-4338	248	1	doi	doi	NOUN
dpc-4338	248	2	:	:	PUNCT
dpc-4338	248	3	10.1016	10.1016	NUM
dpc-4338	248	4	/	/	SYM
dpc-4338	248	5	j.toxlet.2015.09.026	j.toxlet.2015.09.026	PROPN
dpc-4338	248	6	.	.	PUNCT
dpc-4338	249	1	epub	epub	PROPN
dpc-4338	249	2	2015	2015	NUM
dpc-4338	249	3	oct	oct	NOUN
dpc-4338	249	4	9	9	NUM
dpc-4338	249	5	.	.	PUNCT
dpc-4338	250	1	pmid	pmid	NOUN
dpc-4338	250	2	:	:	PUNCT
dpc-4338	250	3	26456176	26456176	NUM
dpc-4338	250	4	.	.	PUNCT
dpc-4338	251	1	27	27	NUM
dpc-4338	251	2	.	.	PUNCT
dpc-4338	252	1	coogan	coogan	PROPN
dpc-4338	252	2	tp	tp	PROPN
dpc-4338	252	3	,	,	PUNCT
dpc-4338	252	4	latta	latta	PROPN
dpc-4338	252	5	dm	dm	PROPN
dpc-4338	252	6	,	,	PUNCT
dpc-4338	252	7	snow	snow	PROPN
dpc-4338	252	8	et	et	PROPN
dpc-4338	252	9	,	,	PUNCT
dpc-4338	252	10	costa	costa	ADJ
dpc-4338	252	11	m.	m.	NOUN
dpc-4338	252	12	toxicity	toxicity	NOUN
dpc-4338	252	13	and	and	CCONJ
dpc-4338	252	14	carcinogenicity	carcinogenicity	NOUN
dpc-4338	252	15	of	of	ADP
dpc-4338	252	16	nickel	nickel	NOUN
dpc-4338	252	17	compounds	compound	NOUN
dpc-4338	252	18	.	.	PUNCT
dpc-4338	253	1	crit	crit	PROPN
dpc-4338	253	2	rev	rev	PROPN
dpc-4338	253	3	toxicol	toxicol	PROPN
dpc-4338	253	4	.	.	PUNCT
dpc-4338	254	1	1989;19(4):34184	1989;19(4):34184	X
dpc-4338	254	2	.	.	PUNCT
dpc-4338	255	1	doi	doi	NOUN
dpc-4338	255	2	:	:	PUNCT
dpc-4338	255	3	10.3109/10408448909029327	10.3109/10408448909029327	NUM
dpc-4338	255	4	.	.	PUNCT
dpc-4338	256	1	erratum	erratum	PROPN
dpc-4338	256	2	in	in	ADP
dpc-4338	256	3	:	:	PUNCT
dpc-4338	256	4	crit	crit	PROPN
dpc-4338	256	5	rev	rev	VERB
dpc-4338	256	6	toxicol	toxicol	PROPN
dpc-4338	256	7	1989;20(2):135	1989;20(2):135	PROPN
dpc-4338	256	8	.	.	PUNCT
dpc-4338	257	1	pmid	pmid	NOUN
dpc-4338	257	2	:	:	PUNCT
dpc-4338	257	3	2663022	2663022	NUM
dpc-4338	257	4	.	.	PUNCT
dpc-4338	258	1	28	28	NUM
dpc-4338	258	2	.	.	PUNCT
dpc-4338	258	3	stinson	stinson	PROPN
dpc-4338	258	4	tj	tj	PROPN
dpc-4338	258	5	,	,	PUNCT
dpc-4338	258	6	jaw	jaw	PROPN
dpc-4338	258	7	s	s	PROPN
dpc-4338	258	8	,	,	PUNCT
dpc-4338	258	9	jeffery	jeffery	PROPN
dpc-4338	258	10	eh	eh	INTJ
dpc-4338	258	11	,	,	PUNCT
dpc-4338	258	12	plewa	plewa	PROPN
dpc-4338	258	13	mj	mj	PROPN
dpc-4338	258	14	.	.	PUNCT
dpc-4338	259	1	the	the	DET
dpc-4338	259	2	relationship	relationship	NOUN
dpc-4338	259	3	between	between	ADP
dpc-4338	259	4	nickel	nickel	NOUN
dpc-4338	259	5	chloride	chloride	NOUN
dpc-4338	259	6	-	-	PUNCT
dpc-4338	259	7	induced	induce	VERB
dpc-4338	259	8	peroxidation	peroxidation	NOUN
dpc-4338	259	9	and	and	CCONJ
dpc-4338	259	10	dna	dna	NOUN
dpc-4338	259	11	strand	strand	NOUN
dpc-4338	259	12	breakage	breakage	NOUN
dpc-4338	259	13	in	in	ADP
dpc-4338	259	14	rat	rat	NOUN
dpc-4338	259	15	liver	liver	NOUN
dpc-4338	259	16	.	.	PUNCT
dpc-4338	260	1	toxicol	toxicol	PROPN
dpc-4338	260	2	appl	appl	PROPN
dpc-4338	260	3	pharmacol	pharmacol	PROPN
dpc-4338	260	4	.	.	PROPN
dpc-4338	261	1	1992	1992	NUM
dpc-4338	261	2	nov;117(1):98	nov;117(1):98	PROPN
dpc-4338	261	3	-	-	PUNCT
dpc-4338	261	4	103	103	NUM
dpc-4338	261	5	.	.	PUNCT
dpc-4338	262	1	doi	doi	NOUN
dpc-4338	262	2	:	:	PUNCT
dpc-4338	262	3	10.1016/0041	10.1016/0041	NUM
dpc-4338	262	4	-	-	PUNCT
dpc-4338	262	5	008x(92)90222	008x(92)90222	NUM
dpc-4338	262	6	-	-	PUNCT
dpc-4338	262	7	e.	e.	PROPN
dpc-4338	262	8	pmid	pmid	PROPN
dpc-4338	262	9	:	:	PUNCT
dpc-4338	262	10	1440619	1440619	NUM
dpc-4338	262	11	.	.	PUNCT
dpc-4338	263	1	2	2	X
dpc-4338	263	2	.	.	X
dpc-4338	263	3	alinaghi	alinaghi	PROPN
dpc-4338	264	1	f	f	X
dpc-4338	264	2	,	,	PUNCT
dpc-4338	264	3	bennike	bennike	ADP
dpc-4338	264	4	nh	nh	PROPN
dpc-4338	264	5	,	,	PUNCT
dpc-4338	264	6	egeberg	egeberg	PROPN
dpc-4338	264	7	a	a	X
dpc-4338	264	8	,	,	PUNCT
dpc-4338	264	9	thyssen	thyssen	PROPN
dpc-4338	264	10	jp	jp	PROPN
dpc-4338	264	11	,	,	PUNCT
dpc-4338	264	12	johansen	johansen	PROPN
dpc-4338	264	13	jd	jd	PROPN
dpc-4338	264	14	.	.	PUNCT
dpc-4338	265	1	prevalence	prevalence	NOUN
dpc-4338	265	2	of	of	ADP
dpc-4338	265	3	contact	contact	NOUN
dpc-4338	265	4	allergy	allergy	NOUN
dpc-4338	265	5	in	in	ADP
dpc-4338	265	6	the	the	DET
dpc-4338	265	7	general	general	ADJ
dpc-4338	265	8	population	population	NOUN
dpc-4338	265	9	:	:	PUNCT
dpc-4338	265	10	a	a	DET
dpc-4338	265	11	systematic	systematic	ADJ
dpc-4338	265	12	review	review	NOUN
dpc-4338	265	13	and	and	CCONJ
dpc-4338	265	14	meta	meta	ADJ
dpc-4338	265	15	-	-	PUNCT
dpc-4338	265	16	analysis	analysis	NOUN
dpc-4338	265	17	.	.	PUNCT
dpc-4338	266	1	contact	contact	NOUN
dpc-4338	266	2	dermatitis	dermatitis	PROPN
dpc-4338	266	3	.	.	PUNCT
dpc-4338	267	1	2019	2019	NUM
dpc-4338	267	2	feb;80(2):77	feb;80(2):77	NOUN
dpc-4338	267	3	-	-	PUNCT
dpc-4338	267	4	85	85	NUM
dpc-4338	267	5	.	.	PUNCT
dpc-4338	268	1	doi	doi	NOUN
dpc-4338	268	2	:	:	PUNCT
dpc-4338	268	3	10.1111	10.1111	NUM
dpc-4338	268	4	/	/	SYM
dpc-4338	268	5	cod.13119	cod.13119	NOUN
dpc-4338	268	6	.	.	PUNCT
dpc-4338	269	1	epub	epub	PROPN
dpc-4338	269	2	2018	2018	NUM
dpc-4338	269	3	oct	oct	PROPN
dpc-4338	269	4	29	29	NUM
dpc-4338	269	5	.	.	PUNCT
dpc-4338	270	1	pmid	pmid	NOUN
dpc-4338	270	2	:	:	PUNCT
dpc-4338	270	3	30370565	30370565	NUM
dpc-4338	270	4	.	.	PUNCT
dpc-4338	271	1	3	3	X
dpc-4338	271	2	.	.	X
dpc-4338	271	3	gittler	gittler	PROPN
dpc-4338	271	4	jk	jk	PROPN
dpc-4338	271	5	,	,	PUNCT
dpc-4338	271	6	krueger	krueger	PROPN
dpc-4338	271	7	jg	jg	PROPN
dpc-4338	271	8	,	,	PUNCT
dpc-4338	271	9	guttman	guttman	ADJ
dpc-4338	271	10	-	-	PUNCT
dpc-4338	271	11	yassky	yassky	ADJ
dpc-4338	271	12	e.	e.	PROPN
dpc-4338	271	13	atopic	atopic	PROPN
dpc-4338	271	14	dermatitis	dermatitis	PROPN
dpc-4338	271	15	results	result	VERB
dpc-4338	271	16	in	in	ADP
dpc-4338	271	17	intrinsic	intrinsic	ADJ
dpc-4338	271	18	barrier	barrier	NOUN
dpc-4338	271	19	and	and	CCONJ
dpc-4338	271	20	immune	immune	ADJ
dpc-4338	271	21	abnormalities	abnormality	NOUN
dpc-4338	271	22	:	:	PUNCT
dpc-4338	271	23	implications	implication	NOUN
dpc-4338	271	24	for	for	ADP
dpc-4338	271	25	contact	contact	NOUN
dpc-4338	271	26	dermatitis	dermatitis	NOUN
dpc-4338	271	27	.	.	PUNCT
dpc-4338	272	1	j	j	PROPN
dpc-4338	272	2	allergy	allergy	PROPN
dpc-4338	272	3	clin	clin	PROPN
dpc-4338	272	4	immunol	immunol	PROPN
dpc-4338	272	5	.	.	PUNCT
dpc-4338	273	1	2013	2013	NUM
dpc-4338	273	2	feb;131(2):300	feb;131(2):300	ADJ
dpc-4338	273	3	-	-	PUNCT
dpc-4338	273	4	13	13	NUM
dpc-4338	273	5	.	.	PUNCT
dpc-4338	274	1	doi	doi	NOUN
dpc-4338	274	2	:	:	PUNCT
dpc-4338	274	3	10.1016	10.1016	NUM
dpc-4338	274	4	/	/	SYM
dpc-4338	274	5	j.jaci.2012.06.048	j.jaci.2012.06.048	PROPN
dpc-4338	274	6	.	.	PUNCT
dpc-4338	275	1	epub	epub	PROPN
dpc-4338	275	2	2012	2012	NUM
dpc-4338	275	3	aug	aug	PROPN
dpc-4338	275	4	28	28	NUM
dpc-4338	275	5	.	.	PUNCT
dpc-4338	276	1	pmid	pmid	NOUN
dpc-4338	276	2	:	:	PUNCT
dpc-4338	276	3	22939651	22939651	NUM
dpc-4338	276	4	;	;	PUNCT
dpc-4338	276	5	pmcid	pmcid	ADJ
dpc-4338	276	6	:	:	PUNCT
dpc-4338	276	7	pmc4281264	pmc4281264	NOUN
dpc-4338	276	8	.	.	PUNCT
dpc-4338	277	1	4	4	X
dpc-4338	277	2	.	.	X
dpc-4338	277	3	clark	clark	PROPN
dpc-4338	277	4	sc	sc	PROPN
dpc-4338	277	5	,	,	PUNCT
dpc-4338	277	6	zirwas	zirwas	PROPN
dpc-4338	277	7	mj	mj	PROPN
dpc-4338	277	8	.	.	PUNCT
dpc-4338	277	9	management	management	PROPN
dpc-4338	277	10	of	of	ADP
dpc-4338	277	11	occupational	occupational	ADJ
dpc-4338	277	12	dermatitis	dermatitis	NOUN
dpc-4338	277	13	.	.	PUNCT
dpc-4338	278	1	dermatol	dermatol	PROPN
dpc-4338	278	2	clin	clin	PROPN
dpc-4338	278	3	.	.	PUNCT
dpc-4338	279	1	2009	2009	NUM
dpc-4338	279	2	jul;27(3):365	jul;27(3):365	PROPN
dpc-4338	279	3	-	-	PUNCT
dpc-4338	279	4	83	83	NUM
dpc-4338	279	5	,	,	PUNCT
dpc-4338	279	6	vii	vii	PROPN
dpc-4338	279	7	-	-	PUNCT
dpc-4338	279	8	viii	viii	NOUN
dpc-4338	279	9	.	.	PUNCT
dpc-4338	280	1	doi	doi	NOUN
dpc-4338	280	2	:	:	PUNCT
dpc-4338	280	3	10.1016	10.1016	NUM
dpc-4338	280	4	/	/	SYM
dpc-4338	280	5	j.	j.	PROPN
dpc-4338	280	6	det.2009.05.002	det.2009.05.002	PROPN
dpc-4338	280	7	.	.	PUNCT
dpc-4338	281	1	pmid	pmid	NOUN
dpc-4338	281	2	:	:	PUNCT
dpc-4338	281	3	19580930	19580930	NUM
dpc-4338	281	4	.	.	PUNCT
dpc-4338	282	1	5	5	X
dpc-4338	282	2	.	.	X
dpc-4338	282	3	nosbaum	nosbaum	PROPN
dpc-4338	282	4	a	a	PROPN
dpc-4338	282	5	,	,	PUNCT
dpc-4338	282	6	vocanson	vocanson	NOUN
dpc-4338	282	7	m	m	PROPN
dpc-4338	282	8	,	,	PUNCT
dpc-4338	282	9	rozieres	roziere	VERB
dpc-4338	282	10	a	a	PRON
dpc-4338	282	11	,	,	PUNCT
dpc-4338	282	12	hennino	hennino	PROPN
dpc-4338	282	13	a	a	PROPN
dpc-4338	282	14	,	,	PUNCT
dpc-4338	282	15	nicolas	nicolas	PROPN
dpc-4338	282	16	jf	jf	PROPN
dpc-4338	282	17	.	.	PROPN
dpc-4338	282	18	allergic	allergic	PROPN
dpc-4338	282	19	and	and	CCONJ
dpc-4338	282	20	irritant	irritant	VERB
dpc-4338	282	21	contact	contact	NOUN
dpc-4338	282	22	dermatitis	dermatitis	NOUN
dpc-4338	282	23	.	.	PUNCT
dpc-4338	283	1	eur	eur	PROPN
dpc-4338	283	2	j	j	PROPN
dpc-4338	283	3	dermatol	dermatol	NOUN
dpc-4338	283	4	.	.	PUNCT
dpc-4338	284	1	2009	2009	NUM
dpc-4338	284	2	jul	jul	PROPN
dpc-4338	284	3	-	-	PUNCT
dpc-4338	284	4	aug;19(4):325	aug;19(4):325	PROPN
dpc-4338	284	5	-	-	PUNCT
dpc-4338	284	6	32	32	NUM
dpc-4338	284	7	.	.	PUNCT
dpc-4338	285	1	doi	doi	NOUN
dpc-4338	285	2	:	:	PUNCT
dpc-4338	285	3	10.1684	10.1684	NUM
dpc-4338	285	4	/	/	SYM
dpc-4338	285	5	ejd.2009.0686	ejd.2009.0686	PROPN
dpc-4338	285	6	.	.	PUNCT
dpc-4338	285	7	pmid	pmid	NOUN
dpc-4338	285	8	:	:	PUNCT
dpc-4338	285	9	19447733	19447733	NUM
dpc-4338	285	10	.	.	PUNCT
dpc-4338	286	1	6	6	NUM
dpc-4338	286	2	.	.	X
dpc-4338	286	3	bonneville	bonneville	PROPN
dpc-4338	286	4	m	m	PROPN
dpc-4338	286	5	,	,	PUNCT
dpc-4338	286	6	chavagnac	chavagnac	VERB
dpc-4338	286	7	c	c	PROPN
dpc-4338	286	8	,	,	PUNCT
dpc-4338	286	9	vocanson	vocanson	NOUN
dpc-4338	286	10	m	m	PROPN
dpc-4338	286	11	,	,	PUNCT
dpc-4338	286	12	et	et	PROPN
dpc-4338	286	13	al	al	PROPN
dpc-4338	286	14	.	.	PROPN
dpc-4338	287	1	skin	skin	NOUN
dpc-4338	287	2	contact	contact	NOUN
dpc-4338	287	3	irritation	irritation	NOUN
dpc-4338	287	4	conditions	condition	VERB
dpc-4338	287	5	the	the	DET
dpc-4338	287	6	development	development	NOUN
dpc-4338	287	7	and	and	CCONJ
dpc-4338	287	8	severity	severity	NOUN
dpc-4338	287	9	of	of	ADP
dpc-4338	287	10	allergic	allergic	ADJ
dpc-4338	287	11	contact	contact	NOUN
dpc-4338	287	12	dermatitis	dermatitis	NOUN
dpc-4338	287	13	.	.	PUNCT
dpc-4338	288	1	j	j	PROPN
dpc-4338	288	2	invest	invest	VERB
dpc-4338	288	3	dermatol	dermatol	NOUN
dpc-4338	288	4	.	.	PUNCT
dpc-4338	289	1	2007	2007	NUM
dpc-4338	289	2	jun;127(6):1430	jun;127(6):1430	PROPN
dpc-4338	289	3	-	-	SYM
dpc-4338	289	4	5	5	NUM
dpc-4338	289	5	.	.	PUNCT
dpc-4338	289	6	doi	doi	NOUN
dpc-4338	289	7	:	:	PUNCT
dpc-4338	289	8	10.1038	10.1038	NUM
dpc-4338	289	9	/	/	SYM
dpc-4338	289	10	sj.jid.5700726	sj.jid.5700726	NOUN
dpc-4338	289	11	.	.	PUNCT
dpc-4338	289	12	epub	epub	PROPN
dpc-4338	289	13	2007	2007	NUM
dpc-4338	289	14	feb	feb	NOUN
dpc-4338	289	15	1	1	NUM
dpc-4338	289	16	.	.	PUNCT
dpc-4338	290	1	pmid	pmid	NOUN
dpc-4338	290	2	:	:	PUNCT
dpc-4338	290	3	17273160	17273160	NUM
dpc-4338	290	4	.	.	PUNCT
dpc-4338	291	1	7	7	X
dpc-4338	291	2	.	.	X
dpc-4338	291	3	vocanson	vocanson	PROPN
dpc-4338	291	4	m	m	PROPN
dpc-4338	291	5	,	,	PUNCT
dpc-4338	291	6	hennino	hennino	PROPN
dpc-4338	291	7	a	a	NOUN
dpc-4338	291	8	,	,	PUNCT
dpc-4338	291	9	rozières	rozière	VERB
dpc-4338	291	10	a	a	DET
dpc-4338	291	11	,	,	PUNCT
dpc-4338	291	12	poyet	poyet	NOUN
dpc-4338	291	13	g	g	NOUN
dpc-4338	291	14	,	,	PUNCT
dpc-4338	291	15	nicolas	nicolas	PROPN
dpc-4338	291	16	jf	jf	PROPN
dpc-4338	291	17	.	.	PROPN
dpc-4338	291	18	effector	effector	PROPN
dpc-4338	291	19	and	and	CCONJ
dpc-4338	291	20	regulatory	regulatory	ADJ
dpc-4338	291	21	mechanisms	mechanism	NOUN
dpc-4338	291	22	in	in	ADP
dpc-4338	291	23	allergic	allergic	ADJ
dpc-4338	291	24	contact	contact	NOUN
dpc-4338	291	25	dermatitis	dermatitis	NOUN
dpc-4338	291	26	.	.	PUNCT
dpc-4338	292	1	allergy	allergy	NOUN
dpc-4338	292	2	.	.	PUNCT
dpc-4338	293	1	2009	2009	NUM
dpc-4338	293	2	dec;64(12):1699	dec;64(12):1699	NOUN
dpc-4338	293	3	-	-	PUNCT
dpc-4338	293	4	714	714	NUM
dpc-4338	293	5	.	.	PUNCT
dpc-4338	294	1	doi	doi	NOUN
dpc-4338	294	2	:	:	PUNCT
dpc-4338	294	3	10.1111	10.1111	NUM
dpc-4338	294	4	/	/	SYM
dpc-4338	294	5	j.1398	j.1398	PROPN
dpc-4338	294	6	-	-	NOUN
dpc-4338	294	7	9995.2009.02082.x	9995.2009.02082.x	NUM
dpc-4338	294	8	.	.	PUNCT
dpc-4338	295	1	epub	epub	NOUN
dpc-4338	295	2	2009	2009	NUM
dpc-4338	295	3	oct	oct	NOUN
dpc-4338	295	4	12	12	NUM
dpc-4338	295	5	.	.	PUNCT
dpc-4338	296	1	pmid	pmid	NOUN
dpc-4338	296	2	:	:	PUNCT
dpc-4338	296	3	19839974	19839974	NUM
dpc-4338	296	4	.	.	PUNCT
dpc-4338	297	1	8	8	X
dpc-4338	297	2	.	.	X
dpc-4338	297	3	dasilva	dasilva	PROPN
dpc-4338	297	4	sc	sc	PROPN
dpc-4338	297	5	,	,	PUNCT
dpc-4338	297	6	sahu	sahu	PROPN
dpc-4338	297	7	rp	rp	PROPN
dpc-4338	297	8	,	,	PUNCT
dpc-4338	297	9	konger	konger	PROPN
dpc-4338	297	10	rl	rl	PROPN
dpc-4338	297	11	,	,	PUNCT
dpc-4338	297	12	perkins	perkins	PROPN
dpc-4338	297	13	sm	sm	PROPN
dpc-4338	297	14	,	,	PUNCT
dpc-4338	297	15	kaplan	kaplan	PROPN
dpc-4338	297	16	mh	mh	PROPN
dpc-4338	297	17	,	,	PUNCT
dpc-4338	297	18	travers	travers	PROPN
dpc-4338	297	19	jb	jb	PROPN
dpc-4338	297	20	.	.	PROPN
dpc-4338	297	21	increased	increase	VERB
dpc-4338	297	22	skin	skin	NOUN
dpc-4338	297	23	barrier	barrier	NOUN
dpc-4338	297	24	disruption	disruption	NOUN
dpc-4338	297	25	by	by	ADP
dpc-4338	297	26	sodium	sodium	NOUN
dpc-4338	297	27	lauryl	lauryl	NOUN
dpc-4338	297	28	sulfate	sulfate	NOUN
dpc-4338	297	29	in	in	ADP
dpc-4338	297	30	mice	mouse	NOUN
dpc-4338	297	31	expressing	express	VERB
dpc-4338	297	32	a	a	DET
dpc-4338	297	33	constitutively	constitutively	ADV
dpc-4338	297	34	active	active	ADJ
dpc-4338	297	35	stat6	stat6	NOUN
dpc-4338	297	36	in	in	ADP
dpc-4338	297	37	t	t	PROPN
dpc-4338	297	38	cells	cell	NOUN
dpc-4338	297	39	.	.	PUNCT
dpc-4338	298	1	arch	arch	ADJ
dpc-4338	298	2	dermatol	dermatol	NOUN
dpc-4338	298	3	res	re	NOUN
dpc-4338	298	4	.	.	PROPN
dpc-4338	298	5	2012	2012	NUM
dpc-4338	298	6	jan;304(1):65	jan;304(1):65	NOUN
dpc-4338	298	7	-	-	PUNCT
dpc-4338	298	8	71	71	NUM
dpc-4338	298	9	.	.	PUNCT
dpc-4338	299	1	doi	doi	NOUN
dpc-4338	299	2	:	:	PUNCT
dpc-4338	299	3	10.1007/	10.1007/	NUM
dpc-4338	299	4	s00403	s00403	PROPN
dpc-4338	299	5	-	-	PUNCT
dpc-4338	299	6	011	011	NUM
dpc-4338	299	7	-	-	PUNCT
dpc-4338	299	8	1168	1168	NUM
dpc-4338	299	9	-	-	SYM
dpc-4338	299	10	2	2	NUM
dpc-4338	299	11	.	.	PUNCT
dpc-4338	300	1	epub	epub	NOUN
dpc-4338	300	2	2011	2011	NUM
dpc-4338	300	3	sep	sep	PROPN
dpc-4338	300	4	30	30	NUM
dpc-4338	300	5	.	.	PUNCT
dpc-4338	301	1	pmid	pmid	NOUN
dpc-4338	301	2	:	:	PUNCT
dpc-4338	301	3	21959772	21959772	NUM
dpc-4338	301	4	;	;	PUNCT
dpc-4338	301	5	pmcid	pmcid	ADJ
dpc-4338	301	6	:	:	PUNCT
dpc-4338	301	7	pmc3249512	pmc3249512	ADJ
dpc-4338	301	8	.	.	PUNCT
dpc-4338	302	1	9	9	X
dpc-4338	302	2	.	.	X
dpc-4338	302	3	fu	fu	PROPN
dpc-4338	302	4	k	k	PROPN
dpc-4338	302	5	,	,	PUNCT
dpc-4338	302	6	qu	qu	PROPN
dpc-4338	302	7	l	l	PROPN
dpc-4338	302	8	,	,	PUNCT
dpc-4338	302	9	shimada	shimada	PROPN
dpc-4338	302	10	sg	sg	PROPN
dpc-4338	302	11	,	,	PUNCT
dpc-4338	302	12	nie	nie	PROPN
dpc-4338	302	13	h	h	PROPN
dpc-4338	302	14	,	,	PUNCT
dpc-4338	302	15	lamotte	lamotte	PROPN
dpc-4338	302	16	rh	rh	PROPN
dpc-4338	302	17	.	.	PROPN
dpc-4338	302	18	enhanced	enhance	VERB
dpc-4338	302	19	scratching	scratching	NOUN
dpc-4338	302	20	elicited	elicit	VERB
dpc-4338	302	21	by	by	ADP
dpc-4338	302	22	a	a	DET
dpc-4338	302	23	pruritogen	pruritogen	NOUN
dpc-4338	302	24	and	and	CCONJ
dpc-4338	302	25	an	an	DET
dpc-4338	302	26	algogen	algogen	NOUN
dpc-4338	302	27	in	in	ADP
dpc-4338	302	28	a	a	DET
dpc-4338	302	29	mouse	mouse	NOUN
dpc-4338	302	30	model	model	NOUN
dpc-4338	302	31	of	of	ADP
dpc-4338	302	32	contact	contact	NOUN
dpc-4338	302	33	hypersensitivity	hypersensitivity	NOUN
dpc-4338	302	34	.	.	PUNCT
dpc-4338	303	1	neurosci	neurosci	PROPN
dpc-4338	303	2	lett	lett	PROPN
dpc-4338	303	3	.	.	PUNCT
dpc-4338	304	1	2014	2014	NUM
dpc-4338	304	2	sep	sep	PROPN
dpc-4338	304	3	5;579:190	5;579:190	NUM
dpc-4338	304	4	-	-	PUNCT
dpc-4338	304	5	4	4	NUM
dpc-4338	304	6	.	.	PUNCT
dpc-4338	304	7	doi	doi	NOUN
dpc-4338	304	8	:	:	PUNCT
dpc-4338	304	9	10.1016	10.1016	NUM
dpc-4338	304	10	/	/	SYM
dpc-4338	304	11	j.neulet.2014.03.062	j.neulet.2014.03.062	PROPN
dpc-4338	304	12	.	.	PUNCT
dpc-4338	305	1	epub	epub	PROPN
dpc-4338	305	2	2014	2014	NUM
dpc-4338	305	3	apr	apr	NOUN
dpc-4338	305	4	3	3	NUM
dpc-4338	305	5	.	.	PUNCT
dpc-4338	306	1	pmid	pmid	NOUN
dpc-4338	306	2	:	:	PUNCT
dpc-4338	306	3	24704378	24704378	NUM
dpc-4338	306	4	;	;	PUNCT
dpc-4338	306	5	pmcid	pmcid	NOUN
dpc-4338	306	6	:	:	PUNCT
dpc-4338	306	7	pmc4138274	pmc4138274	NOUN
dpc-4338	306	8	.	.	PUNCT
dpc-4338	307	1	10	10	NUM
dpc-4338	307	2	.	.	PUNCT
dpc-4338	308	1	martin	martin	PROPN
dpc-4338	308	2	sf	sf	PROPN
dpc-4338	308	3	,	,	PUNCT
dpc-4338	308	4	esser	esser	NOUN
dpc-4338	308	5	pr	pr	NOUN
dpc-4338	308	6	,	,	PUNCT
dpc-4338	308	7	schmucker	schmucker	PROPN
dpc-4338	308	8	s	s	PROPN
dpc-4338	308	9	,	,	PUNCT
dpc-4338	308	10	et	et	PROPN
dpc-4338	308	11	al	al	PROPN
dpc-4338	308	12	.	.	PROPN
dpc-4338	308	13	t	t	PROPN
dpc-4338	308	14	-	-	PUNCT
dpc-4338	308	15	cell	cell	NOUN
dpc-4338	308	16	recognition	recognition	NOUN
dpc-4338	308	17	of	of	ADP
dpc-4338	308	18	chemicals	chemical	NOUN
dpc-4338	308	19	,	,	PUNCT
dpc-4338	308	20	protein	protein	NOUN
dpc-4338	308	21	allergens	allergen	NOUN
dpc-4338	308	22	and	and	CCONJ
dpc-4338	308	23	drugs	drug	NOUN
dpc-4338	308	24	:	:	PUNCT
dpc-4338	308	25	towards	towards	ADP
dpc-4338	308	26	the	the	DET
dpc-4338	308	27	development	development	NOUN
dpc-4338	308	28	of	of	ADP
dpc-4338	308	29	in	in	ADP
dpc-4338	308	30	vitro	vitro	X
dpc-4338	308	31	assays	assay	NOUN
dpc-4338	308	32	.	.	PUNCT
dpc-4338	309	1	cell	cell	NOUN
dpc-4338	309	2	mol	mol	ADP
dpc-4338	309	3	life	life	PROPN
dpc-4338	309	4	sci	sci	PROPN
dpc-4338	309	5	.	.	PROPN
dpc-4338	309	6	2010	2010	NUM
dpc-4338	309	7	dec;67(24):4171	dec;67(24):4171	NOUN
dpc-4338	309	8	-	-	PUNCT
dpc-4338	309	9	84	84	NUM
dpc-4338	309	10	.	.	PUNCT
dpc-4338	310	1	doi	doi	NOUN
dpc-4338	310	2	:	:	PUNCT
dpc-4338	310	3	10.1007	10.1007	NUM
dpc-4338	310	4	/	/	SYM
dpc-4338	310	5	s00018	s00018	NOUN
dpc-4338	310	6	-	-	PUNCT
dpc-4338	310	7	010	010	NUM
dpc-4338	310	8	-	-	PUNCT
dpc-4338	310	9	0495	0495	NUM
dpc-4338	310	10	-	-	PUNCT
dpc-4338	310	11	3	3	NUM
dpc-4338	310	12	.	.	PUNCT
dpc-4338	311	1	epub	epub	PROPN
dpc-4338	311	2	2010	2010	NUM
dpc-4338	311	3	aug	aug	PROPN
dpc-4338	311	4	18	18	NUM
dpc-4338	311	5	.	.	PUNCT
dpc-4338	312	1	pmid	pmid	NOUN
dpc-4338	312	2	:	:	PUNCT
dpc-4338	312	3	20717835	20717835	NUM
dpc-4338	312	4	.	.	PUNCT
dpc-4338	313	1	11	11	NUM
dpc-4338	313	2	.	.	PUNCT
dpc-4338	314	1	kaplan	kaplan	PROPN
dpc-4338	314	2	dh	dh	PROPN
dpc-4338	314	3	,	,	PUNCT
dpc-4338	314	4	igyártó	igyártó	PROPN
dpc-4338	314	5	bz	bz	PROPN
dpc-4338	314	6	,	,	PUNCT
dpc-4338	314	7	gaspari	gaspari	PROPN
dpc-4338	314	8	aa	aa	PROPN
dpc-4338	314	9	.	.	PUNCT
dpc-4338	315	1	early	early	ADJ
dpc-4338	315	2	immune	immune	ADJ
dpc-4338	315	3	events	event	NOUN
dpc-4338	315	4	in	in	ADP
dpc-4338	315	5	the	the	DET
dpc-4338	315	6	induction	induction	NOUN
dpc-4338	315	7	of	of	ADP
dpc-4338	315	8	allergic	allergic	ADJ
dpc-4338	315	9	contact	contact	NOUN
dpc-4338	315	10	dermatitis	dermatitis	NOUN
dpc-4338	315	11	.	.	PUNCT
dpc-4338	316	1	nat	nat	PROPN
dpc-4338	316	2	rev	rev	PROPN
dpc-4338	316	3	immunol	immunol	NOUN
dpc-4338	316	4	.	.	PUNCT
dpc-4338	317	1	2012	2012	NUM
dpc-4338	317	2	jan	jan	PROPN
dpc-4338	317	3	13;12(2):114	13;12(2):114	NUM
dpc-4338	317	4	-	-	SYM
dpc-4338	317	5	24	24	NUM
dpc-4338	317	6	.	.	PUNCT
dpc-4338	317	7	doi	doi	NOUN
dpc-4338	317	8	:	:	PUNCT
dpc-4338	317	9	10.1038	10.1038	NUM
dpc-4338	317	10	/	/	SYM
dpc-4338	317	11	nri3150	nri3150	NOUN
dpc-4338	317	12	.	.	PUNCT
dpc-4338	318	1	pmid	pmid	NOUN
dpc-4338	318	2	:	:	PUNCT
dpc-4338	318	3	22240625	22240625	NUM
dpc-4338	318	4	;	;	PUNCT
dpc-4338	318	5	pmcid	pmcid	PROPN
dpc-4338	318	6	:	:	PUNCT
dpc-4338	318	7	pmc3578582	pmc3578582	PROPN
dpc-4338	318	8	.	.	PUNCT
dpc-4338	319	1	12	12	NUM
dpc-4338	319	2	.	.	PUNCT
dpc-4338	320	1	martin	martin	PROPN
dpc-4338	320	2	sf	sf	PROPN
dpc-4338	320	3	.	.	PROPN
dpc-4338	320	4	contact	contact	PROPN
dpc-4338	320	5	dermatitis	dermatitis	PROPN
dpc-4338	320	6	:	:	PUNCT
dpc-4338	320	7	from	from	ADP
dpc-4338	320	8	pathomechanisms	pathomechanism	NOUN
dpc-4338	320	9	to	to	ADP
dpc-4338	320	10	immunotoxicology	immunotoxicology	NOUN
dpc-4338	320	11	.	.	PUNCT
dpc-4338	321	1	exp	exp	NOUN
dpc-4338	321	2	dermatol	dermatol	NOUN
dpc-4338	321	3	.	.	PUNCT
dpc-4338	322	1	2012	2012	NUM
dpc-4338	322	2	may;21(5):382	may;21(5):382	NOUN
dpc-4338	322	3	-	-	PUNCT
dpc-4338	322	4	9	9	NUM
dpc-4338	322	5	.	.	PUNCT
dpc-4338	322	6	doi	doi	NOUN
dpc-4338	322	7	:	:	PUNCT
dpc-4338	322	8	10.1111	10.1111	NUM
dpc-4338	322	9	/	/	SYM
dpc-4338	322	10	j.1600	j.1600	PROPN
dpc-4338	322	11	-	-	PUNCT
dpc-4338	322	12	0625.2012.01471.x	0625.2012.01471.x	PROPN
dpc-4338	322	13	.	.	PUNCT
dpc-4338	323	1	pmid	pmid	NOUN
dpc-4338	323	2	:	:	PUNCT
dpc-4338	323	3	22509837	22509837	NUM
dpc-4338	323	4	.	.	PUNCT
dpc-4338	324	1	13	13	NUM
dpc-4338	324	2	.	.	PUNCT
dpc-4338	325	1	johansen	johansen	PROPN
dpc-4338	325	2	jd	jd	PROPN
dpc-4338	325	3	,	,	PUNCT
dpc-4338	325	4	aalto	aalto	PROPN
dpc-4338	325	5	-	-	PUNCT
dpc-4338	325	6	korte	korte	PROPN
dpc-4338	325	7	k	k	PROPN
dpc-4338	325	8	,	,	PUNCT
dpc-4338	325	9	agner	agner	PROPN
dpc-4338	325	10	t	t	PROPN
dpc-4338	325	11	,	,	PUNCT
dpc-4338	325	12	et	et	PROPN
dpc-4338	325	13	al	al	PROPN
dpc-4338	325	14	.	.	PUNCT
dpc-4338	325	15	european	european	PROPN
dpc-4338	325	16	society	society	PROPN
dpc-4338	325	17	of	of	ADP
dpc-4338	325	18	contact	contact	NOUN
dpc-4338	325	19	dermatitis	dermatitis	NOUN
dpc-4338	325	20	guideline	guideline	NOUN
dpc-4338	325	21	for	for	ADP
dpc-4338	325	22	diagnostic	diagnostic	ADJ
dpc-4338	325	23	patch	patch	NOUN
dpc-4338	325	24	testing	testing	NOUN
dpc-4338	325	25	recommendations	recommendation	NOUN
dpc-4338	325	26	on	on	ADP
dpc-4338	325	27	best	good	ADJ
dpc-4338	325	28	practice	practice	NOUN
dpc-4338	325	29	.	.	PUNCT
dpc-4338	326	1	contact	contact	NOUN
dpc-4338	326	2	dermatitis	dermatitis	PROPN
dpc-4338	326	3	.	.	PUNCT
dpc-4338	327	1	2015	2015	NUM
dpc-4338	327	2	oct;73(4):195	oct;73(4):195	NOUN
dpc-4338	327	3	-	-	SYM
dpc-4338	327	4	221	221	NUM
dpc-4338	327	5	.	.	PUNCT
dpc-4338	328	1	doi	doi	NOUN
dpc-4338	328	2	:	:	PUNCT
dpc-4338	328	3	10.1111	10.1111	NUM
dpc-4338	328	4	/	/	SYM
dpc-4338	328	5	cod.12432	cod.12432	PROPN
dpc-4338	328	6	.	.	PUNCT
dpc-4338	329	1	epub	epub	PROPN
dpc-4338	329	2	2015	2015	NUM
dpc-4338	329	3	jul	jul	PROPN
dpc-4338	329	4	14	14	NUM
dpc-4338	329	5	.	.	PUNCT
dpc-4338	330	1	pmid	pmid	NOUN
dpc-4338	330	2	:	:	PUNCT
dpc-4338	330	3	26179009	26179009	NUM
dpc-4338	330	4	.	.	PUNCT
dpc-4338	331	1	14	14	NUM
dpc-4338	331	2	.	.	PUNCT
dpc-4338	331	3	rustemeyer	rustemeyer	PROPN
dpc-4338	331	4	t	t	PROPN
dpc-4338	331	5	,	,	PUNCT
dpc-4338	331	6	van	van	PROPN
dpc-4338	331	7	hoogstraten	hoogstraten	VERB
dpc-4338	331	8	imw	imw	NOUN
dpc-4338	331	9	,	,	PUNCT
dpc-4338	331	10	von	von	PROPN
dpc-4338	331	11	blomberg	blomberg	PROPN
dpc-4338	331	12	bme	bme	PROPN
dpc-4338	331	13	,	,	PUNCT
dpc-4338	331	14	gibbs	gibbs	PROPN
dpc-4338	331	15	s	s	PROPN
dpc-4338	331	16	,	,	PUNCT
dpc-4338	331	17	scheper	scheper	PROPN
dpc-4338	331	18	rj	rj	PROPN
dpc-4338	331	19	.	.	PUNCT
dpc-4338	332	1	(	(	PUNCT
dpc-4338	332	2	2011	2011	NUM
dpc-4338	332	3	)	)	PUNCT
dpc-4338	332	4	.	.	PUNCT
dpc-4338	333	1	mechanisms	mechanism	NOUN
dpc-4338	333	2	of	of	ADP
dpc-4338	333	3	irritant	irritant	ADJ
dpc-4338	333	4	and	and	CCONJ
dpc-4338	333	5	allergic	allergic	ADJ
dpc-4338	333	6	contact	contact	NOUN
dpc-4338	333	7	dermatitis	dermatitis	NOUN
dpc-4338	333	8	.	.	PUNCT
dpc-4338	334	1	in	in	ADP
dpc-4338	334	2	contact	contact	NOUN
dpc-4338	334	3	dermatitis	dermatitis	NOUN
dpc-4338	334	4	(	(	PUNCT
dpc-4338	334	5	fifth	fifth	ADJ
dpc-4338	334	6	edition	edition	NOUN
dpc-4338	334	7	)	)	PUNCT
dpc-4338	334	8	(	(	PUNCT
dpc-4338	334	9	pp	pp	ADJ
dpc-4338	334	10	.	.	PUNCT
dpc-4338	335	1	43	43	NUM
dpc-4338	335	2	-	-	SYM
dpc-4338	335	3	90	90	NUM
dpc-4338	335	4	)	)	PUNCT
dpc-4338	335	5	.	.	PUNCT
dpc-4338	336	1	springer	springer	PROPN
dpc-4338	336	2	berlin	berlin	PROPN
dpc-4338	336	3	heidelberg	heidelberg	PROPN
dpc-4338	336	4	.	.	PUNCT
dpc-4338	337	1	https://doi	https://doi	PROPN
dpc-4338	337	2	.	.	PUNCT
dpc-4338	337	3	org/10.1007/978	org/10.1007/978	PROPN
dpc-4338	337	4	-	-	PUNCT
dpc-4338	337	5	3	3	NUM
dpc-4338	337	6	-	-	PUNCT
dpc-4338	337	7	642	642	NUM
dpc-4338	337	8	-	-	PUNCT
dpc-4338	337	9	03827	03827	NUM
dpc-4338	337	10	-	-	PUNCT
dpc-4338	337	11	3_3	3_3	NUM
dpc-4338	337	12	original	original	ADJ
dpc-4338	337	13	article	article	NOUN
dpc-4338	337	14	|	|	ADV
dpc-4338	337	15	dermatol	dermatol	ADJ
dpc-4338	337	16	pract	pract	NOUN
dpc-4338	337	17	concept	concept	NOUN
dpc-4338	337	18	.	.	PUNCT
dpc-4338	338	1	2024;14(4):e2024231	2024;14(4):e2024231	NUM
dpc-4338	338	2	9	9	NUM
dpc-4338	338	3	doi	doi	NOUN
dpc-4338	338	4	:	:	PUNCT
dpc-4338	338	5	10.3390	10.3390	NUM
dpc-4338	338	6	/	/	SYM
dpc-4338	338	7	cancers13112596	cancers13112596	PROPN
dpc-4338	338	8	.	.	PUNCT
dpc-4338	339	1	pmid	pmid	NOUN
dpc-4338	339	2	:	:	PUNCT
dpc-4338	339	3	34073193	34073193	NUM
dpc-4338	339	4	;	;	PUNCT
dpc-4338	339	5	pmcid	pmcid	ADJ
dpc-4338	339	6	:	:	PUNCT
dpc-4338	339	7	pmc8199239	pmc8199239	NOUN
dpc-4338	339	8	.	.	PUNCT
dpc-4338	340	1	31	31	NUM
dpc-4338	340	2	.	.	PUNCT
dpc-4338	341	1	kotroni	kotroni	PROPN
dpc-4338	341	2	e	e	PROPN
dpc-4338	341	3	,	,	PUNCT
dpc-4338	341	4	simirioti	simirioti	ADJ
dpc-4338	341	5	e	e	PROPN
dpc-4338	341	6	,	,	PUNCT
dpc-4338	341	7	kikionis	kikionis	PROPN
dpc-4338	341	8	s	s	PROPN
dpc-4338	341	9	,	,	PUNCT
dpc-4338	341	10	et	et	PROPN
dpc-4338	341	11	al	al	PROPN
dpc-4338	341	12	.	.	PROPN
dpc-4338	342	1	in	in	ADP
dpc-4338	342	2	vivo	vivo	ADJ
dpc-4338	342	3	evaluation	evaluation	NOUN
dpc-4338	342	4	of	of	ADP
dpc-4338	342	5	the	the	DET
dpc-4338	342	6	anti	anti	ADJ
dpc-4338	342	7	-	-	ADJ
dpc-4338	342	8	inflammatory	inflammatory	ADJ
dpc-4338	342	9	activity	activity	NOUN
dpc-4338	342	10	of	of	ADP
dpc-4338	342	11	electrospun	electrospun	PROPN
dpc-4338	342	12	micro	micro	PROPN
dpc-4338	342	13	/	/	SYM
dpc-4338	342	14	nanofibrous	nanofibrous	ADJ
dpc-4338	342	15	patches	patch	NOUN
dpc-4338	342	16	loaded	load	VERB
dpc-4338	342	17	with	with	ADP
dpc-4338	342	18	pinus	pinus	NOUN
dpc-4338	342	19	halepensis	halepensis	NOUN
dpc-4338	342	20	bark	bark	NOUN
dpc-4338	342	21	extract	extract	NOUN
dpc-4338	342	22	on	on	ADP
dpc-4338	342	23	hairless	hairless	ADJ
dpc-4338	342	24	mice	mouse	NOUN
dpc-4338	342	25	skin	skin	NOUN
dpc-4338	342	26	.	.	PUNCT
dpc-4338	343	1	materials	material	NOUN
dpc-4338	343	2	(	(	PUNCT
dpc-4338	343	3	basel	basel	PROPN
dpc-4338	343	4	)	)	PUNCT
dpc-4338	343	5	.	.	PUNCT
dpc-4338	344	1	2019	2019	NUM
dpc-4338	344	2	aug	aug	PROPN
dpc-4338	344	3	15;12(16):2596	15;12(16):2596	NUM
dpc-4338	344	4	.	.	PUNCT
dpc-4338	344	5	doi	doi	NOUN
dpc-4338	344	6	:	:	PUNCT
dpc-4338	344	7	10.3390	10.3390	NUM
dpc-4338	344	8	/	/	SYM
dpc-4338	344	9	ma12162596	ma12162596	NOUN
dpc-4338	344	10	.	.	PUNCT
dpc-4338	345	1	pmid	pmid	NOUN
dpc-4338	345	2	:	:	PUNCT
dpc-4338	345	3	31443178	31443178	NUM
dpc-4338	345	4	;	;	PUNCT
dpc-4338	345	5	pmcid	pmcid	ADJ
dpc-4338	345	6	:	:	PUNCT
dpc-4338	345	7	pmc6720688	pmc6720688	NOUN
dpc-4338	345	8	.	.	PUNCT
dpc-4338	346	1	29	29	NUM
dpc-4338	346	2	.	.	PUNCT
dpc-4338	347	1	das	das	PROPN
dpc-4338	347	2	kk	kk	PROPN
dpc-4338	347	3	,	,	PUNCT
dpc-4338	347	4	dasgupta	dasgupta	PROPN
dpc-4338	347	5	s.	s.	PROPN
dpc-4338	347	6	effect	effect	NOUN
dpc-4338	347	7	of	of	ADP
dpc-4338	347	8	nickel	nickel	NOUN
dpc-4338	347	9	on	on	ADP
dpc-4338	347	10	testicular	testicular	ADJ
dpc-4338	347	11	nucleic	nucleic	ADJ
dpc-4338	347	12	acid	acid	NOUN
dpc-4338	347	13	concentrations	concentration	NOUN
dpc-4338	347	14	of	of	ADP
dpc-4338	347	15	rats	rat	NOUN
dpc-4338	347	16	on	on	ADP
dpc-4338	347	17	protein	protein	NOUN
dpc-4338	347	18	restriction	restriction	NOUN
dpc-4338	347	19	.	.	PUNCT
dpc-4338	348	1	biol	biol	PROPN
dpc-4338	348	2	trace	trace	NOUN
dpc-4338	348	3	elem	elem	NOUN
dpc-4338	348	4	res	re	NOUN
dpc-4338	348	5	.	.	PUNCT
dpc-4338	348	6	2000	2000	NUM
dpc-4338	348	7	feb;73(2):175	feb;73(2):175	PROPN
dpc-4338	348	8	-	-	PUNCT
dpc-4338	348	9	80	80	NUM
dpc-4338	348	10	.	.	PUNCT
dpc-4338	349	1	doi	doi	NOUN
dpc-4338	349	2	:	:	PUNCT
dpc-4338	349	3	10.1385	10.1385	NUM
dpc-4338	349	4	/	/	SYM
dpc-4338	349	5	bter:73:2:175	bter:73:2:175	PROPN
dpc-4338	349	6	.	.	PUNCT
dpc-4338	350	1	pmid	pmid	NOUN
dpc-4338	350	2	:	:	PUNCT
dpc-4338	350	3	11049209	11049209	NUM
dpc-4338	350	4	.	.	PUNCT
dpc-4338	351	1	30	30	NUM
dpc-4338	351	2	.	.	PUNCT
dpc-4338	352	1	kyritsi	kyritsi	PROPN
dpc-4338	352	2	a	a	PROPN
dpc-4338	352	3	,	,	PUNCT
dpc-4338	352	4	kikionis	kikionis	PROPN
dpc-4338	352	5	s	s	PROPN
dpc-4338	352	6	,	,	PUNCT
dpc-4338	352	7	tagka	tagka	PROPN
dpc-4338	352	8	a	a	X
dpc-4338	352	9	,	,	PUNCT
dpc-4338	353	1	et	et	PROPN
dpc-4338	353	2	al	al	PROPN
dpc-4338	353	3	.	.	PUNCT
dpc-4338	353	4	management	management	NOUN
dpc-4338	353	5	of	of	ADP
dpc-4338	353	6	acute	acute	PROPN
dpc-4338	353	7	radiodermatitis	radiodermatitis	PROPN
dpc-4338	353	8	in	in	ADP
dpc-4338	353	9	non	non	ADJ
dpc-4338	353	10	-	-	ADJ
dpc-4338	353	11	melanoma	melanoma	ADJ
dpc-4338	353	12	skin	skin	NOUN
dpc-4338	353	13	cancer	cancer	NOUN
dpc-4338	353	14	patients	patient	NOUN
dpc-4338	353	15	using	use	VERB
dpc-4338	353	16	electrospun	electrospun	NOUN
dpc-4338	353	17	nanofibrous	nanofibrous	ADJ
dpc-4338	353	18	patches	patch	NOUN
dpc-4338	353	19	loaded	load	VERB
dpc-4338	353	20	with	with	ADP
dpc-4338	353	21	pinus	pinus	NOUN
dpc-4338	353	22	halepensis	halepensis	NOUN
dpc-4338	353	23	bark	bark	NOUN
dpc-4338	353	24	extract	extract	NOUN
dpc-4338	353	25	.	.	PUNCT
dpc-4338	354	1	cancers	cancer	NOUN
dpc-4338	354	2	(	(	PUNCT
dpc-4338	354	3	basel	basel	PROPN
dpc-4338	354	4	)	)	PUNCT
dpc-4338	354	5	.	.	PUNCT
dpc-4338	355	1	2021	2021	NUM
dpc-4338	355	2	may	may	AUX
dpc-4338	355	3	26;13(11):2596	26;13(11):2596	NUM
dpc-4338	355	4	.	.	PUNCT